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Abstract 
A major challenge to the clinical success of cell-based tissue engineering strategies is 
the ability to obtain sufficient numbers of cells within an acceptable time frame. The 
expansion of cells on microcarriers within spinner flask bioreactor has shown promise 
in meeting that challenge. Spinner flask microcarrier technology is space-saving and 
media utilisation efficient. However, further optimisation in terms of, for example, 
seeding efficiency, expansion rates and harvest efficiency is necessary to realise the 
clinical potential of this technology. The present work is designed to improve cell 
expansion rates. It involves investigation of microcarrier composition and surface 
structure and spinner flask shear stress on cell growth. 
BMSC growth on PHBV microcarriers was superior to PCL and PLGA microcarriers 
and comparable to Cytodex 1 microcarriers. Lower density PHBV microcarriers showed 
promise as a superior alternative to Cytodex 1. Two different impeller designs 
employed in the w/o/w method of microcarrier synthesis resulted in smoother and 
rougher PCL microcarriers with Ra = 1.77 ± 0.42 µm to 6.4 ± 1.48 µm respectively. 
Superior BMSC growth was observed on the rougher PCL microcarriers. Differentiation 
potential along the osteogenic and adipogenic lineages of BMSCs expanded on the 
microcarrier types was retained. 
Particle Image Velocimetry was used to quantify shear stress within a spinner flask 
bioreactor. It was found that 80% of the shear stress was localised within the impeller 
region which occupied 55% of the bioreactor working volume. Shear stress increased as 
Cytodex 1 microcarrier concentration and impeller rotational speed increased. Superior 
BMSC growth rates on microcarriers were observed for the lowest shear stress 
experimental group (3.4 x 10
-3
 N/m
2
 ≤ impeller region mean shear stress ≤ 4.6 x 10-3 
N/m
2
) as compared to the three higher shear stress groups (5.5 x 10
-3
 N/m
2
 ≤ mean shear 
stress ≤ 1.3 x 10-2 N/m2). Expanded BMSCs on the cytodex 1 microcarriers retained 
multipotentiality for the range of shear stresses investigated. 
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Nomenclature 
2D  Two-dimensional 
3D  Three-dimensional 
BMSC  Bone Marrow Stromal Cells 
DMEM Dulbecco’s Modified Eagle’s Medium 
ES cells Embryonic Stem cells 
EPC  Endothelial Progenitor Cells 
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FTIR  Fourier Transform InfraRed 
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1 Literature Review 
1.1 Introduction 
Over a decade ago, there was great excitement about the future impact of tissue 
engineering (Cao et al. 1997; Fischman 1999; Langer and Vacanti 1999; Jacobs 2001), 
which was a field that was initiated barely a dozen years earlier (Skalak and Fox 1988). 
This multidisciplinary science promises to regenerate damaged/diseased tissues and 
organs, and reduce the US$800 billion healthcare costs associated with Americans 
suffering from tissue loss or end-stage organ failure (Langer and Vacanti 1993). Whilst 
significant advancements have been made in tissue engineering (Muschler et al. 2004), 
there are scarce examples of human application (Horwitz et al. 2002). Next to the issue 
of cell survival (Meijer et al. 2007), a major challenge to the clinical success of cell-
based tissue engineering strategies is the ability to obtain sufficient numbers of cells 
within an acceptable time frame (Vacanti 2006) with minimal handling, reproducibility 
and better online monitoring of the culture process. This thesis investigates the 
expansion of cells on microcarriers, and in particular, explores the effect of microcarrier 
composition and surface structure on cell growth, and shear stress on cell growth within 
a spinner flask bioreactor. 
1.2 Stem Cells 
“It is the great prerogative of Mankind above other Creatures, that we are not only able 
to behold the works of Nature, or barely to sustain our lives by them, but we have also 
the power of considering, comparing, altering, assisting, and improving them to various 
uses.” This is the opening line to the book, “Micrographia” (Hooke 1667) by English 
scientist, Robert Hooke, who first coined the term, “cell”. It is intriguing that this line 
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from the 17
th
 century perfectly describes how the global scientific community functions 
today. The cell, in particular, stem cells, evokes such public dialogue, religious debate, 
political drama and perhaps most importantly, medical determination. 
Stem cells possess the ability to self-renew and make at least one identical copy of itself 
(Till et al. 1964). They have the ability to differentiate or form other cell types. Stem 
cells may be divided into two groups: embryonic and adult (somatic) stem cells (Melton 
and Cowan 2004). Embryonic stem cells are derived from the embryo and can give rise 
to progeny from all three germ layers (endoderm, mesoderm and ectoderm) (Melton and 
Cowan 2004). Adult stem cells are undifferentiated stem cells which reside in 
differentiated tissues which are responsible for the growth, tissue maintenance and 
regeneration of diseased or damaged tissue (Melton and Cowan 2004). Alternatively, 
stem cells may be divided on the basis of potency (toti-, pluri-, multi-, uni-), which will 
be discussed in the next section. 
1.2.1 Stem Cell Hierarchy 
The stem cell hierarchy consists of the following in decreasing order of differentiation 
potential: totipotent stem cells, pluripotent stem cells, multipotent stem cells, unipotent 
stem cells. Totipotent stem cells have unlimited capability as they can specialise into 
extra-embryonic membranes and tissues, the embryo and all postembryonic tissues and 
organs. The fertilised oocyte (the zygote) and the descendants of the first two cell 
divisions are examples of totipotent stem cells (refer to Figure 1). The blastocyst 
contains a cluster of cells called the inner cell mass (ICM). The cells within the ICM are 
considered pluripotent and are referred to as embryonic stem cells. Pluripotent stem 
cells are capable of giving rise to most tissues of an organism, including those from the 
ectodermal, endodermal and mesodermal lineages. Pluripotent stems cells are unable to 
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give rise to the placenta and supporting tissues. Multipotent stem cells are capable of 
producing a limited range of differentiated cell lineages appropriate to their own germ 
layer, for example, bone marrow-derived stromal cells (BMSCs) and hematopoietic 
stem cells (HSCs) from the bone marrow. Unipotent stem cells, such as spermatogonial 
stem cells, form cells from a single lineage. (Alison et al. 2002; Macdonald et al. 2002; 
Jukes et al. 2008) 
 
Figure 1: The path of the embryo which is transported along the fallopian tube and then implanted 
in the uterine wall. On the right hand side of the diagram, a spermatozoa has fertilised the oocyte 
(fertilization). This is known as the zygote and is totipotent. The first mitotic division at 36 hours 
has yielded two daughter cells which are still totipotent, each of which divide again to form 
totipotent stem cells. Specialisation occurs which results in a hollow ball of cells (blastocyst) and a 
cluster of cells (ICM), which are the embryonic stem cells. (Drife 2004) 
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1.2.2 Stem Cell Niches 
Stem cell niches are composed of microenvironments that nurture stem cells and enable 
them to maintain tissue homeostasis (Schofield 1978). An appropriate spatiotemporal 
dialog occurs between stem and niche cells in order to fulfil lifelong demands for 
differentiated cells. Niche cells provide a sheltering environment that sequesters stem 
cells from differentiation stimuli, apoptotic stimuli and other stimuli that would 
challenge stem cell reserves. The niche also safeguards against excessive stem cell 
production that could lead to cancer. Stem cells must periodically activate to produce 
progenitor or transit amplifying (TA) cells that are committed to produce mature cell 
lineages. Hence, maintaining a balance of stem cell quiescence and activity is a 
hallmark of a functional niche (Moore and Lemischka 2006). In vivo, the homeostatic 
microenvironment of the niche ensures that stem cells retain their phenotype (Ohlstein 
et al. 2004). 
1.2.3 Dedifferentiation, Redifferentiation, Transdifferentiation and 
Plasticity 
Dedifferentiation is basically the reverse of differentiation, where differentiated cells 
can change into a less mature phenotype. For example, chondrocytes lose their 
phenotype when cultured in vitro on tissue culture plastic as they stop expressing the 
cartilage-specific marker collagen type II (von der Mark et al. 1977). However, in the 
presence of growth factors, such as TGFβ, they redifferentiate into chondrocytes and 
express collagen II markers. Transdifferentiation is a switch of a cell into another cell, 
of the same or completely different tissue, of the same or different germ layer (Reh et al. 
1987; Lagasse et al. 2000). The conversion of pancreatic cells to hepatocytes is an 
example of transdifferentiation (Slack and Tosh 2001). There are studies (Terada et al. 
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2002; Ying et al. 2002) which have demonstrated spontaneous cell fusion which raised 
the possibility that earlier findings were the result of cell fusion, rather than 
transdifferentiation. In other words, transdifferentiation may not actually happen. 
Stem cell plasticity has been defined as “the ability of adult stem cells to acquire mature 
phenotypes that are different from their tissue of origin” (Grove et al. 2004). 
Hematopoetic stem cells have been shown to differentiate into hepatocytes in vivo 
(Lagasse et al. 2000). Skeletal muscle satellite cells have the capacity to form 
hematopoietic cells (Jackson et al. 1999). However, claims of plasticity have proven 
controversial. Firstly, hematopoetic stem cells and bone marrow-derived stromal cells 
may demonstrate plasticity, but they are essentially heterogeneous cell populations that 
are not fully defined. Consequently, it is unclear which cells give rise to originally 
sourced and unrelated cell types (Slayton and Spangrude 2004). Secondly, it cannot be 
ascertained whether the plasticity of cells resulting from in vitro culture is due to native 
plasticity or epigenetic modification (Slayton and Spangrude 2004). Epigenetics 
examines how genotypes give rise to phenotypes through an investigation of causal 
interactions rather than of the DNA sequence (Waddington 1962; Waddington 1966; 
Bird 2007). Epigenetics has alternatively been defined as “the study of mitotically 
and/or meiotically heritable changes in gene function that cannot be explained by 
changes in DNA sequence” (Russo et al. 1996). 
1.3 Mesenchymal Stem Cells 
Mesenchymal stem cells (MSCs) were discovered during the 1960s (Friedenstein et al. 
1966; Friedenstein et al. 1970) where they were first described as colony-forming unit-
fibroblasts (CFU-f). MSCs have been called bone marrow stromal cells (Ashton et al. 
1980) and are found in the bone marrow and peripheral blood, in a 20:1 ratio in rabbits 
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(Wan et al. 2006). Recent evidence suggests that they are also found in the 
subcutaneous fat (Zuk et al. 2002; Tepliashin et al. 2005), umbilical cord blood (Lee et 
al. 2004), amniotic fluid (In 't Anker et al. 2003), synovial membrane of the knee (De 
Bari et al. 2001), hair follicles (Van Exan and Hardy 1980), muscle (Ferrari et al. 1998), 
trabecular bone (Noth et al. 2002) and foetal liver (Gotherstrom et al. 2003). 
1.3.1 Characteristics 
Bone marrow-derived stromal cell (BMSC) populations are heterogeneous (Bartl and 
Frisch 2003; Yin and Li 2006). MSCs are one of a number of BMSC populations, with 
a concentration of less than 1 MSC in 100,000 to 500,000 nucleated cells in the bone 
marrow (Caplan 2005). 
Within the stem cell hierarchy, MSCs are designated as multipotent (Caplan 1991; 
Caplan 1994). MSCs have the potential to differentiate into mesenchymal tissues 
including bone, cartilage, muscle, tendon and fat (Figure 2). Recent research suggest 
that MSCs may in fact be pluripotent, rather than just multipotent (Jiang et al. 2002; 
Salingcarnboriboon et al. 2003). These studies underline the ability of MSCs to 
differentiate into many lineages and consequently demonstrate potential in regenerative 
strategies. 
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Figure 2: The Mesengenic Process. A depiction of a mesenchymal stem cell proliferating, and then 
differentiating into several lineages which result in the formation of bone, cartilage, muscle, 
marrow, tendon/ligament and connective tissue. (Caplan and Bruder 2001) 
MSCs are anchorage-dependent, which means that any successful in vitro expansion 
requires the cell to attach to a surface. In vitro, it has been shown that as these cells age, 
the number of population doublings decrease (Zimmermann et al. 2003; Delorme et al. 
2009). Studies (Bruder et al. 1997; Zimmermann et al. 2003) have revealed that MSC 
proliferation remains within Hayflick’s limit of 50 ± 10 cell doublings (Hayflick 1979). 
The in vitro lifespan of human MSCs plated at 3000-6000 cells/cm
2
 was found to be 
18.7 ± 2.5 population doublings (Zimmermann et al. 2003). An earlier study found that 
human MSCs from bone marrow plated at 5000 cells/cm
2
 had an average lifespan of 38 
± 4 population doublings (Bruder et al. 1997). 
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1.3.2 Identification 
There is no single method to identify MSCs. The methods of MSC identification 
include morphology, differentiation potential and antigenic markers. The morphology of 
MSCs, when viewed under a microscope, cannot be used as concrete proof of 
identification. However, it is well-documented that they are fibroblastic and plastic-
adherent in culture (Colter et al. 2000; Dominici et al. 2006). Another means of 
identification is through differentiation potential (Jiang et al. 2002; Dominici et al. 
2006; Schop et al. 2009b). This is a method which usually involves differentiation along 
the osteogenic, adipogenic and chondrogenic lineages. 
Flow cytometry has been used to detect antigens on MSCs. Human MSCs have tested 
positive for SH2, SH3, CD29, CD44, CD71, CD90, CD106 and CD120a and negative 
for CD14, CD34 and CD45 (Pittenger et al. 1999). Recent work identified the 
expression of integrins: alpha1, alpha2, alpha3, alpha5, alpha6, alphav, beta1, beta3 and 
beta4, in addition to ICAM-1, ICAM-2, VCAM-1,CD72 and LFA-3 (Conget and 
Minguell 1999; Majumdar et al. 2003). Furthermore, CD105 has become the most used 
marker of MSCs (Bussolati et al. 2008; Odabas et al. 2008; Smiler et al. 2008). There is 
no single exclusive marker for MSCs, which hinders comparison of study outcomes 
which involve different approaches to cell characterisation (Dominici et al. 2006). In 
2006, the Mesenchymal and Tissue Stem Cell Committee of the International Society 
for Cellular Therapy proposed minimum criteria for the antigenic identification of 
MSCs through expression (≥ 95% of MSC population) of CD105, CD73 and CD90, and 
the lack of expression (≤ 2% positive) of CD45, CD34, CD14 or CD11b, CD79α or 
CD19 and HLA class II surface molecules (Dominici et al. 2006). 
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1.3.3 Differentiation 
In the previous section, it was established that in vitro differentiation along multiple 
lineages was a means of identifying MSCs. This section examines the osteogenic, 
adipogenic and chondrogenic lineages in terms of markers. 
1.3.3.1 Osteogenic Lineage 
Osteogenesis is the process of bone formation. The constituents of the bone 
extracellular matrix, and hence the markers, are collagen I, byglican, decorin, 
osteonectin, thrombospondin, fibronectin, osteopontin, bone sialoprotein and 
osteocalcin. Alkaline Phosphatase is an enzyme found in high concentrations in bone 
cells and is an early marker for bone formation (Jaiswal et al. 1997; Tonomura et al. 
2007). 
1.3.3.2 Adipogenic Lineage 
Adipogenesis is the process of adipocyte or fat cell production. Oil red O staining 
(Koopman et al. 2001) is a technique used to identify lipid droplets of fat cells. 
Mest/Peg1 imprinted gene enlarges adipocytes and has been demonstrated as a marker 
for adipocyte size (Takahashi et al. 2005). Activin receptor-like kinase 7 (ALK7) is a 
novel marker for late phase adipocyte differentiation (Kogame et al. 2006). 
1.3.3.3 Chondrogenic Lineage 
Chondrogenesis is the process of cartilage formation. The markers of articular cartilage 
include collagen II (the predominant collagen type), VI, IX, X, XI, XII & XIV, 
proteoglycans (aggrecan, leucine-rich core proteins, decorin, fibromodulin, lumican, 
biglyan, perlecan), cartilage oligomeric protein, link protein, matrix-γ-carboxyglutamic 
acid protein, fibrilin-1, hyaluronic acid, superficial zone protein, chondroadherin and 
   Page | 42  
 
CD44 (Poole et al. 2001). Safranin O is a method of staining the proteoglycan (Shepard 
and Mitchell 1976). Alcian blue staining at acidic pH is used to test for the presence of 
sulphated aggrecan (Lemare et al. 1998). 
1.4 Scaffolds 
MSCs are anchorage-dependent. They require support in order to expand. This section 
seeks to explore certain varieties of scaffolds and focuses upon the polymers which will 
be used in this project. 
1.4.1 Scaffolds and Cell Expansion Techniques 
T-flasks and well-plates are examples of two-dimensional (2-D) scaffolds which 
support proliferation of anchorage-dependent cells. Tissue culture plastic has proven 
beneficial for cell attachment, proliferation and harvest. However, laboratory procedures 
are labour-intensive and susceptible to contamination (Freshney 2000a). There are 
several routes to contamination when a laboratory operator has to handle multiple T-
flasks over a period of weeks. Some routes include air particulates (spores and dust), 
faulty laminar hoods and poor technique (Freshney 2000a). 
Microcarriers are examples of three-dimensional (3-D) scaffolds which support the 
proliferation of MSCs. 3-D scaffolds provide a greater surface area to volume ratio than 
2-D scaffolds for expansion purposes. The 3-D structure allows for more efficient 
utilisation of culture media and is a space-saving technique (Malda and Frondoza 2006). 
If a seeding density of 2000 MSCs/cm
2
 were applied to a 100 ml spinner flask 
containing a microcarrier concentration of 20 cm
2
/ml, then in order to achieve a target 
of 60 million MSCs, an equivalent of 12 T175-flasks are required. Hence, a target of 60 
million MSCs may be achieved using 1 100 ml spinner flask or 12 T-flasks (half the 
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space of the incubator). As a consequence, the employment of a spinner flask reduces 
media consumption by roughly two-thirds. The potential for contamination of a 
microcarrier spinner flask cell culture is lower than the employment of 12 T-flasks in 
terms of handling and media replenishment. 
1.4.2 Scaffold Manufacture 
A variety of processing techniques have been developed which synthesise scaffolds 
made from both natural and synthetic polymers. The techniques include solvent 
casting/particulate leaching, phase inversion, fiber bonding, melt-based technologies, 
freeze-drying and rapid prototyping technologies (Salgado et al. 2004). 
There are several methods of microcarrier synthesis. Some of these methods include 
spinning disk atomisation (Senuma et al. 2000), spray drying technique (Wang et al. 
2004) and the water-in-oil-in-water (w/o/w) double-emulsion solvent 
extraction/evaporation method (Yang et al. 2000). The basic principle of the spinning 
disk atomisation method involves the break-up of fluid at the rim of the spinning disk 
resulting in droplet formation, as a consequence of interfacial forces (Senuma et al. 
2000). The spray-drying technique dries a liquid feed through hot gas and an atomiser 
produces fine droplets or microspheres (Wang et al. 2004). The w/o/w method is 
relatively simple and cheap, and is used for the encapsulation of proteins for growth 
factor release (Zhu et al. 2007a; Zhu et al. 2009). The w/o/w method will be used to 
synthesise microcarriers to achieve some of the objectives of this thesis. 
1.4.3 Polymers 
Polymers are long-chain molecules that consist of a number of small repeating units 
(monomers). Polymers differ from monomers through the loss of unsaturation or the 
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elimination of small molecules such as water or HCL during the process of 
polymerisation. Cellulose, starches, rubber and deoxyribonucleic acid are all varieties of 
polymers (Visser et al. 1996). For tissue engineering applications, synthetic polymers 
are mostly employed owing to their biocompatibility, biodegradability and bulk 
mechanical stiffness characteristics. These synthetic polymeric biomaterials include 
poly(lactic acid), poly(glycolic acid), poly(lactic-co-glycolic acid), poly(ε-
caprolactone), multi-block co-polymers comprising poly(ethylene oxide) and butylenes 
terephtalate units, polyphospho-esters, polyphosphazenes, polyanhydrides, 
polyorthoesters, poly(propylene fumarate)-diacrylate networks and poly(ethylene 
glycol)-diacrylate networks (van Dijkhuizen-Radersma et al. 2008). There are several 
examples of polymers used for cell growth and proliferation. Poly (ethylene 
terepthalene) PET has been used to support long-term human MSC growth (Zhao and 
Ma 2005). A blend of corn starch and poly (-caprolactone) has also been developed 
and, in conjunction with growth factors, was used to seed marrow stromal cells to grow 
bone-like cells (Gomes et al. 2006). Cytodex 1 microcarriers, which is composed of a 
cross-linked dextran, has demonstrated increasing promise for the 3D expansion of 
MSCs (Frauenschuh et al. 2007; Schop et al. 2008; Schop et al. 2009a; Schop et al. 
2009b). 
1.4.4 Polymer Candidates 
This section examines the polymers which will be used to expand MSCs. The polymers 
which will serve as scaffolds are PHBV, PCL and PLGA. As will be discussed in 
greater detailed in the following sections, these polymers were chosen owing to their 
their biocompatibility properties, ability to be synthesised as microcarriers and potential 
as scaffolds for MSC proliferation. 
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1.4.4.1 PHBV [poly (3-hydroxybutyrate-co-3-hydroxyvalerate)] 
Polyhydroxybutyrate (PHB) was first isolated by Lemoigne in 1925 and identified as a 
naturally occurring β-hydroxyacid. PHB is relatively abundant, being found in many 
different microorganisms as energy storage granules (similar to glycogen function in 
humans) at 1-30% dry weight (Doyle et al. 1991; Gomes et al. 2006). PHB has 
demonstrated excellent biocompatibility as evident by lack of toxicity (Saito et al. 
1991), compatibility in contact with tissue (Malm et al. 1992) and blood (Clarotti et al. 
1992; Malm et al. 1994). However, PHB homopolymers, like all other PHA 
homopolymers, are highly crystalline, extremely brittle, and relatively hydrophobic,  
(Lanza et al. 2000) which lacked structural integrity for certain tissue engineering 
applications. 
 
Figure 3: Chemical structure of PHBV, which is made up of the co-polymers PHB (portion 1) and 
HV (portion 2) 
PHBV results when hydroxyvaleric acid (HV) is added to PHB (refer to Figure 3). 
Compared with PHB, PHBV exhibits reduced brittleness and enhanced flexibility (Yan 
Chen 2002). PHBV has been utilised in tissue engineering. Cartilage defects treated 
with chondrocyte-seeded PHBV showed better healing response than chondrocyte 
seeded CaP-Gelfix
®
 matrices (Kose et al. 2005). PHBV has been shown to support in 
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vitro osteogenesis (Kumarasuriyar et al. 2005). It is expected that owing to the 
biocompatibility, reduced brittleness and ability to be synthesised as microcarriers, that 
PHBV microcarriers would support the attachment and proliferation of MSCs. 
1.4.4.2 PCL [poly (-caprolactone)] 
 
Figure 4: Chemical Structure of PCL 
PCL is an organic biomaterial of synthetic origin (refer to Figure 4). It is a linear, 
aliphatic polyester formed by the ring-opening addition polymerisation of ε-
caprolactone. The polymer has a regular structure and is crystallisable. The crystalline 
polymer has a melting point of approximately 63°C and the wholly amorphous polymer 
has a glass transition temperature of about -70°C (Klee et al. 1999). PCL (Lanza et al. 
2000) has a high thermal stability. It is always in a rubbery state at room temperature, 
which contributes to the high permeability property for many therapeutic drug 
applications (Pitt et al. 1987). Extensive testing of the monomer and the polymer, PCL, 
has led to the general consensus that they are non-toxic and tissue-compatible materials. 
Osteoblasts have been seeded onto PCL-ceramic composites and in conjunction with 
rhBMP-2, significantly improved bone cell growth was noted (Rai et al. 2004). PCL-
based hybrid scaffolds seeded with BMSC has shown promise for the treatment of large 
osteochondral defects in high-loading sites (Shao et al. 2006). It is expected that owing 
   Page | 47  
 
to the biocompatibility and ability to be synthesised as microcarriers, that PCL 
microcarriers would support the attachment and proliferation of MSCs. 
1.4.4.3 PLGA [polyglycolide-co-lactide] 
 
Figure 5: Chemical Structure of PLGA which is a co-polymer of lactic acid (portion 1) and glycolic 
acid (portion 2). 
PLGA is a copolymer of polyglycolic acid (PGA) and polylactic acid (PLA) (refer to 
Figure 5). It is an organic biomaterial of synthetic origin. The degraded products of 
PLGA are lactic and glycolic acids which are both metabolites of the Krebs cycle 
(Gilding 1981); lactic acid is removed through aerobic respiration (Meisenberg and 
Simmons 2006b) and gluconeogenesis within the liver and kidneys (Meisenberg and 
Simmons 2006a). PLGA can be easily processed into a desired configuration owing to 
their chemical, physical, mechanical and degradative properties (Lu and Mikos 1996). 
PLGA copolymers are among the few synthetic polymers approved for human clinical 
uses (Kang et al. 2005). With regard to this project, it is expected that owing to the 
biocompatibility and ability to be synthesised as microcarriers, that PLGA microcarriers 
would support the attachment and proliferation of MSCs. 
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1.5 Bioreactors 
“A bioreactor is a general term applied to a closed culture environment, that is usually 
mixed, that enables control of one or more environmental or operating variables that 
affect biological processes” (Ellis et al. 2005). Bioreactors currently used for tissue 
engineering applications include stirred-tank, perfusion, spinner flask, biowave, 
rotational wall, radial flow, packed-bed, fluidised-bed, and rotating (Goodwin et al. 
1993b; Bancroft et al. 2003; Dang et al. 2004; Schroeder et al. 2005; Zhao and Ma 
2005; Cameron et al. 2006). The aforementioned bioreactors have primarily been used 
for tissue culture; spinner flasks (Frauenschuh et al. 2007; Schop et al. 2008; Schop et 
al. 2009a; Schop et al. 2009b) and biowave (Schlaeppi et al. 2006; Eibl et al. 2010) 
bioreactors are gaining prominence in cell expansion. 
1.5.1 Static Systems 
Test tubes, T-flasks and well-plates are traditional means of facilitating static cultures. 
These represent a basis for the comparison of dynamic culture techniques. Dynamic 
systems offer many distinct advantages: superior rates of oxygen transfer, waste 
removal and nutrient supply; faster homogeneity achievement of nutrient concentration 
and temperature profiles; pH equilibrium more assured (Ellis et al. 2005). 
1.5.2 Spinner Flasks and Stirred-tanks 
Stirred culture systems have been extensively applied to the culture of microbial and 
mammalian cells. It is only recently that this type of system was applied to tissue 
engineering. This was driven by the need to develop human tissue repair strategies, 
which required significant quantities of cells (Vacanti 2006). The spinner flask and 
   Page | 49  
 
stirred tank offered a dynamic environment which has been proven to improve cell yield 
and production rates (Kim et al. 2007; Stiehler et al. 2009). 
 
Figure 6: Spinner Flask manufactured by Bellco Glass Inc (USA).  It is used specifically for 
microcarrier culture and has a working volume of up to 100 ml. The impeller is coloured white and 
has a magnet attached to it. A magnetic stirrer is used to rotate the impeller. 
There are several examples of stirred cultures being optimised for use in tissue culture. 
Encapsulated mouse embryonic stem cells with low-gelling temperature agarose placed 
in stirred-suspension bioreactors have produced scalable quantities of hematopoietic 
progenitor cells under controlled environmental conditions for potential short-term 
engraftment in host animals (Dang et al. 2004). A 15-fold expansion in the total number 
of human EB-derived cells cultured for 21 days in a stirred flask has been demonstrated, 
as compared to a 4-fold expansion in static culture; the initial inoculation cell 
concentration was 2-3 x 10
6
 cells/ml, which highlighted the advantage of the dynamic 
compared to the static cultures (Cameron et al. 2006). A 2L stirred-tank bioreactor with 
a pitch-blade-turbine has been developed and optimised to yield high-density 
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genetically-engineered suspension cultures; for the production of cardiomyocytes 
(Schroeder et al. 2005). 
The previous studies focussed on tissue culture. Recently, there has been research 
undertaken on the expansion of MSCs within spinner flask Cytodex 1 microcarrier 
cultures. As compared to cytodex 2 and 3, cytodex 1 has been demonstrated as the best 
3D scaffold for the adherence of porcine MSCs (Frauenschuh et al. 2007). This study 
postulated that MSCs migrated from the surface of the colonised less positively charged 
microcarriers to freshly-added non-colonised more positively charged microcarriers. 
Research has revealed information on the growth, metabolism and inhibitors of goat, rat 
and human MSCs (Schop et al. 2009a). Specifically, goat MSCs grew faster than rat and 
human MSCs, glucose consumption for cellular energy was through the glycolysis 
pathway for human and rat MSCs and the oxidative phosphorylation pathway and rat 
MSCs were more sensitive to lactate than human and goat MSCs. Information has been 
revealed on optimised feeding regimes as the longest proliferation phase of goat MSCs 
was noted when adding 30% fresh medium containing microcarriers as opposed to 30% 
fresh medium or no medium replenishment (Schop et al. 2008). This study indicated 
that the optimised feeding regime diluted the metabolites, added new energy sources 
(glucose and glutamine) and provided increased surface area for goat MSCs which tend 
to detach from one microcarrier to another during spinner flask culture. 
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1.5.3 Rotating Wall Vessel 
 
Figure 7: Basic make-up of a rotating-wall vessel reactor taken from (Hammond and Hammond 
2001) and originating from the article of (Goodwin et al. 1993a). Basically the bioreactor from the 
left-hand side is attached horizontally to the end-piece on the right-hand side. Rotation is relative to 
the horizontal axis; rotation in the spinner flask from the preceding section is along the vertical 
axis. 
Features of a rotating-wall vessel reactor include a cylinder attached to a vertical surface 
or wall and rotation about a horizontal axis. This type of bioreactor has been used for 
the purposes of tissue culture and efforts have been devoted for optimisation purposes. 
The National Aeronautics and Space Administration (NASA) has worked on low shear 
stress, small turbulence microcarrier culture system for three-dimensional tissue culture. 
One experiment (Goodwin et al. 1993b) explored the co-cultivation of small intestine 
epithelium and MSCs on Cytodex 3 microcarriers. The conclusion of that experiment 
led to a new tissue culture model for further investigation. A review paper (Hammond 
and Hammond 2001) discussed the trade-offs of optimised cell culture within this type 
of bioreactor: minimise terminal velocity by selecting microcarrier beads and culture 
media with similar density, reduce coriolis and centrifugal forces, maximise nutrient 
flow. This paper found that (1) a reduction in gravity minimised terminal velocity (2) 
rotation induced coriolis and centrifugal forces, which in turn was directly proportional 
to terminal velocity and (3) nutrient mass transport to a cell was directly dependent on 
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terminal velocity and nutrient diffusion. Further to the third conclusion, it put forward 
that limitations to nutrient supply could be rectified through lower culture medium 
viscosity and/or providing a nutrient supply to form a concentration gradient. 
1.5.4 Biowave Reactor 
 
Figure 8: Picture of a Biowave Reactor taken at Xpand Biotechnology BV (The Netherlands). The 
red liquid is medium located in a bag. Below the bag lies the rocking unit which moves the tray 
from side-to-side thereby creating a dynamic environment within the medium. 
Biowave reactors are relatively new technologies (Schlaeppi et al. 2006; Eibl et al. 
2010). They have been used to process cells, bacteria and yeast. These bioreactors have 
been used mainly for cell expansion rather than for tissue culture. Wave Biotech AG is a 
company based in Switzerland which manufactures these bioreactors. Their design is 
based on a disposable Wave Bag

 reactor and an accompanying rocking (agitation) unit, 
which together creates wave induced motion in order to achieve the desired degree of 
   Page | 53  
 
mixing and oxygen transfer. Continuous aeration and de-aeration of the headspace 
guarantees an optimum supply of oxygen and the removal of metabolic gases. 
Sterilisation of the system is not required as the disposable reactor chambers are 
supplied pre-sterilised through gamma irradiation, which represents an alternative to 
maintenance-prone, time-intensive systems. The rocker facilitates wave motion which 
optimises nutrient transfer and prevents the cells from settling, simultaneously 
maintaining minimum shear stress and hence no requirement for aeration units or 
mechanical stirrers. There is some degree of unpredictability of fluid body formation 
and of the velocity and direction of bodies of fluid formation, which highlights the level 
of infancy of this developing technology. 
1.5.5 Perfusion Bioreactor 
Perfusion culture is the steady flow of media over or through a cell population/bed of 
cells (refer to Figure 9 and Figure 10). Common features of perfusion bioreactors 
include flow chambers, media reservoirs, peristaltic pumps, circulation loops and 
controls for temperature, pressure, carbon dioxide and oxygen. The flow chamber is the 
site for cell seeding, expansion and differentiation, depending on the environmental 
conditions. Perfusion bioreactors offer several advantages (Bancroft et al. 2003) for 
culturing scaffolds in tissue engineering. It provides enhanced delivery of nutrients 
throughout the entire scaffold by mitigating both external and internal diffusional 
limitations. Fluid shear stress provides mechanical stimulation to the cells which has 
proven convenient for research aims of stimulating bone cells (Hillsley and Frangos 
1994). Cell shear stress may be varied by adjusting flow rates. The end-product 
advantage of the perfusion system is the 3-D layered scaffold of attached cells, made 
possible by enhanced nutrient delivery/waste removal. 
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Figure 9: The perfusion system consists of the ancillary equipment and the perfusion bioreactor. 
There are two perfusion bioreactors in this picture and they are the two petridishes located in the 
middle of the two relatively large pumps. The Duran bottles represent the culture medium 
reservoir and the waste reservoir. Human embryonic stem cells were expanded in the perfusion 
bioreactors. (Fong et al. 2005) 
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Figure 10: Medium flows in a downward direction through a scaffold with attached cells. This 
scaffold is held in place by the scaffold and does not move whatsoever. Hence, the culture medium 
flows through or perfuses the scaffold. (Bancroft et al. 2003) 
A perfusion system has been designed using non-woven poly (ethylene terepthalate) 
(PET) matrices as scaffold for expansion and differentiation of human bone marrow-
derived stromal cells (Zhao and Ma 2005). Braccini et al. engineered constructs by 
seeding, expansion and differentiation of bone marrow stromal cells (Braccini et al. 
2005). This group maintained that the developed system may be used as a 3D in vitro 
model of bone marrow to study interactions between BMSCs and hematopoietic cells 
and also to streamline manufacture of osteoinductive grafts within the context of 
regenerative medicine. Fong et al. enhanced human embryonic cell numbers by 70% 
compared to a static conditions, through feeder conditioned media produced by mouse 
embryonic fibroblasts (Fong et al. 2005). The study was conducted in order to scale-up 
the bioprocess of undifferentiated human embryonic stem cells in sufficient quantities 
for tissue regeneration. 
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1.6 Fluid Flow 
A fluid is a substance which undergoes continuous deformation when subjected to a 
shearing force (Doran 2002). In 1883, Osborne Reynolds first examined why the pattern 
of fluid flow, on a surface or through a pipe, varied with velocity, fluid physical 
properties and surface geometry (Coulson and Richardson 1999). His experiments 
categorised fluid flow based on velocity. Laminar or streamline flow is indicative of 
parallel streams which do not interact at low velocity, that is, no bulk movement at right 
angles to the major stream direction; however, some radial dispersion does take place 
owing to diffusion. Turbulent flow occurs at higher velocities and is featured by the lack 
of parallel streams, the presence of eddies and a higher level of radial mixing. Reynolds 
found that during turbulent flow in a pipe, a laminar sub-layer existed immediately 
adjacent to the wall. 
Reynolds number (Re) is a parameter used to characterise fluid flow, so as to determine 
laminar, transition or turbulent flow regimes. The regimes are mathematically 
determined for fluid flow in a smooth pipe as Re < 2100 (laminar), 2100 ≤ Re ≤ 4000 
(transition) and Re > 4000 (turbulent) (Doran 2002). For stirred tank vessels, Re is 
dependent on a number of factors and mathematical determination is done on a case-by-
case basis. But generally, Re (stirred vessels) ≤ 10 for laminar flow regimes (Doran 
2002). It is important to establish Re in cell culture so as to evaluate fluid flow on cell 
growth. 
Fluid flow regime (Riddle et al. 2006; Zhao et al. 2007) has a distinct influence on the 
MSC yield and phenotype. A shearing force is required to move fluid. Therefore, as 
mammalian cells are shear-sensitive (Chia et al. 2005), a flow regime with an optimum 
range of shear stress is preferred in order to maximise the MSC yield. For example, 
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Zhao et al. examined the effects of shear stress on 3-D human BMSC constructs within 
a perfusion bioreactor system (Zhao et al. 2007). That study involving laminar flow 
found higher proliferation rates at the lower end of the shear stress range of 1.0 x 10
-4
 
N/m
2
 to 1.0 x 10
-5
 N/m
2
. This demonstrated improved growth rates when subjected to 
lower shear stress (1.0 x 10
-4
 N/m
2
). 
 
Figure 11: In (a) plug flow, the fluid streams have equal velocity resulting in a straight line profile. 
The stream velocities differ in (b) turbulent flow and (c) laminar flow resulting in more parabolic 
profiles. (Doran 2002) 
An ideal plug flow reactor (refer to Figure 11) is characterised by fluid flow with no 
mixing whatsoever and fluid velocity is equal across the diameter of a pipe. Plug flow 
has been achieved in column or tubular reactors in an upward or downward manner at 
   Page | 58  
 
high Re numbers. This type of flow is important when achieving continuous 
sterilisation, especially in the fermentation industry because contaminants reaching the 
outlet of the steriliser is not desirable (Doran 2002). 
Viscosity is a measure of the resistance of a fluid to shear stress (Coulson and 
Richardson 1999; Doran 2002). It is determined by correlating the fluid velocity 
gradients to the shear forces. A Newtonian fluid may be defined as “one in which, 
provided that the temperature and pressure remain constant, the shear rate increases 
linearly with shear stress over a wide range of shear rates” (Coulson and Richardson 
1999). In mathematical terms, both viscosity and shear rate are functions of shear stress; 
they are also both directly proportional to shear stress. 
1.7 Particle Image Velocimetry 
 
Figure 12: An example of an experimental arrangement for PIV (Raffel et al. 2007). 
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Particle Image Velocimetry (PIV) is a flow visualisation technique. With reference to 
Figure 12, in brief, fluid hydrodynamics may be assessed through the use of tracer 
particles, which follow fluid flow. These tracer particles scatter light which is recorded 
by a camera. A plane light sheet within the flow is illuminated twice by a laser. The 
time delay between the two illuminations forms the basis of quantitative analyses, for 
example, in terms of particle velocities, velocity magnitudes and shear distribution. 
(Raffel et al. 2007) 
The employment of PIV to characterise the hydrodynamics of fluid flow in bioreactors 
is relatively new. Within regenerative medicine, PIV is used to develop tissue growth 
models relating hydrodynamic parameters to tissue properties (Sucosky et al. 2004; 
Bilgen et al. 2006; Dusting et al. 2006; Bilgen and Barabino 2007). Given the 
requirements of the PIV set-up, researchers have faced tough practical challenges to 
replicate the stem cell culture environmental conditions and bioreactor dimensions 
(Sucosky et al. 2004; Bilgen and Barabino 2007). Often, significant changes have been 
made to those conditions and dimensions. However, valid conclusions were possible 
through established scale-up/scale-down models and careful material selection (Venkat 
et al. 1996; Sucosky et al. 2004). 
In this project, the tracer particle velocities determined by the PIV will be used to 
evaluate Re and shear forces. Shear stress, τ, will be calculated using Equation 1, μ = 
viscosity and 
.
  = shear rate. (Coulson and Richardson 1999) 
Equation 1: Newton’s Law of Viscosity 
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The Reynolds number, Re, was calculated using Equation 2, where ρ = density, Ni = 
Impeller Speed and Di = Impeller Diameter. (Doran 2002) 
Equation 2: Reynolds Number 
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1.8 Aims and Objectives of the Thesis 
A major challenge to the clinical success of cell-based tissue engineering strategies is 
the ability to obtain sufficient numbers of cells within an acceptable time frame. The 
expansion of BMSCs on 3D scaffolds has shown promise and the benefits compared to 
expansion on 2D scaffolds has been discussed within this literature review. Henceforth, 
the overall aim of this project is to further understand the expansion of BMSCs on 3D 
microcarriers, so as to maximise proliferation rates. This will be achieved through an 
examination of microcarrier polymer types and surface roughness and the effects of 
shear stress in dynamic culture. In consideration of the bioreactors, specifically those 
concerned with cell expansion rather than tissue growth, discussed within this chapter, 
spinner flasks will be employed to study the effects of shear stress on BMSC expansion 
on microcarriers in dynamic culture. This aim will be achieved by the following 
objectives: 
 Preparation and characterisation of microcarrier polymeric types 
 Investigation of the growth of BMSCs on different microcarrier polymeric types 
 Evaluating BMSC growth on polymeric microcarriers with two levels of surface 
roughness 
 Analysis of the shear stress within a spinner flask bioreactor for cell culture with 
the aid of PIV 
 Examining the effects of shear stress on BMSC expansion on microcarriers 
within spinner flask bioreactors 
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2 The Preparation and Characterisation of PHBV, 
PCL and PLGA microcarriers for cell expansion 
2.1 Abstract 
Microcarriers have shown promise as scaffolds for cell expansion. This study focuses 
on the preparation and characterisation of three polymeric microcarriers in order to 
assess their suitability as scaffolds for the expansion of cells. PHBV [poly (3-
hydroxybutyrate-co-3-hydroxyvalerate)], PCL [poly (-caprolactone)] and PLGA 
[polyglycolide-co-lactide] microcarriers were prepared employing the w/o/w (water in 
oil in water) method. Fourier transform infrared and raman data demonstrated that the 
synthesised microcarriers were all composed of the polymers. The scanning electron 
microscopy (SEM) results showed nanoporous PHBV and PLGA surfaces and a 
comparatively smooth PCL surface topography. The environmental SEM results 
indicated no microcarrier diameter changes when subjected to temperature and humidity 
changes. 
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2.2 Introduction 
Cell expansion on two-dimensional (2-D) scaffolds is well-documented and has been in 
use for several decades (Freshney 2000b). T-flasks and well-plates are common 
examples of 2-D scaffolds. However, there exists a need to reduce the amount of 
incubator space occupied by the 2-D scaffolds (Figure 13) owing to the high usage of 
cell growth media and the potential of contamination associated with handling multiple 
T-flasks and well-plates over periods of weeks (Freshney 2000a). One promising 
alternative is the employment of 3-D microcarriers within a bioreactor. Cell expansion 
on these microcarriers has been proven to be more space-saving and media utilisation 
efficient (Malda and Frondoza 2006). 
 
Figure 13: The surface area of microcarriers within the spinner flask on the right is equivalent to 
the surface area of the T-flasks within the incubator. 
Cytodex 1 is manufactured by GE Healthcare and it is a positively-charged, cross-linked 
dextran microcarrier which expands in liquid from powder form by twenty times the 
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original volume. Recent literature has demonstrated promising data involving bone 
marrow stromal cell (BMSC) expansion on Cytodex 1 microcarriers (Frauenschuh et al. 
2007; Weber et al. 2007; Schop et al. 2008; Schop et al. 2009a; Schop et al. 2009b). 
Whilst significant advances have been made in the optimisation of the bioprocessing of 
human BMSC spinner flask Cytodex 1 microcarrier culture, there is still a need to 
improve the seeding and harvesting efficiencies, as well as the expansion rates (Weber 
et al. 2007; Schop et al. 2008). It is therefore prudent that other microcarrier types 
should be explored to meet this need. It has previously been shown that surface 
topography affects cell growth (Degasne et al. 1999; Deligianni et al. 2001a; Deligianni 
et al. 2001b), where rougher surfaces significantly increased cell attachment and 
proliferation. In spinner flask culture, impeller rotation, which imparts shear stress, is 
necessary in order to suspend Cytodex 1 microcarriers. There is evidence which details 
the impact of shear stress on cells in terms of expansion, viability and morphology 
(Stathopoulos and Hellums 1985; Zeng et al. 2006; Zhao et al. 2007). Microcarrier 
types with lower densities than Cytodex 1 may conceivably require lower rotational 
speeds which would impart lower shear stress on cells. 
PHBV [poly (3-hydroxybutyrate-co-3-hydroxyvalerate)], PCL [poly (-caprolactone)] 
and PLGA [polyglycolide-co-lactide] are three polymeric candidates for human BMSC 
microcarrier expansion. All three polymers have been demonstrated to be biocompatible 
(Doyle et al. 1991; Yagmurlu et al. 1999; Hutmacher et al. 2001; Kose et al. 2003; Dai 
et al. 2004; Kang et al. 2005; Kose et al. 2005; Kumarasuriyar et al. 2005; Shao et al. 
2006). They can be processed into desired configurations (Lu and Mikos 1996; Yang et 
al. 2001; Zhu et al. 2007b; Zhu et al. 2009). It has previously been shown that lower 
crystalline/amorphous ratios within polymers favour cell attachment and growth (Park 
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and Cima 1996; Balasundaram et al. 2006; Czarnecki et al. 2008).  Previous studies 
have shown that decreasing crystalline portions of polymeric blends (1) increase oxygen 
permeability (Deng et al. 2002)  (2) maximise surface energy in order to maximise cell 
adhesion (Zheng et al. 2005) and (3) increases surface polarity which influences cell 
morphology on the scaffold (Zheng et al. 2005). PHBV has a lower crystallinity 
compostion than PHB (polyhydroxybutyrate) owing to a higher HV (hydroxvalerate) 
content (Moore and Saunders 1998). PCL has high crystallinity, but its biodegradability 
and non-toxicity drive studies which aim to create PCL blends and co-polymers in order 
to control crystallinity (Jiang et al. 2001; Gomes et al. 2003). PLGA is far more 
amorphous than the semi-crystalline and more hydrophobic PLA (poly-L-lactide) owing 
to the lactic acid content (Çatiker et al. 2000; Tewes et al. 2006). On the basis of 
crystallinity content, it would be expected that BMSC expansion would be superior on 
PHBV and PLGA microcarriers, than on PCL microcarriers. However, the magnitude of 
influence of surface roughness as a competing factor in determining expansion rates is 
unknown. 
The aims of this chapter are 
I. to synthesise microcarriers composed of PHBV, PCL and PLGA through the 
employment of the w/o/w method 
II. to examine the surface topography of the microcarriers through scanning 
electron microscopy (SEM) in order to evaluate its potential for cell attachment 
and proliferation 
III. to assess the impact of temperature and humidity changes on the microcarriers 
through environmental SEM. 
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2.3 Materials and Method 
2.3.1 Polymeric Raw Materials 
Poly (3-hydroxybutyrate-co-3-hydroxyvalerate) [PHBV] was purchased from Sigma 
Aldrich, United Kingdom. The poly (hydroxyvalerate) [PHV] content was 5% by 
weight of PHBV. The melting point is 165 °C. 
Poly (-caprolactone) [PCL] was purchased from Sigma Aldrich, United Kingdom. The 
average Mw was 65000. The melting point is 60 °C.  
Polyglycolide-co-lactide [PLGA] was purchased from Sigma Aldrich, United Kingdom. 
The lactide:glycolide ratio was 50:50 by percentage molecular weight. The average Mw 
was 40000 – 75000. The glass transition temperature is 45-50 °C. 
2.3.2 Microcarrier Synthesis 
The water in oil in water (w/o/w) method (Yang et al. 2000) was employed to 
synthesise the microcarriers from the polymers, PHBV, PCL and PLGA. Figure 14 is a 
basic illustration of the method. 
Briefly, 0.60g polymer was dissolved in 12 ml of chloroform under mild stirring (“oil”). 
Stock solutions were composed of polyvinyl alcohol (PVA) (Sigma Aldrich, United 
Kingdom), dissolved in 0.01M PBS (Sigma Aldrich, United Kingdom) at 0.5 g/L for 
PHBV, 0.7 g/L for PCL and 0.7 g/L for PLGA. A 1.2 ml stock solution represented the 
first aqueous volume (“water”). A 300 ml stock solution represented the second aqueous 
volume (“water”). 
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A 10/1 oil/water ratio was chosen, hence 1.2 ml of the first aqueous volume (“water”) 
was then added to the 12 ml organic solvent solution (“oil”) containing the completely 
dissolved polymer. Emulsification was carried out immediately using a homogenizer 
(Citenco F.H.P. motors LC9, England) for 30s at 1000 rpm. The emulsion was then 
transferred into the second aqueous volume (“water”). The solution was then placed 
under mechanical stirring at 200 rpm using a stirrer (Citenco F.H.P. motors LC9, 
England) for 3 hours to allow for the evaporation of residual chloroform. The 
temperature was kept constant at 37°C over a water bath. The final mixture was filtered 
with the residue collected and the filtrate discarded. 
The residue which contained the microcarriers was washed with de-ionized water 
several times. Glass vials were weighed and then filled with the residual microcarriers 
produced by the w/o/w technique. The microcarriers were frozen in liquid nitrogen at -
1000 rpm, 30s, 
1.2 ml First 
Aqueous Volume 
+ 12 ml Polymer 
dissolved in 
Chloroform 
200 rpm, 3h, 37°C, 
300 ml Second 
Aqueous Volume + 
Synthesised 
Microcarriers 
Filter 
microcarrier 
residue, 
discard 
filtrate 
Freeze-dryer 
Figure 14: Microcarrier Synthesis 
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o
C for 2 minutes, dried using a freeze-dryer (Biopharma Process Systems, United 
Kingdom) for 24 hours and weighed, repeatedly, until the mass was constant in order to 
completely remove moisture. The dried microcarriers were stored at 4C. 
2.3.3 Surface area measurements 
Brass frame stainless steel meshes (Endecotts Limited, United Kingdom) were 
employed to separate the microcarriers into the 212-300 µm diameter size range. The 
mass of known volumes of sieved microcarriers was measured thrice as described in 
previous studies (Fischer et al. 2003; Ahmadi et al. 2009) assuming a spherical 
morphology. The average value was used to calculate the surface area of PHBV, PCL 
and PLGA microcarriers for a given diameter. Refer to appendix 8.1 for sample 
calculations. Light microscopy images of the diameter range are illustrated in that 
appendix. 
2.3.4 Spectroscopy 
Fourier transform infrared was necessary to determine the chemical structure 
(specifically, the functional groups) of the PHBV and PCL polymeric microcarriers. 
The sample was placed on a gold background and the spectra were obtained using the 
Nicolet 8700 FT-IR Continuum microscope (Thermo Fisher Corporation, USA). Nicolet 
Almega XR dispersive raman spectrometer equipped with a 785 nm laser, accumulating 
1285 scans and an exposure time of 2s at 4 cm
-1
 resolution, was used to determine the 
chemical structure of the PLGA polymeric microcarriers. 
   Page | 69  
 
2.3.5 Scanning Electron Microscopy 
The purpose of the Scanning Electron Microscopy (SEM) was to examine the surface 
topography of the microcarriers. The microcarriers were placed onto a stub with sticky 
carbon tape, coated with gold (20 nm thickness) and placed into the JEOL JSM 6300 
scanning electron microscope. The accelerating voltage and working distance are stated 
beneath the images. 
The purpose of environmental SEM was to assess the effects of humidity and 
temperature changes on the particle diameter and surface topography of the 
microcarriers. The QUANTA 3D FEG (The Netherlands) machine was utilised to adjust 
the humidity levels (10% and 100%) and the temperatures (4°C and 15°C). The 
microcarriers were placed on a stub and distilled water was used to keep the 
microcarriers on the stub. The accelerating voltage and working distance are stated 
beneath the images. 
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2.4 Results 
2.4.1 Spectroscopy 
Spectra of the raw polymers, PHBV, PCL and PLGA and synthesised microcarriers 
were compared. Based on the spectra, it was deduced that the microcarrier synthesis 
method had not affected the chemical constitutions of both the raw material and the 
synthesised microcarriers. 
2.4.1.1 PHBV 
 
Figure 15: Spectra of the raw and synthesised microcarrier PHBV. 
-OH 
-CH2 
(asymmetric) 
-CH3 
C=O 
-CH2 
(symmetric) 
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Figure 16: PHBV. 1 – PHB (polyhydroxybutyrate) portion; 2 – HV (hydroxyvalerate) portion. 
Figure 15 illustrates the spectra of the raw PHBV starting material and of the 
synthesised PHBV microcarrier. Figure 16 illustrates the chemical structure of PHBV. 
Table 1 lists the chemical groups of PHBV and their corresponding wavelengths as seen 
in the spectra of Figure 15. As seen in Figure 15, the peaks of both the starting material 
and the synthesised microcarriers match. It was therefore concluded that they were 
constitutionally the same. Additionally, “-OH” was detected because the terminal 
carbon of the polymeric chain (Figure 16 – right-hand side connected to the C=O) must 
have four bonds to be chemically stable. 
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2.4.1.2 PCL 
 
Figure 17: Comparison of Spectra for the raw starting material and PCL microcarriers. 
 
Figure 18: Chemical Structure of PCL 
Figure 17 illustrates the spectra of the raw PCL starting material and of the synthesised 
PCL microcarrier. Figure 18 illustrates the chemical structure of PCL. Table 1 lists the 
chemical groups of PCL and their corresponding wavelengths as seen in the spectra of 
-CH2 
(asymmetric) 
-OH 
-CH2 
(symmetric) 
C=O 
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Figure 17. As seen in Figure 21, the peaks of both the starting material and the 
synthesised microcarriers match. It was therefore concluded that they were 
constitutionally the same. 
2.4.1.3 PLGA 
 
Figure 19: Comparison of the Spectra of raw starting material and PLGA microcarriers. 
 
Figure 20: Chemical Structure of PLGA. It is a co-polymer of lactic acid (portion 1) and glycolic 
acid (portion 2). 
-CH2 
(asymmetric) 
-CH2 
(symmetric) 
-OH 
-CH3 
C=O 
Delta -CH2 
Delta -CH 
C-O-C 
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Table 1: Chemical groups of PHBV, PCL and PLGA and the corresponding wavelengths. 
Group Wavenumber (cm
-1
) Reference 
-OH 
-CH3 
Asymmetric –CH2 
Symmetric –CH2 
Bonded carbonyl C=O 
Free carbonyl Ester 
Delta -CH2 
Delta -CH 
C-O-C 
3600-3000 
2960 
2925 
2850 
1850-1650 
1735 
1434 
1365 
1091 
(George 1987) 
(Nakanishi 1962b) 
(Nakanishi 1962b) 
(Nakanishi 1962b) 
(George 1987) 
(Nakanishi 1962a) 
(Nakanishi 1977b) 
(Nakanishi 1977b) 
(Nakanishi 1977a) 
Figure 19 illustrates the spectra of the raw PLGA starting material and of the 
synthesised PLGA microcarrier. Figure 20 illustrates the chemical structure of PLGA. 
Table 1 lists the chemical groups of PLGA and their corresponding wavelengths, as 
seen in the spectra of Figure 19. As seen in Figure 19, the peaks of both the starting 
material and the synthesised microcarriers match. It was therefore concluded that they 
were constitutionally the same. Additionally, “-OH” was detected because the terminal 
carbon of the polymeric chain (Figure 20 – the right-hand side adjacent to the C=O) 
must have four bonds to be chemically stable. 
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2.4.2 Scanning Electron Microscopy 
 
PHBV 
 
PCL 
 
PLGA 
 
Cytodex 1 
Figure 21: Surface topography of dry PHBV, PCL, PLGA and Cytodex 1 microcarriers. The 
working distance was 10 mm and the magnification was set at x 1000 with a working distance of 9.9 
mm. 
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PHBV 
 
PCL 
 
PLGA 
 
Cytodex 1 
Figure 22: Surface topography of dry PHBV, PCL, PLGA and Cytodex 1 microcarriers. PHBV, 
PCL and PLGA were at x 15000 with a working distance of 19.0 mm. The cytodex 1 microcarrier 
was at x 120000 with a working distance of 10.1 mm. 
Figure 21 illustrates the surface topographies of the microcarriers at low magnification. 
These images demonstrate the spherical appearance of the microcarriers with the PHBV 
microcarrier possessing a comparatively rough surface. Additionally, the Cytodex 1 
microcarrier has a significantly smaller diameter. At higher magnification however, as 
seen in Figure 22, more detail emerges about the microcarrier surface topography. 
PHBV and PLGA microcarriers are nanoporous. PCL microcarriers possess surfaces 
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which are generally non-porous and exhibit ripples. Cytodex 1 microcarriers possess 
features which resemble ridges. 
Figure 23 illustrates the morphology of the PHBV, PCL, PLGA and Cytodex 1 
microcarriers when exposed to variations in temperature and humidity. As seen in the 
images, the microcarrier diameter does not significantly change with temperature and 
humidity variation. Internal porosity appears more visibly under 100% humidity, 
especially for the PHBV and PLGA microcarriers. The diameter of pores in PLGA 
appears to increase in size slightly as humidity was increased. 
PHBV PCL PLGA Cytodex 1 
 
15°C, 100% 
humidity 
 
15°C, 100% 
humidity 
 
15°C, 100% 
humidity 
 
25°C, wet 
 
4°C, 10% 
humidity 
 
4°C, 10% 
humidity 
 
4°C, 10% 
humidity 
 
25°C, dry 
Figure 23: PHBV. PCL and PLGA microcarriers subjected to different temperatures and 
humidities using the environmental SEM (working distance of 5.4 mm and magnification of x 400). 
The wet Cytodex 1 image was obtained using the light microscope; the dry Cytodex 1 image was 
obtained using SEM. 
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2.4.3 Microcarrier Surface Area 
Table 2 shows the surface area of PHBV, PCL and PLGA microcarriers of the diameter 
range 212-300 µm; Cytodex 1 data was obtained from the manufacturer and its wet 
diameter range was 147-248 µm. Clearly, whilst the control, Cytodex 1 has the highest 
surface area, PLGA microcarriers possess the highest surface area of the three 
experimental groups. These data indicate that PLGA microcarriers are of the lowest 
density amongst the synthesised microcarriers. 
Table 2: Diameter ranges and surface areas of the microcarriers. * denotes GE Healthcare 
manufacturer data in terms of wet surface area per dry mass of Cytodex 1. 
Microcarrier Dry Diameter 
Range (μm) 
Dry Surface 
Area (cm
2
/g) 
Wet Diameter 
Range (μm) 
Surface Area 
Available for 
Cell 
Attachment 
(cm
2
/g) 
PHBV 
PCL 
PLGA 
Cytodex 1 
212 - 300 
212 – 300 
212 – 300 
54 - 86 
1429 ± 4 
891 ± 10 
1973 ± 7 
991 ± 1 
212 – 300 
212 – 300 
212 – 300 
147 - 248 
1429 ± 4 
891 ± 10 
1973 ± 7 
4400* 
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2.5 Discussion 
The SEM images demonstrated distinct surface features of the synthesised 
microcarriers. PHBV and PLGA microcarriers possessed nanoporous surfaces whilst 
PCL surfaces were shown to be comparatively smooth. Polymeric microcarriers with 
similar surface topographies and diameter ranges have been shown to support the 
growth of different cell types (Shen et al. 2006; Jabbarzadeh et al. 2007; Zhu et al. 
2007b; Zhu et al. 2009). Furthermore, coupled with evidence of biocompatibility (Doyle 
et al. 1991; Hutmacher et al. 2001; Dai et al. 2004; Kang et al. 2005; Shao et al. 2006), 
it is expected that PHBV, PCL and PLGA microcarriers will support the attachment and 
proliferation of BMSCs. Surface roughness on 2D scaffolds have been shown to 
significantly influence cell expansion (Degasne et al. 1999; Deligianni et al. 2001a; 
Deligianni et al. 2001b). In view of the smooth surface topography of the PCL 
microcarriers examined in this chapter, the level of surface roughness of this 
microcarrier type will be increased in order to evaluate the effect of microstructure on 
BMSC expansion in chapter 4. 
In chapter 3, the BMSC proliferation rates on the microcarrier types will be assessed. 
The SEM images in this study have revealed rougher surfaces on PHBV and PLGA, as 
compared to the PCL microcarriers. Previous studies (Degasne et al. 1999; Deligianni et 
al. 2001a; Deligianni et al. 2001b) have reported superior expansion rates on 2D 
surfaces at the higher end of the surface roughness range: 0.3 μm ≤ Ra ≤ 5.1 μm. 
Futhermore, higher amorphous and lower crystallinity content favours cell expansion 
(Park and Cima 1996; Balasundaram et al. 2006; Czarnecki et al. 2008). On the basis of 
crystallinity content and surface roughness, it would be expected that BMSC expansion 
would be superior on PHBV and PLGA as compared to PCL microcarriers. 
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These microcarriers are intended for use in spinner flasks bioreactors. The control, 
Cytodex 1 microcarriers, has shown promise in BMSC expansion (Frauenschuh et al. 
2007; Weber et al. 2007; Schop et al. 2008; Schop et al. 2009a; Schop et al. 2009b). It 
has previously been shown that as density differences between the microcarrier and the 
culture medium increased, so did the shear stress imparted on the microcarrier (Qiu et 
al. 1998). There is evidence which describes the impact of different levels of shear 
stress on cells in terms of expansion, viability and morphology (Stathopoulos and 
Hellums 1985; Zeng et al. 2006; Zhao et al. 2007). It is conceivable that microcarriers 
with lower densities than Cytodex 1 may require lower impeller rotational rates, thus 
imparting lower shear stress, in order to achieve suspension within spinner flask 
bioreactors. This study has provided surface area data, but there is no indication of the 
density consistency of the synthesised individual microcarriers. Hence, in chapter 3, the 
microcarrier density in culture medium will be qualitatively assessed. 
The environmental SEM data indicated that the applied temperature and humidity 
changes resulted in no alterations in microcarrier diameter. The dry microcarriers are 
stored at 4°C after synthesis. As they are intended for cell culture work, they are 
subjected to incubating conditions of proliferation medium at 37°C. Whilst such 
conditions were not replicated exactly in the Environment SEM machine, an 11°C 
temperature rise, submergence in distilled water and 100% humidity resulted in no 
microcarrier diameter changes. The resistance of the polymeric microcarrier diameter 
under these conditions provided support for the method of surface area measurement 
(section 2.3.3 and appendix 8.1). This is a method which has been used successfully in 
previous studies (Fischer et al. 2003; Ahmadi et al. 2009), which assumes a spherical 
morphology. The measurements were performed thrice on each polymeric microcarrier 
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type and were compacted in eppendorf vials in order to improve data accuracy. This 
method will be employed in chapters 3 and 4. 
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2.6 Conclusion 
PHBV, PCL and PLGA microcarriers were successfully synthesised and characterised 
by means of fourier transform infrared, scanning electron microscopy and 
environmental scanning electron microscopy. The SEM results showed nanoporous 
PHBV and PLGA surfaces and a comparatively smooth PCL surface morphology. 
Under humid conditions and temperature changes, the PHBV, PCL and PLGA 
microcarriers did not change in size. The diameter of the PLGA pores appeared to 
increase in size slightly when humidity was increased.  The next step will be to examine 
the attachment and proliferation of bone marrow-derived mesenchymal stromal cells on 
the synthesised microcarriers. 
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3 PHBV, PCL and PLGA Microcarriers support the 
Attachment and Proliferation of Human BMSCs 
3.1 Abstract 
Previously, PHBV, PCL and PLGA microcarriers were characterised for their suitability 
as scaffolds for bone marrow stromal cell (BMSC), or mesenchymal stem cell 
expansion. In this study, the ability of these microcarriers to support human BMSC 
attachment and proliferation is evaluated. Human BMSCs were seeded on the 
microcarrier types and their numbers were assessed with the alamarBlue
TM
 assay over a 
five-day period. Passage one BMSCs from three human donors were used in this 
experiment. Light and fluorescent microscopy was employed to monitor attachment and 
proliferation. The BMSCs were harvested from the microcarriers and evaluated for 
differentiation along the osteogenic and adipogenic lineages. BMSC expansion on the 
PHBV and Cytodex 1 microcarriers and the tissue culture plastic demonstrated no 
significant differences in proliferation rates and they were superior to PCL and PLGA 
microcarriers.  
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3.2 Introduction 
PHBV [poly (3-hydroxybutyrate-co-3-hydroxyvalerate)], PCL [poly (-caprolactone)] 
and PLGA [polyglycolide-co-lactide] are examples of polymers which have been used 
in a wide variety of tissue engineering applications. Their biocompatibility has been 
established (Doyle et al. 1991; Hutmacher et al. 2001; Dai et al. 2004; Kang et al. 2005; 
Shao et al. 2006). The three polymers have been synthesised as 2D films and 3D discs 
for the purpose of evaluating in vitro growth, and also in vivo growth in animal models 
such as sheep and rabbits, in conjunction with BMSCs (Ren et al. 2005; Uematsu et al. 
2005; Tang and Wu 2006; Curran et al. 2009). However, studies evaluating human 
BMSC growth on these three polymers are limited. Although, PLGA scaffolds, in 
particular, microcarriers, discs and nanofibers, have been utilised in conjunction with 
human BMSCs for pre-clinical studies (Moioli et al. 2007; Xin et al. 2007; Stiehler et 
al. 2009). To our knowledge, the employment of microcarriers composed of these three 
polymers have not been utilised for the purpose of human BMSC expansion. 
Chapter 2 characterised PHBV, PCL and PLGA microcarriers which were prepared in-
house. SEM images revealed that the surfaces of PHBV and PLGA microcarriers were 
nanoporous and that the PCL surfaces were comparatively smooth. From the literature, 
polymeric microcarriers with smooth and nanoporous topographies and diameter ranges 
have been shown to support the growth of different cell types (Shen et al. 2006; 
Jabbarzadeh et al. 2007; Zhu et al. 2007b; Zhu et al. 2009). Furthermore, pilot studies 
were conducted which successfully demonstrated the attachment and proliferation of 
goat BMSCs on the microcarriers; however, expanded BMSC harvests from the 
microcarriers resulted in dead cells (refer to appendix 8.2). It is therefore expected that 
human BMSCs will successfully attach and proliferate on the three microcarriers. 
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Human BMSCs expanded on 2D and 3D scaffolds have been shown to differentiate 
along more than one lineage (Pittenger et al. 1999; Schop et al. 2009a). Curran et al. 
demonstrated that adjustments in hydrophilicity, and the resultant surface chemistry, of 
PLGA-doped PCL films can induce human BMSC differentiation in the absence of 
biological stimuli (Curran et al. 2009). Furthermore, doping of PCL with PLGA 
increased the hydrophilic nature of PCL. As this study will be conducted over a 
relatively short time frame, the effect of the polymeric microcarrier differences in 
hydrophilicity on phenotypic retention is not expected to be significant. 
As discussed in chapter 2, microcarriers possessing lower densities than Cytodex 1 
would conceivably require lower impeller rotational rates in order to achieve suspension 
within spinner flask bioreactors. These lower rotational rates would impart lower shear 
stress on BMSCs. 
The aims of this chapter are 
I. To demonstrate the attachment of BMSCs on the PHBV, PCL and PLGA 
microcarriers 
II. To evaluate and to compare the proliferation rates of human BMSCs on the 
microcarriers 
III. To harvest expanded human BMSCs from the microcarriers and to evaluate 
differentiation potential 
IV. To qualitatively assess the microcarrier densities of PHBV, PCL and PLGA. 
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3.3 Materials and Method 
3.3.1 Human BMSC Sources 
The human BMSCs were kindly donated by Xpand Biotechnology BV (The 
Netherlands). Three human donors were used. Bone marrow was obtained from three 
patients who underwent total hip arthroplasty in the Netherlands. The donors were: (1) 
female, aged 56, iliac crest, arthrodesis surgery, 59.8 million nucleated cells/cm
3
 bone 
marrow (2) female, aged 37, iliac crest, arthrodesis surgery, 25.0 million nucleated 
cells/cm
3
 bone marrow and (3) male, aged 45, acetabulum, total hip replacement 
surgery, 15.7 million nucleated cells/cm
3
 bone marrow. The bone marrow was placed in 
T-flasks at a density of 500,000 nucleated cells/cm
2
, expanded in proliferation medium 
(refer to section 3.3.2) within a 5% CO2, 37°C incubator, harvested and cryopreserved 
(Both et al. 2007). Passage one BMSCs were utilised for this study. 
3.3.2 Proliferation Medium for Human BMSCs 
The proliferation medium consisted of sterile α-Minimum Essential Medium 
(Invitrogen, United Kingdom) supplemented with 8.9% v/v heat inactivated Fetal 
Bovine Serum (Invitrogen, United Kingdom), 100 U/ml Penicillin (Sigma Aldrich, 
United Kingdom), 100 µg/ml Streptomycin (Sigma Aldrich, United Kingdom), 2 mM 
L-glutamine (Sigma Aldrich, United Kingdom), 0.2
 
mM ascorbic acid (Sigma Aldrich, 
United Kingdom) and 1 ng/ml basic fibroblast growth factor (AbD Serotec, United 
Kingdom). The maximum shelf-life was one month and this medium was stored at 4°C. 
(Both et al. 2007; Ahmadi and de Bruijn 2008) 
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3.3.3 Osteogenic Medium for Human BMSCs 
The osteogenic medium consisted of the proliferation medium (refer to section 3.3.2) 
without the basic fibroblast growth factor, but additionally supplemented with 10 mM 
β-glycerophosphate (Sigma Aldrich, United Kingdom) and 1 x 10-8 M dexamethasone 
(Sigma Aldrich, United Kingdom). The maximum shelf-life was one month and this 
medium was stored at 4°C (Jaiswal et al. 1997; Mendes et al. 1998; Both et al. 2007; 
Ahmadi et al. 2009). 
3.3.4 Adipogenic Medium for Human BMSCs 
The adipogenic medium consisted of sterile Dulbecco’s Minimum Essential Medium 
(Invitrogen, United Kingdom) supplemented with 10% v/v heat inactivated Fetal 
Bovine Serum (Invitrogen, United Kingdom), 0.05 M 3-Isobutyl-1-methylxanthine 
(Sigma Aldrich, United Kingdom), 0.02 M Indomethacin (Sigma Aldrich, United 
Kingdom), 0.1 nM insulin (Sigma Aldrich, United Kingdom), 100 U/ml Penicillin 
(Sigma Aldrich, United Kingdom), 100 µg/ml Streptomycin (Sigma Aldrich, United 
Kingdom), and 1 M dexamethasone (Sigma Aldrich, United Kingdom). The maximum 
shelf-life was one month and this medium was stored at 4°C. (Pittenger et al. 1999; 
Sekiya et al. 2002; Schop et al. 2009a) 
3.3.5 Pre-culture 
Cryopreserved Passage 1 human BMSCs were defrosted and plated on T-flasks at 2000 
cells/cm
2
. They were expanded in standard expansion medium until approximately 70% 
confluency. 
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3.3.6 Microcarrier Sterilisation, Cleaning and Pre-conditioning 
Prior to cell seeding, 10 cm
2
 of weighed synthesised microcarriers (refer to section 
2.4.3), PHBV, PCL and PLGA, were placed into each well of 24 square well plates 
which does not allow cell attachment (Greiner Bio-One Limited, United Kingdom) in a 
fume cupboard for 10 minutes under uv light for sterlisation. After such time, the well-
plate was shaken gently and then replaced into the fume cupboard for a further 10 
minutes. The synthesised microcarriers were cleaned with pre-warmed, sterile 
phosphate-based saline solution (Sigma Aldrich, United Kingdom) in order to remove 
debris from the surface of the microcarriers to maximise cell attachment. Sterile 
Cytodex 1 microcarriers of 10 cm
2
 surface area were then placed into wells. For pre-
conditioning, 0.3 ml of pre-warmed standard expansion medium was placed into each 
well and the well-plates were then placed into a 5% CO2, 37°C incubator for 30 
minutes. 
3.3.7 Cell Seeding 
On Day 0, BMSCs were harvested from 70% confluent T-flasks using 0.25% trypsin 
w/v in 1 mM EDTA (Invitrogen, United Kingdom) and then seeded onto microcarriers 
and 6-well plates at a density of 2000 cells/cm
2
. The volume of cells delivered to each 
well was 0.2 ml, thus increasing the volume to a total of 0.5 ml (0.2 ml cells and 0.3 ml 
conditioned medium containg microcarriers). This was shaken gently for 3 minutes and 
then left in the 5% CO2, 37°C incubator for 4 hours to allow BMSC attachment to the 
microcarriers. After this period, the volume of each well was made up to 2 ml with 
standard expansion medium. 
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3.3.8 BMSC Growth Analysis 
Two controls, in triplicate, were employed – Cytodex 1 microcarriers and tissue culture 
plastic well-plates. The experimental groups, again in triplicate, were (i) PHBV 
microcarriers, 212-300 micron diameter range (ii) PCL microcarriers, 212-300 micron 
diameter range (iii) PLGA microcarriers, 212-300 micron diameter range. The 
alamarBlue
TM
 (Serotec, United Kingdom) assay was used to calculate the number of 
cells at 24, 72 and 120 hours. 
At each time-point, the standard expansion medium was removed and 1 ml of 10% v/v 
alamarBlue
TM
 in medium was added to each well. The well-plates were then placed into 
the incubator for 4 hours. After this period, 200 µl of each group was pippetted into 96 
well-plates (VWR, United Kingdom). The fluorimeter (FLUOstar Galaxy, Germany) 
was used to measure the fluorescence at excitation and emission wavelengths of 544 nm 
and 590 nm respectively. 
A standard curve of cell number versus wavelength was prepared per passage per donor 
specific to the BMSCs used in this study (refer to appendix 8.3). This curve was used to 
determine cell populations at different time-points and consequently to calculate the 
number of population doublings and the doubling times. 
BMSC population growth curves were constructed based on the three time-point 
population measurements. The specific growth rate (μ) and doubling times (td) were 
calculated using Equation 3, Equation 4 and Equation 5, (Doran 2002), where xt and x0 
represented the cell populations at different time-points. The number of population 
doublings for a given time-frame, Δt, was calculated using Equation 6. 
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Equation 3: Exponential Growth 
μt
0t exx   
Equation 4: Specific Growth Rate 
t
)ln(x)ln(x
μ 0t


  
Equation 5: Doubling Time 
μ
ln(2)
t d   
Equation 6: Population Doublings 
0
t
x
x
Doublings   
3.3.9  Human BMSC Harvest 
At the final time-point of 120 hours, the microcarriers were placed on 100 µm pore size 
cell strainers (BD Falcon, United Kingdom) and washed thoroughly with pre-warmed, 
sterile Phosphate-based saline solution. The strainers containing the microcarriers were 
then placed into 6-well plates containing pre-warmed 0.25% trypsin-edta. The well-
plates were placed into the incubator for 20 minutes. After such time, the standard 
expansion medium was added to stop the action of the enzyme trypsin, and the cells 
centrifuged at 300 x g. Pellets were obtained and the proliferation medium was 
discarded. 
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3.3.10 Differentiation of harvested human BMSCs 
3.3.10.1 Osteogenic Differentiation 
For osteogenic differentiation, human MSCs were seeded in 48-well plates at a density 
of 5000 cells/cm
2
. Osteogenic medium (plus dexamethasone) represented the 
experimental group and the proliferation medium (minus dexamethasone) (section 
Proliferation Medium for Human BMSCs) represented the control. Medium was 
refreshed twice weekly. On day 12, the cells were fixed in 4 % w/v paraformaldehyde in 
PBS (Sigma Aldrich, United Kingdom). ALP staining was employed using the Alkaline 
Phosphatase Detection kit (Millipore

, International). 
ALP staining was employed to stain the alkaline phosphatase enzyme using the 
Alkaline Phosphatase Detection kit (Millipore

, International). Briefly, the stain 
involved the fixation of cells for 1 minute, followed by rinse buffer TBST (20 mM Tris-
HCL, pH 7.4, 0.15 M NaCl, 0.05 % v/v Tween, Millipore

, International). Then, the 
cells were incubated with a solution of mix fast red violet solution (0.8 g/L stock), 
naphthol AS-BI phosphate solution (4 mg/L in 2 mol/L AMPD buffer, pH 9.5) and 
water (2:1:1 ratio) for 15 minutes in the dark at room temperature. Then, the solution 
was removed after incubation, rinsed again with TBST and finally the cells were 
covered with PBS. A false positive control (excluding napthol AS-BI phosphate 
solution from the procedure) was used. A red precipitate confirmed the presence of 
ALP. 
3.3.10.2 Adipogenic Differentiation 
For adipogenic differentiation, human MSCs were seeded in 48-well plates at a density 
of 5000 cells/cm
2
. Adipogenic media represented the experimental group and the 
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proliferation medium (section 3.3.2) represented the control. Medium was refreshed 
twice weekly. On day 21, the cells were fixed in 3.7 % formaldehyde. Oil Red O 
(Sigma Aldrich, United Kingdom) staining was employed to stain fat droplets. 
Briefly, 3 mg/ml Oil Red O (Sigma Aldrich, United Kingdom) in isopropanol (Sigma 
Aldrich, United Kingdom) was diluted with deionised water (2:1 ratio). This working 
solution was filtered after 10 minutes and the resulting solution was used within 120 
minutes. The formaldehyde was removed from the well-plates and the cells were 
washed gently with deionised water. Then, 60% isopropanol v/v was used to cover the 
cells for 5 minutes. The isopropanol was removed and the working solution of Oil Red 
O was allowed to cover the cells for 5 minutes. After this time, the well-plates were 
rinsed with deionised water. Fat droplets were stained in the colour of red. (Pittenger et 
al. 1999; Sekiya et al. 2002) 
3.3.11 Microscopy 
Light microscopy was used to qualitatively assess the cell attachment and proliferation. 
Fluorescent microscopy was used to assess live/dead cell proportions. Calcein AM dye 
(Invitrogen, United Kingdom) was used to stain live MSCs attached to the 
microcarriers. Ethidium homodymer (Invitrogen, United Kingdom) was used to stain 
dead cells. 
3.3.12 Statistical Analysis 
Statistical analyses were performed on the number of population doublings using 
Genstat version 10.1 software. An ANOVA was performed when comparing all three 
experimental groups and two control groups for significant differences. The number of 
independent replicates was 3. A student t-test was performed when comparing any 
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significant differences detected by the ANOVA. The level of significance was set at p < 
0.05. 
   Page | 94  
 
3.4 Results 
 
Figure 24: Human BMSC growth on the different scaffold types over a 120-hour period. Note that 
the seeding density applied was 2000 BMSCs/cm
2
 at time 0 hours. 
The human BMSC growth curves (Figure 24) showed general cell population increases 
on the different scaffold types over the 120-hour period. These cell population increases 
were also seen in the light and fluorescent micrographs (Figure 27). PHBV and Cytodex 
1 microcarriers and the tissue culture plastic (2-D) scaffolds possessed superior final 
time-point BMSC populations as compared to the PLGA and PCL microcarriers. 
The population doublings (Figure 25) and doubling time (Figure 26) graphical 
illustrations revealed that there were no significant differences in proliferation rates 
amongst the PHBV and Cytodex 1 microcarriers and the tissue culture plastic scaffolds 
over the 120-hour time period. PHBV microcarriers and the tissue culture plastic 
demonstrated superior BMSC proliferation rates as compared to the PCL and PLGA 
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microcarriers. Cytodex 1 microcarriers possessed superior BMSC proliferation rates 
over the PCL microcarriers; no significant differences were detected in the BMSC 
proliferations rates between Cytodex 1 and PLGA microcarriers. 
At time-point 120 hours, harvested cells from the microcarriers and tissue culture plastic 
were subjected to osteogenic and adipogenic media. On day 12, ALP staining was 
performed and it was found that BMSCs harvested from the microcarriers and tissue 
culture plastic had differentiated into osteoblast-like cells owing to positive tests for 
ALP (Figure 28). On day 21, Oil red O staining was performed and it was found that 
BMSCs harvested from the microcarriers and tissue culture plastic had differentiated 
into adipocyte-like cells owing to positive tests for stained oil droplets (Figure 29). No 
differences in differentiation potential were seen. 
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Figure 25: Human BMSC Population Doublings on the scaffold types. The data was calculated 
utilising BMSC population numbers at time-points 24 and 120 hours. 
 
Figure 26: Human BMSC doubling times on the scaffold types. The data was calculated utilising 
BMSC population numbers at time-points 24 and 120 hours. 
p < 0.001 
p = 0.011 
p < 0.001 
p = 0.018 
p = 0.003 
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Scaffold 
Type 
24 hours 120 hours 
L F L F 
PHBV 
    
PCL 
    
PLGA 
    
Cytodex 1 
(3D 
Control) 
    
Well-plate 
(2D 
Control) 
  
Figure 27: Light (L) and Fluorescence (F) micrographs of human BMSCs on microcarriers and 
well-plates after 24 and 120 hours after seeding. The green colour in the fluorescent micrographs 
indicates live cells, which correspondingly shows the location of the cells in light micrographs. The 
white scale bar represents 200µm. Magnification was at x100. Only light micrographs are shown 
for the 2D control. 
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PHBV 
 
PCL 
 
PLGA 
 
Cytodex 1 
 
2D 
 
2D (Proliferation Medium) 
Figure 28: Day 12 ALP staining on the three experimental groups (PHBV, PCL and PLGA) and the 
two control groups (Cytodex 1 and 2D well-plates), which were all harvested BMSCs subjected to 
osteogenic medium (plus dexamethasone). A 2D well-plate group subjected to proliferation medium 
(minus dexamethasone) was introduced as a negative control. 
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PHBV 
 
PCL 
 
PLGA 
 
Cytodex 1 
 
2D 
 
2D subjected to proliferation media 
Figure 29: Day 21 light micrographs of harvested BMSCs from the experimental (PHBV, PCL and 
PLGA microcarriers) and control (Cytodex 1 and 2D) groups subjected to adipogenic media and 
the 2D group subjected to proliferation media (negative control). 
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3.5 Discussion 
This study has demonstrated superior BMSC growth on PHBV microcarriers as 
compared to the PLGA and PCL microcarriers, and similar growth rates on cytodex 1 
and tissue culture plastic 2D control. Human BMSCs proliferated more on PHBV 
microcarriers (4.22 ± 0.68 population doublings) as compared to PCL (2.15 ± 0.42 
population doublings) and PLGA (2.95 ± 0.34 population doublings) microcarriers. The 
statistics backed these trends indicating significant evidence of a difference (p < 0.001) 
between PHBV and PCL and of a difference (p = 0.011) between PHBV and PLGA. 
These trends were evident for BMSCs from the three human donors (see appendix 8.5). 
No significant differences were observed in the proliferation rates among the PHBV and 
Cytodex 1 microcarriers and the tissue culture plastic. This data demonstrated that 
BMSC expansion rates on microcarriers are comparable to those on 2D scaffolds, and 
thus microcarrier culture shows even more promise as an alternative to 2D culture. 
Additionally, PHBV microcarriers exhibited comparable, rather than superior, 
proliferation rates to Cytodex 1 microcarriers. 
Chapter 2 and observations from this investigation revealed that during static culture, 
Cytodex 1 and PHBV microcarriers sank to the bottom of proliferation medium within 
the well-plates. The only exception was that a proportion of the PHBV microcarriers did 
not sink to the bottom, but occupied different levels of the proliferation medium. It is 
conceivable that within a spinner flask bioreactor culture, the lower density PHBV 
microcarriers may require lower impeller rotational rates as compared to the Cytodex 1 
microcarriers. As previously discussed in chapter 2, there is evidence which details the 
impact of different levels of shear stress on cells in terms of expansion, viability and 
morphology (Stathopoulos and Hellums 1985; Zeng et al. 2006; Zhao et al. 2007). 
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Although beyond the scope of this thesis, BMSC expansion on the Cytodex 1 
microcarriers, the higher density PHBV microcarrier and the lower density PHBV 
microcarriers should be investigated within a spinner flask culture environment to 
compare proliferation rates and to assess the impact of shear stress from different 
impeller rotational speeds. However, any such study must consider that the diameter 
ranges of Cytodex 1 (147 – 248 μm) and PHBV (212 - 300 μm) microcarriers would 
influence the magnitude of shear stress on the microcarriers, as Qiu et al. (1998) found 
that as the density difference between the microcarrier and the culture medium 
increased, so did the shear stress imparted on the microcarrier (Qiu et al. 1998). 
This investigation revealed that the harvested BMSCs were successfully differentiated 
along the osteogenic and adipogenic lineages, and that no differences were detected 
between the experimental and control groups in terms of differentiation potential. This 
was expected as previous research (Li et al. 2002; Gauthaman et al. 2009) showed stem 
cells retaining their stemness on various polymeric scaffolds. Considering that ALP 
activity peaks between days 10-14 (Storrie and Stupp 2005) during in vitro osteogenesis 
and that the oil droplets were stained at day 21 during adipogenesis, the expansion of 
BMSCs on the polymeric microcarriers took place over 5 days which is a relatively 
short period of time. Curran et al. (2009) showed that PLGA doping of PCL affected the 
plastic potential of human BMSCs on films over a 28-day period (Curran et al. 2009). 
This study found that PCL containing 0 – 30 wt % PLGA enhanced chondrogenic 
potential both in basal and chondrogenic conditioned media, in particular 30 wt % 
PLGA showing the greatest enhanced chondrogenic potential. Furthermore, the 
osteogenic potential of these PCL/PLGA films were found to be lacking osteogenic 
potential (Marletta et al. 2007; Curran et al. 2009), with only PCL containing 20 wt % 
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PLGA facilitating osteogenic differentiation of BMSCs under osteogenic conditions. 
Any expansion strategy involving BMSC culture on polymeric microcarriers greater 
than 5 days may affect the differentiation potential of attached or harvested cells. 
Therefore, although outside the scope of this thesis, future work should focus on the 
differentiation potential of attached and harvested BMSCs from polymeric microcarrier 
cultures over longer periods of culture. 
The SEM images from chapter 2 revealed differences in the surface topography of the 
polymeric microcarriers. As such and through this investigation, surface topography and 
chemical constitution are two of the variables which may explain the significant 
variation of human BMSC expansion rates on the three microcarrier types. 
Consequently, the effect of surface morphology will be investigated in the next chapter. 
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3.6 Conclusion 
Human BMSCs successfully attached and proliferated on PHBV, PCL and PLGA 
microcarriers. This study has demonstrated superior BMSC growth on PHBV 
microcarriers as compared to the PLGA and PCL microcarriers, and similar growth 
rates on cytodex 1 and tissue culture plastic 2D control. This superiority was evident for 
all three human donors. Expanded BMSCs were harvested from the microcarriers and 
showed the ability to differentiate along the osteogenic and adipogenic lineages. This 
investigation demonstrated that human BMSC expansion rates on PHBV microcarriers 
is comparable to those on tissue culture plastic and therefore shows promise as an 
alternative to 2D-based culture. As compared to Cytodex 1 microcarriers, the lower 
density PHBV microcarriers would be expected to require lower spinner flask rotational 
rates, thus imparting lower shear stress on cells, in order to achieve suspension. Surface 
morphology and chemical constitution were identified as two variables which may have 
accounted for the different proliferation rates of the polymeric microcarriers. The next 
chapter shall focus on evaluating the effect of microcarrier surface morphology on 
human BMSC expansion. 
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4 BMSC Expansion on Microcarriers: The Effect of 
Surface Microstructure 
4.1 Abstract 
This chapter builds on the previous results by investigating the effect of microcarrier 
surface microstructure on BMSC expansion. The surface roughness of PCL 
microcarriers was altered by using two impeller designs during microcarrier synthesis. 
The effect of impeller design on surface microstructure was shown with SEM and laser 
profilometry. These two characterisation techniques revealed visual differences in the 
surface roughness of PCL-r (rough PCL) and PCL-s (smooth PCL) and Ra values of 1.8 
± 0.5 µm and 6.4 ± 1.5 µm respectively. BMSCs from all three human donors showed 
superior proliferation rates on PCL-r as opposed to PCL-s, and maintained their 
differentiation potential along the osteogenic and adipogenic lineages. 
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4.2 Introduction 
Polymeric surface modification has been demonstrated to have an effect on biological 
processes (Sittinger et al. 1996; Park et al. 1998; Wan et al. 2004; Thissen et al. 2006). 
For example, oxygen plasma treatment on PLGA films increased hydrophilicity and 
surface roughness which resulted in increased mouse fibroblast cell adhesion and shear 
stress endurance within a parallel plate flow chamber (Wan et al. 2004). Emulsion 
solvent evaporation techniques are a common means of polymeric microcarrier 
synthesis (Yang et al. 2000; Zhu et al. 2007b). Variations of this method have been 
employed to manipulate their physical features (Crotts and Park 1998; Yang et al. 2000; 
Chun et al. 2004). Cationic composite microcarriers, synthesised by single emulsion, 
exhibited superior chondrogenic performance in attachment, proliferation and function 
compared to hydrophobic and anionic microcarriers (Chun et al. 2004). A higher water 
proportion in the first emulsion was shown to increase the porosity of PLGA 
microcarriers (Crotts and Park 1998). Qualitative results (Yang et al. 2000) have 
suggested that PLGA microcarriers synthesised at higher temperatures (38ºC and 42ºC) 
possessed a higher degree of surface roughness. Whilst thermal and chemical means 
have been used to alter surface roughness, to our knowledge, impeller designs have not 
been explored as an alternative. It is known that impeller design defines flow patterns 
which influence mixing regimes, levels of shear stress, the intensity of agitation and 
vortex frequency (Hooker et al. 1990; Doran 2002; Chua et al. 2008). However, 
impeller design effects on microcarrier surface roughness during the w/o/w method of 
preparation are unclear. 
It has previously been shown that cell expansion rates on 2D surfaces increase as 
surface roughness, Ra, increases. Degasne et al. showed that human osteoblast-like cell 
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attachment and proliferation increased on titanium disks as the Ra increased from 0.30 ± 
0.01 to 0.94 ± 0.09 µm (Degasne et al. 1999). This trend was seen in work by 
Deligianni et al. with human BMSCs on hydroxyapatite disks with Ra increasing from 
0.733 ± 0.203 µm to 4.680 ± 0.433 µm (Deligianni et al. 2001b). Again, this was seen in 
work presented by Deligianni et al. with human BMSCs on Ti-6Al-4V disk surfaces 
with Ra increasing from 0.320 ± 0.065 µm to 0.874 ± 0.185 µm (Deligianni et al. 
2001a). Chapters 2 and 3 revealed differences in surface microstructure as well as 
differences in BMSC expansion rates; superior expansion rates were noted on the 
rougher polymeric surfaces. To our knowledge, there are no studies of cell expansion 
rates on microcarriers with different levels of surface roughness. Based on the combined 
minimum and maximum levels of 2D surface roughness of previous studies (Degasne et 
al. 1999; Deligianni et al. 2001a; Deligianni et al. 2001b), 0.30 μm ≤ Ra ≤ 5.1 μm, it 
would be expected that BMSC expansion on microcarriers with Ra at the higher end of 
the range would be higher than the lower end. 
The aims and objectives of this study were: 
I. To prepare microcarriers of different surface microstructure roughness. 
II. To characterise the surface roughness of PCL microcarriers produced by the 
novel method of manufacture. 
III. To evaluate the growth of human BMSCs on PCL microcarriers and to test the 
hypothesis that increasing the degree of PCL microcarrier surface microstructure 
(0.29 μm ≤ Ra ≤ 5.11 μm) from the lower to higher end of the range would 
increase the expansion rates of human BMSCs. 
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IV. To harvest expanded BMSCs from the PCL microcarriers and to evaluate 
retention of differentiation potential. 
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4.3 Materials and Method 
4.3.1 Microcarrier Synthesis and Surface Roughness Alteration 
The w/o/w method was employed to synthesise and prepare microcarriers as previously 
described in sections 2.3.2 and 2.3.3 using the polymer, PCL (section 2.3.1). A 
polyvinyl alcohol concentration of 0.6 g/l (for smoother PCL microcarriers) or 0.9 g/l 
(for rougher PCL microcarriers) was employed to ensure that the microcarriers were 
completely separated from each other. 
 
Figure 30: Propeller-design impeller (30 mm diameter) on the left-hand side for the production of 
smoother PCL microcarrier surfaces. Pitch-blade impeller (49 mm diameter) on the right-hand side 
for the production of rougher PCL microcarrier surfaces. 
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4.3.2 Scanning Electron Microscopy 
Scanning Electron Microscopy (SEM) was used to examine the surface topography of 
the microcarriers. Section 2.3.5 describes how this was performed. 
4.3.3 Laser Profilometry 
 
Figure 31: The variable components of the surface roughness parameters. x represents the 
microcarrier diameter and l represents diameter intervals. Z(x) represents the amplitude. 
The level of dry microcarrier surface roughness was measured with a laser profilometer 
(Proscan 2000A, Scantron Industrial Products Limited, England). The non-contact 
sensor head (model S29/12 Chromatic) possessed a measuring range of 12 mm, a stand-
off distance of 29 mm, a resolution of 280 nm and a nominal spot size of 22 µm. 
Microcarrier surface roughness was measured using an area of 100 µm x 100 µm at 1 
µm step size (n = 6). The surface filter was set to 1 so as to convert the spherical 
dimensions of the microcarriers into a 2D surface. The parameters evaluated were Ra, 
Rq and RzDIN, which are amplitude characterisations. Figure 31 and Table 3 describe 
these parameters (Wieland 1999). Appendix 8.4 describes the method of surface 
roughness measurement. 
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Table 3: Table of surface roughness parameter definitions. They are amplitude parameters which 
are measures of the vertical characteristics of the microcarrier surface. 
Parameter Definition Formula 
Ra Arithmetic mean of the 
absolute departures of the 
roughness profile from the 
mean line. 
 
Rq Root Mean Square. This 
parameter gives leverage to 
the extreme Ra values.  
RzDIN Numerically the average 
height difference between the 
five highest peaks (p) and the 
five lowest valleys (v) within 
the sampling length. 
 
4.3.4 Human BMSC Sources 
The human BMSCs were provided by Xpand Biotechnology BV (The Netherlands). 
BMSCs from three human donors were used. Bone marrow was obtained from three 
patients who underwent total hip arthroplasty in the Netherlands. Their details are listed 
in section 3.3.1. The bone marrow was placed in T-flasks, expanded in proliferation 
medium (refer to section 3.3.2), harvested and either cryopresevered or replated. 
Passage two BMSCs were utilised for this study. 
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4.3.5 MSC Pre-cultivation, Culture, Population Monitor, Harvest and 
Differentiation 
BMSC pre-cultivation, culture, population monitor, harvest and differentiation into 
more than one lineage were carried out as per sections 3.3.5, 3.3.6, 3.3.7, 3.3.8, 3.3.9 
and 3.3.10. The experimental groups, conducted in triplicate, were smooth PCL (PCL-s) 
microcarriers and rough PCL (PCL-r) microcarriers. The control groups were Cytodex 1 
microcarriers and expansion on plastic tissue culture well-plates (2D). 
4.3.6 Microscopy 
Light and fluorescent microscopy was used to qualitatively assess the cell attachment 
and proliferation on the microcarriers and tissue culture well-plates. Fluorescent 
microscopy was used to assess live/dead cell proportions on the microcarriers. Calcein 
AM dye (Invitrogen, United Kingdom) was used to stain live BMSCs attached to the 
microcarriers whilst Ethidium homodymer (Invitrogen, United Kingdom) was used to 
stain dead cells. 
4.3.7 Statistical Analyses 
Statistical analysis was performed on the number of population doublings and the 
surface roughness data using Genstat version 10.1 software. An ANOVA was selected 
when comparing all two experimental groups and two control groups for significant 
differences. The number of independent replicates was 3 (for cell culture studies) and 6 
(for surface roughness studies). A student t-test was performed when comparing any 
significant differences detected by the ANOVA. A student t-test was performed for the 
surface roughness parameters. The level of significance was set at p < 0.05. 
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4.4 Results 
The SEM images of PCL-s and of PCL-r, show visible differences in the surface 
roughness of the two microcarriers (Figure 32 and appendix 8.4). This observation was 
supported by the laser profilometry data (Figure 34 and Figure 35) which showed that 
PCL-r has a Ra = 6.4 ± 1.5 microns and PCL-s has a Ra = 1.8 ± 0.5 microns (p = 0.025). 
The root mean square (Rq) data showed that the surfaces of the PCL-r (Rq = 17.9 ± 5.7 
microns) and PCL-s (Rq = 4.6 ± 0.5 microns) microcarriers do contain small areas of 
extreme surface roughness. The Environmental SEM results showed no changes in 
diameter as temperature and humidity increased by 11°C and 90% respectively (Figure 
33). 
The results of one human donor are presented within this section and the trends are 
representative of all three human donor BMSCs (see appendix 8.6). Cell population 
curves (Figure 36), population doublings (Figure 37), population doubling times (Figure 
38) and light and fluorescent images (Figure 39) demonstrated BMSC cell growth and 
attachment on both surfaces. The PCL-r surface (2.16 ± 0.11 population doublings) 
favoured cell growth (p = 0.02) as compared to the PCL-s surface (1.33 ± 0.20 
population doublings). Cell growth was superior on the control groups (tissue culture 
plastic and Cytodex 1) as compared to the experimental groups. 
After harvesting, the BMSCs were successfully differentiated along the osteogenic and 
adipogenic lineages (Figure 40) for both the experimental and control groups which 
were subjected to the differentiation media. The ALP staining and lipid droplets were 
clearly visible as compared to the control groups which had been subjected to 
proliferation medium. These data showed that the expanded BMSCs have retained a 
differentiation potential to at least the osteogenic and adipogenic lineages. No 
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differences in differentiation potential were seen between the experimental and control 
groups. 
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4.4.1 Scanning Electron Microscopy 
 
PCL-s 
 
PCL-r 
 
PCL-s 
 
PCL-r 
Figure 32: External morphologies of PCL-s (left-hand side) and PCL-r (right-hand side) 
microcarriers at two different magnifications at 10kV. The working distance and magnification of 
the top images were 10 mm and x1000 respectively, and of the bottom images were 19 mm and 
x1500 respectively. 
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4.4.2 Environmental SEM 
PCL-s PCL-r 
 
15°C, 100% humidity 
 
15°C, 100% humidity 
 
4°C, 10% humidity 
 
4°C, 10% humidity 
Figure 33: PCL-s and PCL-r subjected to different temperatures and humidities using the 
environmental SEM. 
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4.4.3 Laser Profilometry 
 
PCL-s 
 
PCL-r 
Figure 34: Laser Profilometry Scans of PCL-s and PCL-r microcarriers. 
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Figure 35: Surface roughness parameters (Ra, Rq and RzDIN) of PCL-r and PCL-s which were 
obtained from the laser profilometer scans. 
p = 0.08 p = 0.006 
p = 0.011 
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4.4.4 Human BMSC Population Analyses 
 
Figure 36: Human BMSC populations on the different scaffold types over a 120-hour period. 
Cytodex 1 is the 3D control and well-plates are the 2D control. The seeding density of 2000 
BMSCs/cm
2
 was applied at time 0 hours. 
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Figure 37: Human BMSC Population Doublings on the scaffold types. The data was calculated 
utilising BMSC population numbers at time-points 24 and 120 hours. 
 
Figure 38: Human BMSC doubling times on the scaffold types. The data was calculated utilising 
BMSC population numbers at time-points 24 and 120 hours. 
p < 0.001 
p < 0.001 
p = 0.025 
p = 0.01 
p < 0.001 
p < 0.001 
   Page | 120  
 
Scaffold 
Type 
24 hours 120 hours 
L F L F 
PCL-s 
    
PCL-r 
    
Cytodex 1 
(3D 
Control) 
    
Well-plate 
(2D 
Control) 
  
Figure 39: Light (L) and Fluorescence (F) micrographs of human BMSCs on microcarriers and 
well-plates after 24 and 120 hours after seeding. The green colour in the fluorescent micrographs 
indicates live cells, which correspondingly shows the location of the cells in light micrographs. The 
white scale bar represents 200µm. Magnification was at x100. Only light micrographs are shown 
for the 2D control. 
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4.4.5 Differentiation into the osteogenic and adipogenic lineages 
Scaffold Type Osteogenesis Adipogenesis 
PCL-s 
  
PCL-r 
  
Cytodex 1 
  
2D 
  
2D 
(proliferation 
media only) 
  
Figure 40: Day 12 ALP and Oil Red O staining on the two experimental groups (PCL-s and PCL-r) 
and the two control groups (Cytodex 1 and 2D well-plates), which were all harvested BMSCs 
subjected to osteogenic medium (plus dexamethasone) or adipogenic medium. A 2D well-plate 
group subjected to proliferation medium was introduced as a negative control. The white scale bar 
represents 200µm. 
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4.5 Discussion 
We have shown that two different impeller designs allow the synthesis of PCL 
microcarriers with different surface roughness. This was demonstrated by both SEM 
and laser profilometry. Based on laser profilometry, PCL-r microcarriers had Ra = 6.4 ± 
1.5 microns and PCL-s microcarriers had a Ra = 1.7 ± 0.4 microns (p = 0.006). 
Although outside the scope of this thesis, the reason why the two designs produced PCL 
microcarriers of different surface roughness needs further investigation. We postulate 
that during the process of synthesis (refer to section 2.3.2), when the emulsion of 
dissolved PCL in chloroform is placed into the second aqueous volume and stirred for 
three hours, the mixing regimes differ significantly per impeller design, thereby altering 
the surface roughness of the microcarriers. On closer inspection of the three-hour 
stirring stage, it was noted that the circulating microcarriers (both PCL-s and PCL-r) did 
not reside within the impeller region. This suggested that different mixing regimes, 
rather than direct interaction of the PCL microcarriers with impeller blades, caused the 
difference in the microcarrier surface roughness. To support this postulation, it has 
previously been shown that impeller design defines the flow patterns which ultimately 
determine the mixing regime (Doran 2002). For the cultivation of plant cells in a stirred 
vessel, it has been shown that for a given impeller rotational speed, the intensity of 
agitation increased as the impeller diameter increased and a greater intensity of mixing 
was achieved throughout the vessel as the distance between the impeller and the air-
liquid interface increased (Hooker et al. 1990). Within a biocentrifugal pump, it was 
found that for a given impeller rotational speed, a 16 forward-swept-blade impeller 
resulted in a lower frequency of vortices and high-shear-stress spots as compared to the 
   Page | 123  
 
16-straight blade impeller, and differing velocity vector distribution and lower shear 
stress levels as compared to the 8-backward-swept blade impeller (Chua et al. 2008). 
This study explored the effect of microcarrier surface roughness (Ra from 1.77 ± 0.49 
µm to 6.4 ± 1.48 µm) on human BMSC proliferation. Surface roughness measurements 
were taken on dry microcarriers. The drying effect may have led to artefacts owing to 
shrinkage. However, the environmental SEM images showed no changes in diameter 
and very little differences in surface roughness when subjected to temperature and 
humidity variations. BMSCs from all three human donors showed superior proliferation 
rates on PCL-r as opposed to PCL-s. For the human donor presented in this study, 2.16 
± 0.11 population doublings were recorded for PCL-r as compared to the 1.33 ± 0.20 
population doublings for the PCL-s (p = 0.025) over the 120-hour culture period. This is 
consistent with previous findings (Degasne et al. 1999; Deligianni et al. 2001a; 
Deligianni et al. 2001b) where a variety of cell types were expanded on 2D surfaces 
with a combined range of degrees of surface roughness, 0.29 μm ≤ Ra ≤ 5.11 μm. 
The harvested BMSCs from the microcarriers were successfully shown to differentiate 
along the osteogenic and adipogenic lineages through qualitative analyses (ALP and Oil 
Red O staining respectively). There were no visual differences in the intensity of 
staining amongst the PCL-s, PCL-r and control groups. Cell culture on smooth and 
rough PCL surfaces over a 120-hour period had no effect on the BMSC differentiation 
potential as compared to the tissue culture plastic and Cytodex 1 control groups. 
Previous research has showed stem cells retaining their stemness on various polymeric 
scaffolds (Li et al. 2002; Gauthaman et al. 2009). MG 63 osteoblast-like cells have been 
cultured on smoother and rougher titanium disks (0.22 μm ≤ Ra ≤ 4.37 μm) and it has 
been found that the rougher surface resulted in higher concentrations of differentiation 
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markers (Lincks et al. 1998). Increased osteogenic differentiation potential has been 
supported by other studies (Martin et al. 1995; Lohmann et al. 1999). Furthermore, 
mesenchymal stem cell differentiation has been induced in the absence of biological 
stimuli, namely doping PCL with PLGA (Curran et al. 2009). Future research should 
therefore focus on the evaluation of differentiation potential of the harvested BMSCs, 
which have been cultured over a longer time frame on polymeric surfaces of different 
degrees of surface roughness. 
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4.6 Conclusion 
A novel method of employing two impeller designs was used to prepare smooth and 
rough PCL microcarriers. The effect of impeller design on surface microstructure was 
shown with SEM and laser profilometry. These two characterisation techniques 
revealed visual differences in the surface roughness of PCL-r (rough PCL) and PCL-s 
(smooth PCL) and Ra values of 1.8 ± 0.5 µm and 6.4 ± 1.5 µm respectively. BMSCs 
from all three human donors showed superior proliferation rates on PCL-r as opposed to 
PCL-s, and maintained their differentiation potential along the osteogenic and 
adipogenic lineages. Future work is recommended to understand the mixing regimes 
which led to PCL microcarriers of significantly distinct microstructures, and to evaluate 
the effects of surface microstructure on differentiation potential over a longer cell 
culture period. 
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5 The Use of Particle Imaging Velocimetry to assess 
shear stress within a Spinner Flask Bioreactor 
5.1 Abstract 
The level of shear stress within a spinner flask bioreactor has been quantified with PIV 
(Particle Imaging Velocimetry). A PIV replica was constructed to closely mimic a 
spinner flask bioreactor used for 3D cell culture. With the aid of the PIV system, the 
shear was measured through systematically altering the microcarrier concentration and 
impeller speed. Cytodex 1 microcarriers were found to be adequate tracers within the 
PIV system. The mean shear stress within the impeller region was found to be 
approximately four times that within the non-impeller region. As expected, mean shear 
stress increased as microcarrier concentration and impeller speed increased. 
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5.2 Introduction 
In the simplest terms, a bioreactor may be defined as any environment which supports 
biological activity. However, for the purposes of regenerative medicine, specifically 
stem cell production, this definition needs to be refined as environmental control is 
essential in any cell culture process. The variables that influence the viability and 
expansion of cells on microcarriers within a spinner flask bioreactor include stirring 
rate, microcarrier concentration, temperature, media pH, nutrients and metabolic waste 
concentration and dissolved gaseous pressures. This chapter focuses on quantifying 
shear stress within a spinner flask so that it may be used to determine its effect on cell 
culture. 
Methods of shear stress measurement have proven vital in order to understand the 
nature of stem cells. Relatively simple laminar flow bioreactors have been utilised to 
measure shear stress based on flow rate and channel dimensions (Zeng et al. 2003; Zeng 
et al. 2006). Cell-based constructs in perfusion bioreactor systems, though laminar flow-
based, have posed a greater challenge in terms of obtaining reliable shear stress data 
(Zhao et al. 2007). Shear stress measurements in such systems are based on flow rate 
and perfusion bioreactor channel dimensions, which involve complex mathematical 
modelling software and sophisticated equations such as Stokes’ flow equations, 
Brinkman’s equation and Poiseuille velocity profiles. Equally challenging was the 
determination of shear stress in spinner flask or stirred-tank bioreactor systems (Venkat 
et al. 1996; Aubin et al. 2004; Sucosky et al. 2004). PIV (Particle Imaging Velocimetry) 
is a flow visualisation technique (Raffel et al. 2007). The use of PIV is a relatively new 
tool for the assessment of shear stress in bioreactors for the purpose of expanding 
BMSCs. In this field, it has mainly been used for experimental studies relating to the 
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regeneration of cartilage (Bilgen et al. 2006; Bilgen and Barabino 2007) where velocity 
and shear profiles were established around cartilage constructs for bioreactor 
optimisation, and liver (Provin et al. 2008), where shear stress profiles provided 
recommendations for optimal liver construct geometry development. These studies have 
traditionally required the development of a bioreactor replica in terms of geometry and 
which accurately replicates cell culture conditions. To complement experimental results 
obtained by the previous studies, the shear stress was calculated through computational 
fluid dynamics (CFD) modelling, which was calculated as the area-weighted average at 
any given time. 
Previous data (Stathopoulos and Hellums 1985; Zhao et al. 2007) have provided 
information on the shear stress that cells can withstand. This chapter not only measures 
shear stress under certain conditions, but it provides data which can determine optimal 
bioreactor design through impeller design, stirring speed and microcarrier 
concentration. 
In this chapter, PIV will be employed to quantify shear stress within a spinner flask for 
the ultimate purpose of evaluating BMSC expansion within spinner flask microcarrier 
culture. The aims and objectives are: 
I. To build a PIV replica of a 100 ml spinner flask. 
II. To establish a viable PIV set-up in order to gather data. 
III. To determine the suitability of Cytodex 1 microcarriers as tracer particles. 
IV. To quantify shear stress levels at different horizontal positions of the spinner 
flask. 
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V. To identify regions of high and low shear stress. 
VI. To perform a basic assessment of spinner flask hydrodynamics. 
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5.3 Materials and Method 
5.3.1 Experimental Groups 
The experimental groups within this study were based on impeller rotation rates and 
Cytodex 1 (GE Healthcare, United Kingdom) microcarrier concentrations. Table 4 
describes the experimental groups in terms of impeller rates and microcarrier 
concentration. Microcarrier concentrations are described both in microcarrier surface 
area per unit volume of proliferation media and in microcarrier mass per unit volume of 
proliferation media. 
Table 4: Description of the Experimental Groups within this study. 
Group Spinner Flask 
Impeller Rate 
(rpm) 
Wet Microcarrier 
Concentration 
(cm
2
/ml) 
Dry Microcarrier 
Concentration 
(g/ml) (g/l) 
1 
2 
3 
4 
45 
45 
60 
60 
20 
60 
20 
60 
0.0045 
0.0136 
0.0045 
0.0136 
4.5 
13.5 
4.5 
13.5 
 
5.3.2 Rheometer 
In order to determine viscosity, a rheometer (TA Instruments, AR2000, USA) was 
employed to analyse proliferation medium (see section 3.3.2 for the constituents) 
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tailored to support the growth of human BMSCs. The purpose was to ensure that the 
cell culture conditions could be accurately reproduced in the PIV experiments using 
varying concentrations of glycerol. A 40 mm (2°) cone head was used in the set-up. 
Each experimental group was subjected to three runs. Each run consisted of 15 time-
point samples of viscosity measurements within a 90 second period with the cone head 
rotating within the medium. Prior to each run, the samples were pre-warmed to 37°C 
and the equilibriation time was 60 seconds. The cone head rotational speeds were 2π 
rad/s (60 rpm) and 3π/2 rad/s (45 rpm). The average values from the three runs were 
taken as the viscosity of the experimental group. 
5.3.3 Identification of Aqueous Glycerol Solutions with Matching 
Experimental Group Viscosities 
Literature values (Kaye and Laby 1995) of aqueous solutions were sought to match the 
viscosity results of the experimental groups from the previous section (section 5.3.2), in 
order to use for the PIV experiments. Two graphs were plotted: (1) viscosity versus 
aqueous glycerol and (2) viscosity versus temperature (see Figure 45). 
5.3.4 PIV Replica and Impeller 
A PIV replica was constructed so as to match closely the dimensions of the working 
volume of the cell culture spinner flask as well as to facilitate PIV measurements. Table 
5 and Figure 41 provide information on the differences between the PIV replica and the 
cell culture spinner flask. The geometry of the PIV replica bears insignificant 
differences to the spinner flask. 
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Table 5: A comparison of the physical dimensions of the spinner flask and the PIV replica. 
Dimension Spinner Flask PIV Replica Difference 
relative to 
Spinner Flask 
(%) 
Internal Diameter (mm) 
Outer Diameter (mm) 
Working Volume Height (mm) 
Working Volume (ml) 
Impeller Height (mm) 
Impeller Diameter (mm) 
Shape of Flask Bottom 
Distance of magnet from top 
and bottom of impeller 
respectively (mm) 
57.56 
63.56 
43.08 
100 
25.50 
50.76 
Curved Middle 
 
 
12.86, 3.32 
58.14 
68.08 
40.00 
100 
25.50 
50.76 
Flat 
 
 
12.86, 3.32 
1.0 
7.1 
7.7 
0 
0 
0 
n/a 
 
 
0, 0 
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Figure 41: PIV replica (left) and the spinner flask (right). 
5.3.5 Tracers 
Cytodex 1 microcarriers (GE Healthcare, United Kingdom) were utilised as tracers. A 
dry mass of 0.07g Cytodex 1 microcarriers (effective concentration of 0.007g dry mass/ 
l volume glycerol or 0.00007g dry mass/ml volume glycerol) was used for each 
experimental group (100 ml). The average diameter of the microcarriers was 147 – 248 
microns. 
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5.3.6 PIV Set-up and Procedure 
 
Figure 42: The Particle-Image Velocimetry system. 
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The TSI laser system was used to record Particle Image Velocimetry (PIV) data. It 
consisted of a 190 mJ Nd:Yag laser, maximum repetition rate 15 Hz and a 4 megapixel 
Power View Plus Camera fitted with a Nikon 105 mm lense. The laser light was 
diverted to the appropriate position for data acquisition by means of a light arm. The 
sheeting optics were attached to the light arm aperture so as to direct the light sheet 
across the PIV replica, illuminating a circular cross-section. In order to reduce specular 
reflections, the impeller surface was treated with matt black paint and the experimental 
area enclosed during data acquisition. 
As shown in Figure 42, the PIV replica was placed in the acrylic holder which was held 
firmly by an 22.5 x 180 mm Optical Rail (Bosch Rexroth, United Kingdom). The 
Optical Rail was held perpendicularly through the use of 45 x 45 x 90 brackets (Bosch 
Rexroth, United Kingdom). A camera was attached to the perpendicular Bosch Rail 
such that the lens was in line with the bottom of the protype flask. The machine spinner 
was positioned such that the impeller would occupy the working volume of the 
prototype flask and skim the surface, in order to mimic the impeller position used 
during cell culture experiments. 
A magnetic trigger system was used to trigger the PIV system. The magnet was secured 
to the spinner to ensure data acquisition at identical positions during each cycle. This 
allowed a number of image pairs to be acquired and ensemble average velocity fields to 
be calculated. The PIV system was controlled through a computer interface, Insight 3G 
version 9.0.3.1 software (TSI, USA). 
As the light sheet passed through the flask, the cytodex 1 microcarriers scattered the 
light such that the camera could record the movement of the particle images over two 
frames. Temperature control of the ambient air was possible using a portable 9k BTU 
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air conditioner of model number 636212 (Homebase, United Kingdom) and a 
thermocouple. Data collection took place within one hour of glycerol-tracer preparation. 
5.3.7 PIV Data Processing 
 
Figure 43: Height in levels of the PIV replica where data was sourced. 
The region of interest was defined to ensure only valid data was included; the same 
region was applied at all heights of data acquisition (see Figure 43). A Fast Fourier 
Transform (FFT) cross-correlation algorithm was applied to image pairs to calculate 
velocity vectors. A recursive nyquist grid processed the images in multiple passes. The 
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displacement from the correlation data was carried out through the three-point estimator 
of a Gaussian peak (peak engine) fitting (Raffel et al. 2007). Data validation occurred 
through 3 x 3 median filtering (Westerweel 1994). 
Ensemble-average data was calculated from 100 image pairs per impeller orientation, 
per height level, per experimental group (see appendix 8.7). Two impeller orientations 
were investigated in this study. Velocity magnitude and strain rate two-dimensional 
maps were constructed. Minimum, maximum, mean, standard deviation and standard 
error of the mean shear stress values were obtained (Freedman et al. 1998; Hines et al. 
2003; Altman and Bland 2005; Bluman 2008). These parameters were plotted against 
PIV replica height levels for given experimental groups. Where mean shear stress was 
plotted against height, statistical analyses were performed using Genstat version 10.1 
software. 
5.3.8 Shear stress, Fluid Regime and Relaxation Time 
Shear stress, τ, was calculated using Equation 7, μ = viscosity and γ = shear rate. 
(Coulson and Richardson 1999) 
Equation 7: Newton’s Law of Viscosity 
 
Tip Speed was calculated using Equation 8, where Ni = Impeller Speed and Di = 
Impeller Diameter. (Doran 2002) 
Equation 8: Tip Speed 
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The Reynolds number, Re, was calculated using Equation 9, where ρ = density. This 
parameter defined flow regime. (Doran 2002) 
Equation 9: Reynolds Number 
 
Kinematic Viscosity, ν, was calculated using Equation 10. (Doran 2002) 
Equation 10: Kinematic Viscosity 
 
Fluid residence time, tresidence ,was calculated using Equation 11, where V = reactor size 
and F = Flow rate. (Doran 2002) 
Equation 11: Fluid Residence Time 
 
Particle Relaxation Time, trelaxation, was calculated using Equation 12, where ρp = particle 
density and dp = particle diameter. (Raffel et al. 2007) 
Equation 12: Particle Relaxation Time 
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5.3.9 Statistical Analysis 
Statistical analyses were performed on regional shear stress using Genstat version 10.1 
software. An ANOVA was performed when comparing all experimental groups for 
significant differences. Specifically, the number of independent replicates was 200 per 
level of the PIV replica. A student t-test was performed when comparing any significant 
differences detected by the ANOVA. The level of significance was set at p < 0.05. 
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5.4 Results and Discussion 
5.4.1 Determination of PIV conditions which reflect the bioreactor 
conditions 
The results of the rheometer experiments (Figure 44) showed that a three-fold increase 
in microcarrier concentration resulted in a roughly two-fold viscosity increase. 
Literature values (Kaye and Laby 1995) pertaining to the viscosity changes of aqueous 
glycerol were plotted (Figure 45) in order to determine concentrations of aqueous 
glycerol and temperature required to replicate cell culture viscosity conditions. The 
exact conditions are shown in Table 6. 
 
Figure 44: Viscosity of Cell Culture Media at different microcarrier concentrations and rotational 
speeds as revealed by the Rheometer at 37ºC. The viscosity values were used to obtain aqueous 
glycerol concentrations and temperatures (Figure 45) which were used for the PIV study. 
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Figure 45: Literature values (Kaye and Laby 1995) illustrating how the viscosity of glycerol varies 
with water concentration and temperature. The viscosity values obtained by the rheometer (Figure 
44) were used to obtain the aqueous glycerol concentration (graph on the left-hand side) and the 
temperature (graph on the right-hand side for 100% glycerol only). The obtained aqueous glycerol 
concentration and the temperature matched the cell culture conditions in terms of viscosity. 
Table 6: Equivalent PIV (impeller speed, aqueous glycerol concentration, temperature) conditions 
for the bioreactor conditions (impeller speed, microcarrier surface concentration, temperature) 
based on the results of Figure 44 and Figure 45. 
Bioreactor Condition Equivalent PIV Condition 
45 rpm, 20 cm
2
/ml, 37°C 
45 rpm, 60 cm
2
/ml, 37°C 
60 rpm, 20 cm
2
/ml, 37°C 
60 rpm, 60 cm
2
/ml, 37°C 
45 rpm, 98% Glycerol, 20°C 
45 rpm, 100% Glycerol, 17.1°C 
60 rpm, 98% Glycerol, 20°C 
60 pm, 100% Glycerol, 17.1°C 
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5.4.2 Relaxation Times and Reynolds Number 
As seen in Table 7, 1.09 ≤ Re ≤ 2.72 for all four experimental groups. This 
demonstrated that laminar flow was prevalent in the spinner flask bioreactor (Coulson et 
al. 1999; Dusting et al. 2006). Table 8 compares the relaxation time of the particle 
(Cytodex 1 microcarrier) and the residence time of the fluid. The relaxation time is a 
measure for the tendency of particles to attain velocity equilibrium with the fluid (Raffel 
et al. 2007). The result demonstrated that trelaxation < tresidence by five orders of magnitude. 
This proved that the Cytodex 1 microcarriers followed fluid flow and thus proved 
suitable as tracers. 
The particle relaxation time (Equation 12) assumes a Stokes’ regime (Re < 1). At 
greater Re, Equation 12 can overestimate the relaxation or response time (Micheletti 
and Yianneskis 2004). Neutrally buoyant particles are generally expected to have no 
influence on the continuous phase; however there are studies which demonstrate a 
significant influence as particle volumetric concentration increase (Zitoun et al. 2001; 
Micheletti and Yianneskis 2004). The experimental groups within our study 
demonstrated 1.09 ≤ Re ≤ 2.72; generally, Re (stirred vessels) ≤ 10 for laminar flow 
regimes (Doran 2002). Therefore, it was assumed that the Cytodex 1 microcarriers still 
followed fluid flow. 
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Table 7: Calculated parameters of impeller speed, tip speed and Reynolds' number for given 
impeller speeds and microcarrier concentration. 
Experimental Impeller Tip Reynolds 
Groups Speed Speed Number 
  Ni πNiDi Re 
  (rps) (m)   
45 rpm, 20 cm
2
/ml 0.75 0.12 2.04 
45 rpm, 60 cm
2
/ml 0.75 0.12 1.09 
60 rpm, 20 cm
2
/ml 1 0.16 2.72 
60 rpm, 60 cm
2
/ml 1 0.16 1.45 
 
Table 8: Comparison of the relaxation times of both the particle and of the fluid. 
Experimental Density of Kinematic Relaxation Time Residence Time 
Groups Fluid Viscosity Particle Fluid 
  ρf µk trelaxation tresidence 
  (kg/m
3
) (m
2
/s) (s) (s) 
45 rpm, 20 cm
2
/ml 984.55 9.47 x 10
-3
 2.39 x 10
-6
 0.21 
45 rpm, 60 cm
2
/ml 993.64 1.77 x 10
-4
 1.27 x 10
-6
 0.16 
60 rpm, 20 cm
2
/ml 984.55 9.47 x 10
-3
 2.39 x 10
-6
 0.21 
60 rpm, 60 cm
2
/ml 993.64 1.77 x 10
-4
 1.27 x 10
-6
 0.16 
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5.4.3 Cytodex 1 microcarrier as tracers 
Figure 46 shows two orientations of the impeller and the cytodex 1 microcarriers 
scattering the laser light. The presence of the impeller and magnet results in shadows. 
Hence, for the purpose of data extraction, the region of interest is in the form of a semi-
circle (top half of the images in Figure 46). Figure 47 shows the microcarriers scattering 
light within the region of interest. 
  
Figure 46: Two horizontal orientations of the impeller (impeller blade upright on the left-hand side 
and magnet upright on the right-hand side as seen on this page) which shows the cytodex 1 
microcarriers scattering the laser light. 
 
Figure 47: A close-up of the region of interest showing the cytodex 1 microcarriers scattering the 
laser energy. 
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5.4.4 Evaluation of Shear Stress within Spinner Flask Bioreactor 
As shown in Figure 48, the magnitude of shear stress for all four groups is 
approximately four-fold higher within the impeller region (levels 4-7) as compared to 
below the impeller region (levels 1-2). The 45 rpm, 20 cm
2
 group has a steady level of 
shear stress and no observable peak at the region of the impeller for all levels, whereas 
for the other groups, a peak is observed between levels 5-6. Furthermore, there is a 
distinct range of mean shear stress for the 45 rpm, 20 cm
2
 group (3.4 x 10
-3
 ≤ shear 
stress ≤ 4.6 x 10-3 N/m2) as opposed to the close proximity of the other three groups (5.5 
x 10
-3
 ≤ shear stress≤ 1.3 x 10-2 N/m2). 
The maximum and minimum spatial shear stress recorded respectively per level for 
given impeller speeds and microcarrier concentrations are shown in Figure 49 and 
Figure 50 respectively. They indicate maximum shear stress to be in the order of 10
-2
 to 
10
-1
 N/m
2
, whereas minimum shear stress was found to be in the order of 10
-7
 to 10
-6
 
N/m
2
. 
The relative shear stress of the impeller versus the non-impeller regions is shown in 
Figure 51. It indicates that 80% of the shear stress by volume is localised at the levels of 
the impeller region. Between the groups, there were statistical differences (p ≤ 0.001) 
which were noted at the impeller region. At the non-impeller region, there was no 
statistical difference with the two exceptions of a difference between 60 rpm, 60 cm
2
/ml 
and 45 rpm, 60 cm
2
/ml (p = 0.01) and a difference between 60 rpm, 60 cm
2
/ml and 60 
rpm, 20 cm
2
/ml (p = 0.037). Figure 52, Figure 53, Figure 54 and Figure 55 show maps 
of the velocity and strains rates at the impeller and non-impeller regions. 
   Page | 146  
 
 
Figure 48: Comparison of the ensemble mean shear stress against levels of height within the 
Spinner Flask replica. The ensemble mean shear stress was calculated based on 100 image pairs per 
two impeller orientations per height level per experimental group taken by the camera. Refer to 
Figure 43 for a description of the levels. The difference between each level was 4 mm. Level 1 was 
6.5 mm from the bottom of the replica; level 7 was 13.5 mm from the top of the working volume; 
level 3 represents the boundary between the impeller and non-impeller regions. 
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Figure 49: The maximum shear stress recorded at different heights of the spinner flask bioreactor 
for given impeller speeds and microcarrier concentrations. 
 
Figure 50: The minimum shear stress recorded at different heights of the spinner flask bioreactor 
for given impeller speeds and microcarrier concentrations. 
   Page | 148  
 
 
Figure 51: Distribution of mean shear stress at the impeller and non-impeller regions of spinner 
flask bioreactor for given impeller speeds and microcarrier concentrations. This distribution was 
based on the average shear stress of the impeller region (levels 4-7) and the non-impeller region 
(levels 1-2). 
p < 0.001 
p < 0.001 
p < 0.001 
p < 0.001 
p = 0.001 
p = 0.014 
p < 0.001 
p < 0.001 
p < 0.001 
p < 0.001 
p = 0.01 
p = 0.037 
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Figure 52: Velocity magnitudes (A, C) and strain rates (B, D) of horizontal orientated impeller of 
the 45 rpm, 20 cm
2
/ml group (A, B) and of the 45 rpm, 60 cm
2
/ml group (C, D) at level 6. Note that 
the positive and negative strain rates represent direction as well as magnitude. The fluid is moving 
in an anti-clockwise direction. 
m/s 
m/s 
1/s 
1/s 
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Figure 53: Velocity magnitudes (A, C) and strain rates (B, D) of horizontal orientated impeller of 
the 60 rpm, 20 cm
2
/ml group (A, B) and of the 60 rpm, 60 cm
2
/ml group (C, D) at level 6. Note that 
the positive and negative strain rates represent direction as well as magnitude. The fluid is moving 
in an anti-clockwise direction. 
m/s 
m/s 
1/s 
1/s 
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Figure 54: Velocity magnitude map at the non-impeller region. It was possible to obtain a map of 
the entire region, and not just the semi-circle. This map was taken from the 60 rpm, 60 cm
2
 group, 
level 2. The fluid is moving anti-clockwise as the impeller rotates. 
 
Figure 55: Strain rate map of non-impeller region (level 2) of the the 60 rpm, 60 cm
2
 group. 
1/s 
m/s 
   Page | 152  
 
Cytodex 1 microcarriers have traditionally been employed in cell culture strategies 
(Hirtenstein et al. 1980; Frauenschuh et al. 2007; Weber et al. 2007; Schop et al. 2008). 
But to our knowledge, this is the only study where these microcarriers have been 
ultilised as tracers within a PIV system. Two main criteria (Somerscales et al. 1981; 
Raffel et al. 2007) were assessed for the suitability of cytodex 1 microcarriers as tracers: 
(1) ability to move with the fluid flow and (2) light scattering properties. The first 
criterion was satisfied as the relaxation time data showed that the fluid residence time 
exceeded the particle relaxation time by five orders of magnitude. The ability of the 
microcarrier to move with fluid flow was therefore a consequence of the fluid residence 
time exceeding the particle relaxation time. Additionally, the maximum velocity 
recorded by the PIV system was within, and did not exceed, the calculated tip speeds (
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Table 7). This suggested that fluid flow was not disrupted by the microcarriers. The 
second criterion was satisfied by the qualitative data (Figure 46 and Figure 47) which 
clearly showed light scatter. 
This study found that mean shear stress within the impeller region was approximately 
four times that within the non-impeller region, with significant statistical differences of 
p < 0.001 for all four experimental groups (Figure 51). With the impeller region 
occupying greater volume than the non-impeller region, it can be concluded that the 
microcarriers spend more than half of the time in regions of much higher mean shear 
stress. In general, when comparing the experimental groups, an increase in microcarrier 
concentration and rotational speed resulted in an increase in mean shear stress for the 
impeller region. However, for the non-impeller region, the increase in mean shear stress 
was far less pronounced as demonstrated by the statistical analyses. In fact, no statistical 
difference was observed when comparing the three lowest mean shear stress groups. 
Work involving PIV and spinner flasks (Bilgen et al. 2006; Bilgen and Barabino 2007) 
has shown shear stress to be in the range of 0 – 0.06 N/m2. However, in this study, 
absolute zero shear stress values were not found in any experimental group. This 
revealed that the PIV system in this study was capable of extracting data lower than 10
-7
 
N/m
2
. There have been extensive studies on the effect of shear stress on stem cells 
(Sawae et al. 2004; Zeng et al. 2006; Grellier et al. 2009). Zhao et al. explored the 
effects of shear stress on human BMSCs within a perfusion bioreactor system (Zhao et 
al. 2007). Whilst PIV was not used to determine the shear stress, that study revealed 
higher BMSCs proliferation rates at the lower end of the shear stress range 1 x 10
-5
 to 1 
x 10
-4
 N/m
2
. Our work revealed shear stress to be 1-2 orders of magnitude higher. In 
fact, there was a distinct level of impeller region mean shear stress for the 45 rpm, 20 
   Page | 154  
 
cm
2
 group (3.4 x 10
-3
 ≤ mean shear stress ≤ 4.6 x 10-3 N/m2) as opposed to the close 
proximity of the other three groups (5.5 x 10
-3
 ≤ mean shear stress ≤ 1.3 x 10-2 N/m2). 
As a consequence, it is hypothesised that ensemble mean spatial shear stress, within the 
impeller region of a 100 ml spinner flask bioreactor, of the range: 3.4 x 10
-3
 ≤ mean 
shear stress ≤ 4.6 x 10-3 N/m2, would result in higher BMSC proliferation rates on 
Cytodex 1 microcarriers, as compared to the range: 5.5 x 10
-3
 ≤ mean shear stress ≤ 1.3 
x 10
-2
 N/m
2
. 
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5.5 Conclusion 
Cytodex 1 microcarriers were found to be suitable tracers for the PIV system. The 
residence time of the fluid was found to be five orders of magnitude higher than the 
relaxation time of the microcarrier. Laser light scattering was found to be adequate for 
this study. The mean shear stress within the impeller region was approximately four 
times that within the non-impeller region, and this, coupled with the higher volumetric 
occupation of the impeller, suggested that microcarriers spent more than half of culture 
time exposed to the higher shear stress of the impeller region. Having measured the 
range of shear stress, it is expected that within the impeller region of a 100 ml spinner 
flask bioreactor, of the range: 3.4 x 10
-3
 N/m
2
 ≤ mean shear stress ≤ 4.6 x 10-3 N/m2, 
would result in higher BMSC proliferation rates on Cytodex 1 microcarriers, as 
compared to the range: 5.5 x 10
-3
 N/m
2
 ≤ mean shear stress≤ 1.3 x 10-2 N/m2 (Zhao et 
al. 2007). 
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6 The Effect of Cytodex 1 Microcarrier Concentration 
and Impeller Speed on the expansion of BMSCs 
within a Spinner Flask Bioreactor 
6.1 Abstract 
Previously, a method of quantifying shear stress within a spinner flask bioreactor was 
established. It was hypothesised that mean shear stress settings with low shear stress, 
3.4 - 4.6 x 10
-3
 N/m
2
, would result in higher BMSC proliferation rates on Cytodex 1 
microcarriers, as compared to high shear stress, 5.5 - 13 x 10
-3
 N/m
2
. Lower 
microcarrier concentration was found to favour BMSC expansion. The results showed 
higher proliferation rates of BMSCs at low shear stress rates whilst maintaining 
multipotency. Interestingly, two experimental groups with similar shear stress resulted 
in significantly different proliferation rates, which were explained by one group having 
higher microcarrier concentrations and thus a higher frequency of microcarrier-
microcarrier collisions. 
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6.2 Introduction 
Within the last decade in the field of regenerative medicine, much effort has been 
devoted to the study of dynamic stem cell culture. Its superiority over static culture has 
been demonstrated through improved proliferation rates (Bancroft et al. 2002; 
Sikavitsas et al. 2002; Stiehler et al. 2009). The science behind dynamic 3D 
microcarrier-based cell culture is being investigated with attention paid to metabolism 
and growth inhibitors (Schop et al. 2008; Higuera et al. 2009; Schop et al. 2009a; Schop 
et al. 2009b). There is an abundance of literature dedicated to the effect of shear stress 
on stem cells (Sawae et al. 2004; Zeng et al. 2006; Grellier et al. 2009). For example, 
laminar flow shear stress was found to be a key regulator for mouse embryonic stem 
cell differentiation into endothelial cells when compared against static culture (Zeng et 
al. 2006). Another study showed that laminar flow shear stress on human BMSCs 
resulted in a significant increase in alkaline phosphatase expression and a substantial 
decrease in type 1 collagen, as compared to static culture (Grellier et al. 2009). 
However, the effect of shear stress in spinner flask bioreactor stem cell cultures is a 
relatively under-explored area (Sen et al. 2002; Fok and Zandstra 2005). Whilst shear 
stress in spinner flasks and stir-tanks has been explored extensively, it is widely related 
to animal cell culture systems (Cherry and Papoutsakis 1988; Cherry and Papoutsakis 
1989b; Cherry and Kwon 1990; Cherry 1993). 
The effect of shear stress on human embryonic kidney cells has been examined through 
laminar fluid flow within a flow channel (Stathopoulos and Hellums 1985). It was 
found that shear stresses of 0.26 N/m
2
 had no apparent effect on cell viability. The shear 
stress range of 0.65 - 1.30 N/m
2
 resulted in the loss of cell viability and an increase in 
post-shear stress urokinase enzyme release, indicating that the cell was functionally 
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capable of producing higher concentrations of enzyme. Shear stress within the range of 
2.60 - 5.40 N/m
2 
caused an even greater loss of cell viability, morphological changes of 
cell disruption and reduced levels of urokinase. Zhao et al. examined the effects of shear 
stress on 3-D human bone marrow-derived stromal cell constructs within a perfusion 
bioreactor system (Zhao et al. 2007). That study involving laminar flow found higher 
proliferation rates at the lower end of the shear stress range of 1.0 x 10
-4
 N/m
2
 to 1.0 x 
10
-5
 N/m
2
. Furthermore, the higher shear stress resulted in an upregulated osteogenic 
potential. From chapter 5, different levels of shear stress are obtained by selecting 
different impeller speeds and microcarrier concentrations within a 100 ml spinner flask 
bioreactor. It is therefore hypothesised that mean shear stress, in the form of 
microcarrier concentration and impeller speed, within the impeller region of a 100 ml 
spinner flask bioreactor, of the range: 3.4 x 10
-3
 ≤ mean shear stress ≤ 4.6 x 10-3 N/m2 
(Figure 48), would result in higher BMSC proliferation rates on Cytodex 1 
microcarriers, as compared to the range: 5.5 x 10
-3
 ≤ mean shear stress ≤ 13 x 10-3 N/m2 
(Figure 48). Shear stress in laminar flow bioreactors is unidirectional, whereas the shear 
stress is multidirectional in spinner flasks. However, the PIV results from chapter 5 
have quantified different levels of shear stress within the spinner flask which provides a 
range of shear stress experienced by the proliferating BMSCs. 
The aims and objectives of this study are: 
I. to investigate the effect of microcarrier concentration and impeller speed on 
BMSC proliferation 
II. to test the hypothesis that mean shear stress, in the form of microcarrier 
concentration and impeller speed, within the impeller region of a 100 ml spinner 
flask bioreactor, of the range: 3.4 x 10
-3
 ≤ mean shear stress ≤ 4.6 x 10-3 N/m2, 
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would result in higher BMSC proliferation rates on Cytodex 1 microcarriers, as 
compared to the range: 5.5 x 10
-3
 ≤ mean shear stress ≤ 1.3 x 10-2 N/m2 
III. to examine the impact of shear stress on BMSC multipotency. 
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6.3 Materials and Method 
6.3.1 Human BMSC Sources 
BMSCs from three human donors were used in this study. The bone marrow was taken 
from consenting patients undergoing total hip arthroplasty and the BMSCs were 
harvested and cryo-preserved. Passage 1 BMSCs were used for this study. The first 
human donor was male, 42 years old. The second donor was male, 19 years old. The 
third donor was male, 25 years old. 
6.3.2 Proliferation Medium for Human BMSCs 
Refer to section 3.3.2 for details of this medium. 
6.3.3 Osteogenic Medium for Human BMSCs 
Refer to section 3.3.3 for details of this medium. 
6.3.4 Adipogenic Medium for Human BMSCs 
Refer to section 3.3.4 for details of this medium. 
6.3.5 Standard Medium for the Differentiation of Human BMSCs 
along the Chondrogenic Lineage 
The chondrogenic medium consisted of sterile Dulbecco’s Minimum Essential Medium 
(Invitrogen, United Kingdom) supplemented with 1% ITS v/v premix (Sigma Aldrich, 
United Kingdom), 50 μg/ml ascorbic acid (Sigma Aldrich, United Kingdom), 100 
units/ml penicillin (Invitrogen, United Kingdom), 100 g/ml streptomycin (Invitrogen, 
United Kingdom), 0.01 nM dexamethasone (Sigma Aldrich, United Kingdom), 40 
μg/ml proline (Sigma Aldrich, United Kingdom), 100 μg/ml sodium pyruvate (Sigma 
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Aldrich, United Kingdom) and 0.01 g/ml TGF1 (Peprotech, United Kingdom). The 
medium was stored at 0°C to 5°C and the maximum shelf-life was one month. 
(Freshney 2005; Campbell et al. 2006; Schop et al. 2009a) 
6.3.6 Spinner Flask/Microcarrier Sterilisation 
Dry Cytodex 1 microcarriers (GE Healthcare, United Kingdom) were loaded into one 
500 ml spinner flask (Bellco, USA). Phosphate-based saline solution (Sigma Aldrich, 
United Kingdom) was poured into the spinner flask at 50 ml/dry g Cytodex 1. The 500 
ml spinner flask and four 100 ml spinner flasks, with side caps loosely open, were 
placed in autoclave bags and partially sealed with autoclave tape. They were then placed 
into an autoclave and exposed to 121ºC for a minimum of 20 minutes. After cooling, the 
phosphate-based solution (PBS) was replenished from the 500 ml spinner flask without 
removing the microcarriers. 
6.3.7 Pre-culture 
Cryo-preserved passage 1 human BMSCs were defrosted and plated on T-flasks at 2000 
cells/cm
2
. They were expanded in proliferation medium until approximately 70 % 
confluency. The PBS was removed from the 500 ml spinner flask and the microcarriers 
were conditioned with proliferation medium. 
6.3.8 Cell Seeding 
In the 500 ml spinner flask, microcarrier surface area concentration was 20 cm
2
/ml. 
BMSCs, harvested from T-flasks, were seeded onto microcarriers of the 500 ml spinner 
flask at a density of 2000 BMSCs/cm
2
. Partial dynamic seeding was employed for 4 
hours by means of 2 minutes at 45 rpm and 30 minutes at 0 rpm on day 0. After such 
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time, the contents of the 500 ml spinner flask were divided such that there were 20 
cm
2
/ml cell-seeded microcarriers in four sterile 100 ml spinner flasks. Fresh pre-
conditioned microcarriers, which contained no BMSCs, were placed into two of the 100 
ml spinner flasks such that the microcarrier concentration was 60 cm
2
/ml. A description 
of the experimental and control groups are displayed in Table 9. 
Table 9: Description of the experimental groups used in this study. The spinner flask regional shear 
is divided into the impeller region (I) and non-impeller region (NI). Each shear stress value 
represents the mean spatial ensemble-height shear stress for the given region as seen in Figure 48 
and is within the shear stress range stated in the hypothesis of the introduction of chapter 6. 
Group Microcarrier Cell Culture Spinner Flask 
  Concentration Impeller Regional Shear Stress 
    Speed     
          
          
          
      I NI 
  
(cm
2
/ml) (rpm) (N/m
2
) (N/m
2
) 
1 20 45 3.9 x 10
-3
 1.1 x 10
-3
 
2 60 45 7.7 x 10
-3
 2.2 x 10
-3
 
3 20 60 9.4 x 10
-3
 1.9 x 10
-3
 
4 60 60 10.7 x 10
-3
 3.5 x 10
-3
 
Control n/a n/a n/a n/a 
 
6.3.9 BMSC Growth Analysis 
The four experimental groups were cultured at different impeller speeds (refer to Table 
9) for a period of 9 days. At days 1, 3, 6 and 9, three samples were taken from each 
spinner flask and washed with pre-warmed PBS. The alamarBlue
TM
 (Serotec, United 
Kingdom) assay was applied to the samples, as well as the 2D control, as described in 
section 3.3.8. On completion of the assay, the microcarriers were washed thoroughly, 
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dried in an oven and an equivalent number of fresh microcarriers were placed back into 
the spinner flasks. A standard curve of cell number versus wavelength was prepared per 
passage per donor specific to the BMSCs used in this study (appendix 8.3). This curve 
was used to determine cell populations at different time-points and consequently 
calculate the number of population doublings. BMSC population growth curves were 
constructed based on the four time-point population measurements and the formulae 
used were as per section 3.3.8. Donor 2 BMSC data is displayed in the results section as 
representative of all three human donors. 
6.3.10 BMSC Harvest 
At day 9, the BMSCs were harvested from the microcarriers and the well-plates as 
described in section 3.3.9. 
6.3.11 Multipotency 
The pellets were re-suspended and differentiated along the osteogenic, adipogenic and 
chondrogenic lineages. The next three sub-sections describe cell culture protocol and 
evaluation of lineage differentiation. 
6.3.11.1 Osteogenic lineage 
For osteogenic differentiation, human MSCs were seeded in 24-well plates at a density 
of 5000 cells/cm
2
. Standard osteogenic media was used, with medium plus 
dexamethasone representing the experimental group and proliferation medium (minus 
dexamethasone) representing the control. Medium was refreshed twice weekly. On day 
12, the cells were fixated in 3.7 % formaldehyde in PBS. 
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ALP staining was employed to stain the alkaline phosphatase enzyme using the 
Alkaline Phosphatase Detection kit (Millipore

, International). The protocol is 
described in section 3.3.10.1. 
An ALP assay (Randox Laboratories, United Kingdom) was performed as a form of 
quantitative analysis. Well-plates from timepoints of days 4, 8, 12 and 20 were kept at -
80°C. Briefly, to measure the ALP concentration, the well-plates were defrosted at room 
temperature. Then, 0.2% triton was added to each well. An ultrasonic water bath filled 
with ice was used to further lyse the cells for 5 minutes. Standards of p-nitrophenol 
were prepared according to the instructions of the manufacturer. Then, 100 μl of 
samples were placed into 96-well plates, followed by 100 μl of PNP solution. Next, 200 
μl standards were placed into another well-plate. The control was 0.2% triton only. The 
well-plates were incubated at 37°C for 1 hour and absorbance was measured at 405 nm. 
Protein concentration was measured using the Pierce

 BCA protein assay kit (Thermo 
Scientific, United Kingdom), which is “a detergent-compatible formulation based on 
bicinchonic acid (BCA) for the colorimetric detection and quantification of protein”. 25 
μl of the samples prepared for the ALP assay were placed into 96-well plates. Briefly, 
dilute albumin (BSA) sample standards and working reagent (WR) were prepared 
according to the instructions of the manufacturer. Then, 25 μl of the samples prepared 
for the ALP assay and BSA standards were placed into 96-well plates. This was 
followed by 200 μl of the WR. The plates were shaken gently for 30 seconds and 
incubated for 30 minutes. After cooling to room temperature, the absorbance was 
measured at 562 nm. 
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Graphs were drawn with ALP activity against timepoints. They were used to analyse the 
osteogenic potential of the harvested BMSCs. 
6.3.11.2 Adipogenic lineage 
For adipogenic differentiation, human BMSCs were seeded in 24-well plates at a 
density of 5000 cells/cm
2
. Standard adipogenic media was used, with adipogenic 
medium representing the experimental group and proliferation medium representing the 
control. Medium was refreshed twice weekly.  
On day 21, the cells were fixated in 3.7 % formaldehyde. The Oil Red O staining 
procedure was performed as described in section 3.3.10.2. 
6.3.11.3 Chondrogenic lineage 
For chondrogenic differentiation, human MSCs were pelleted in centrifuge tubes at 
500,000 cells/pellet. Standard chondrogenic media was used with chondrogenic medium 
representing the experimental group and chondrogenic medium minus TGFβ1 
representing the control. The media was refreshed twice-weekly. On day 21, the pellets 
were placed in 3.7% formaldehyde. 
The histology was carried out by the Institute of Cell and Molecular Sciences Core 
Pathology group of Queen Mary University of London. Briefly, a pellet section was 
dewaxed in xylene and placed in alcohol. It was rehydrated in distilled water, then 
stained with Weigerts Iron Haematoxylin (1:1 solution of 0.1 g/L haematoxylin in 
ethanol to 30% ferric chloride & 1% hydrochloric acid in distilled water) for 6 minutes 
and washed in tap water for 5 minutes. It was incubated with aqueous fast green FCF 
(1:5000 dilution) for 3 minutes and then washed in 1% acetic acid. It was then 
incubated with 0.1% aqueous Safranin O for 6 minutes. Subsequently, it was dehydrated 
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with ethanol. Xylene was used to remove the ethanol and it was finally mounted in 
xylene-based mountant. The glycosaminoglycan content of the chondrocyte-like cells 
was stained in the colour of red. 
6.3.12 Statistical Analysis 
Statistical analysis was performed on the number of population doublings using Genstat 
version 10.1 software. An ANOVA was performed when comparing all four 
experimental groups and one control group for significant differences. The number of 
independent replicates was 3. A student t-test was performed when comparing any 
significant differences detected by the ANOVA. The level of significance was set at p < 
0.05. 
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6.4 Results 
6.4.1 BMSC Expansion 
As seen in Figure 56, higher shear stress (60 cm
2
/ml, 45 rpm and 60 cm
2
/ml, 60 rpm) 
generally results in a lower BMSC population as compared to the day 1 population. 
Higher microcarrier concentrations (60 cm
2
/ml) result in more pronounced differences 
between the initial and final time-point populations for any given experimental group. 
The lowest shear stress group (20 cm
2
/ml, 45 rpm) most closely resembles the growth 
curve of the 2D control, in terms of the day 9 BMSC population being greater than that 
of day 1. Interestingly, the average shear stress for the 60 cm
2
/ml, 45 rpm and 20 
cm
2
/ml, 60 rpm groups were found to be I (Impeller Region) = 7.7 x 10
-3
 N/m
2
, NI 
(Non-Impeller Region)  = 2.2 x 10
-3
 N/m
2
 and I = 9.4 x 10
-3
 N/m
2
, NI = 1.9 x 10
-3
 N/m
2
, 
respectively (Figure 56). These two groups had similar shear stress, yet the BMSC 
growth was superior on the lower microcarrier concentration group (20 cm
2
/ml). 
The lowest shear stress group was superior (p < 0.001) to both the experimental and 
control groups in terms of the number of population doublings between days 3 to 6 
(Figure 57 and Figure 59). Conversely, the control group was superior (p < 0.001) to all 
the experimental groups in terms of the number of population doublings for the entire 
cell culture period (Figure 58). Within the experimental groups, the higher microcarrier 
concentrations resulted in significantly lower population doublings. Micrographs 
provided qualitative proof of BMSC populations at different time-points (Figure 60) as 
lower microcarrier concentrations show higher numbers of attached cells, but with the 
lower rotational rate (20 cm
2
/ml, 45 rpm) being superior to the higher rotational rate (20 
cm
2
/ml, 60 rpm). At day 6, the former shows some microcarriers with rounded cells 
whilst the latter shows flatter cells. 
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Figure 56: Donor 2 BMSC Population growth under bioreactor conditions (microcarrier 
concentration, impeller speed) over 9 days. BMSC seeding at day 0 was 2000 BMSCs/cm
2
 (4.0E+05 
cells for the spinner flask and 2.0E+04 cell for each well of the 2D control). The legend shows the 
mean spatial ensemble-height shear stress for the impeller region (I) and the non-impeller region 
(NI) which was evaluated in the previous chapter. 
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Figure 57: Number of Population Doublings during days 3 to 6 for donor 2. 
  
Figure 58: Number of population doublings for the entire 9-day period for donor 2. 
p < 0.001 
p < 0.001 
p < 0.001 
p < 0.001 
p < 0.001 
p < 0.001 
p < 0.001 
p < 0.001 
p = 0.008 
p =0.041 
p < 0.001 
p < 0.001 
p < 0.001 
p < 0.001 
p =0.027 
   Page | 170  
 
 
Figure 59: The donor 2 BMSC population doublings between days 3 to 6 for bioreactor conditions 
in terms of microcarrier concentration and impeller speed. The shear stress for the impeller and 
non-impeller regions, which was evaluated in the previous chapter, is displayed for given 
microcarrier concentrations and impeller speeds. 
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Group Day 1 Day 6 
45 rpm, 
20 cm
2
/ml 
  
45 rpm, 
60 cm
2
/ml 
  
60 rpm, 
20 cm
2
/ml 
  
60 rpm, 
60 cm
2
/ml 
  
2D 
Control 
  
Figure 60: Micrographs of the microcarriers and well-plates at time-points day 1 and day 6. On 
days 1 & 6, there are fewer cells visible on the higher microcarrier concentration groups. On day 6, 
the lowest shear stress group has the highest cell concentration. 
   Page | 172  
 
6.4.2 BMSC Multipotency 
On day 12 of osteogenic culture, the ALP activity of BMSCs which had been cultured 
on the control is superior (p < 0.001) to the experimental groups (Figure 61 and Figure 
62). Within the experimental groups, the highest shear stress group shows the highest 
ALP activity. The other three lower shear stress groups show no significantly different 
levels of ALP activity. All experimental and control groups retained multipotentiality 
(Figure 63). No differences in the proportion of Oil Red O staining were seen between 
the 2D control and experimental groups for adipogenesis. No differences in the intensity 
of Safranin O staining were noted between the 2D control and experimental groups for 
chondrogenesis. 
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Figure 61: Harvested human BMSCs from different experimental groups subjected to osteogenic 
media (plus dexamethasone) over a 21-day period. Also shown is the impeller and non-impeller 
regional shear stress experienced by the BMSCs in the previous nine days of culture in spinner 
flask bioreactors with different microcarrier concentrations (cm
2
/ml) and impeller speeds (rpm). 
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Figure 62: Day 12 ALP activity (taken from Figure 61) for the harvested BMSCs which were 
previously subjected to nine days of culture within spinner flask bioreactors at different 
microcarrier concentrations (cm
2
/ml) and impeller speeds (rpm). The shear stress experienced by 
the BMSCs during spinner flask bioreactor culture is shown. 
p < 0.001 
p < 0.001 
p < 0.001 
p < 0.001 
p =0.002 
p = 0.013 
p = 0.004 
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Group Osteogenesis Adipogenesis Chondrogenesis 
45 rpm, 
20 cm
2
/ml 
   
45 rpm, 
60 cm
2
/ml 
   
60 rpm, 
20 cm
2
/ml 
   
60 rpm, 
60 cm
2
/ml 
   
2D 
Control 
   
Expansion 
only 
   
Figure 63: Multipotency results along the osteogenic (day 12), adipogenic (day 21) and 
chondrogenic (day 21) lineages. Note that for the "Expansion only" section of chondrogenesis, 
chondrogenic medium minus TGFβ1 was employed. 
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6.5 Discussion 
This study has shown that spinner flask BMSC growth within the lowest shear stress 
group (3.4 x 10
-3
 N/m
2
 ≤ impeller region mean shear stress ≤ 4.6 x 10-3 N/m2; I = 3.9 x 
10
-3
 N/m
2
, NI = 1.1 x 10
-3
 N/m
2
) was superior to the highest shear stress group (I = 10.7 
x 10
-3
 N/m
2
, NI = 3.5 x 10
-3
 N/m
2
) (Figure 56). This was consistent with a previous 
study where lower laminar flow-induced shear stress resulted in higher BMSC 
proliferation rates (Zhao et al. 2007). The apparent absence of a lag phase of the BMSC 
growth on the control is the result of four, rather than nine, time points within the 9-day 
period (Larson et al. 2008). The shorter lag phase is attributed to the stationary cell 
culture on 2D surfaces in the case of the control, as opposed to the longer lag phase 
being the result of centrifugal dynamic cell culture on 3D surfaces which was employed 
in the experimental groups. 
As expected, significantly higher BMSC population doublings (2.6 ± 0.6 doublings) on 
microcarriers were noted in the lowest shear stress group (3.4 x 10
-3
 N/m
2
 ≤ impeller 
region mean shear stress ≤ 4.6 x 10-3 N/m2) as compared to the higher shear stress and 
the control group (Figure 57) during days 3-6. Future work should examine impeller 
design in order to optimise the mixing regime to maximise cell yield (Hooker et al. 
1990; Doran 2002; Chua et al. 2008). Higher impeller speeds and microcarrier 
concentrations resulted in lower proliferation rates (Figure 57 and Figure 58). 
Generally, as shear stress decreased, the proliferation rates increased. However, there 
was an exception in the case of two groups (60 cm
2
/ml, 45 rpm and 20 cm
2
/ml, 60 rpm) 
(Figure 56) with I (Impeller Region) = 7.7 x 10
-3
 N/m
2
, NI (Non-Impeller Region)  = 2.2 
x 10
-3
 N/m
2
 and I = 9.4 x 10
-3
 N/m
2
, NI = 1.9 x 10
-3
 N/m
2
, respectively. The group with 
I = 9.4 x 10
-3
 N/m
2
 had a higher shear stress and superior growth rate as compared to the 
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group with I = 7.7 x 10
-3
 N/m
2
. This may be attributed to the fact that the latter had a 
three-fold microcarrier concentration and thus conceivably higher microcarrier-
microcarrier collisions (Cherry and Papoutsakis 1988; Papoutsakis 1991). Previous 
studies have provided insight on cell damage mechanisms within microcarrier cell 
cultures (Cherry and Papoutsakis 1986; Cherry and Papoutsakis 1988; Croughan et al. 
1988). Microcarrier-bioreactor collisions may not have significantly contributed to the 
lower BMSC growth as, microcarriers are small, almost neutrally buoyant and can 
follow fluid flow (Croughan et al. 1988; Papoutsakis 1991), and previous studies have 
provided evidence of no substantial cell damage between microcarriers and well-
designed impellers (Cherry and Papoutsakis 1988; Cherry and Papoutsakis 1989a). 
Moreover, for high levels of spinner flask agitation, it has been demonstrated that the 
microcarrier-microcarrier interaction becomes the dominant cause of cell damage at 
higher Cytodex 1 microcarrier concentration (Croughan et al. 1988). Additionally, it has 
been demonstrated that as packing fraction increases, the minimum separation distance 
between neighbour particles decreases within solid particle liquid suspensions (Mueller 
et al. 2010). As our study was conducted under a spinner flask laminar mixing regime, 
future work should focus on microcarrier-to-microcarrier collisions in order to assess 
BMSC damage. 
Multipotency was assessed from harvested cells after nine days of cell culture. 
Harvested BMSCs were successfully shown to differentiate along the osteogenic, 
adipogenic and chondrogenic lineages. Hence, the expanded BMSCs retained their 
differentiation potential. ALP assays were performed on the osteogenic lineage. It was 
found that the 2D control group showed significantly higher ALP activity as compared 
to the experimental groups (p < 0.001). This demonstrated an apparent partial loss of 
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osteogenic potential. Cell bridges between microcarriers are known to occur within 
spinner flask culture which may aggregate (Cherry and Papoutsakis 1988; Papoutsakis 
1991) and as seen in Figure 60, some individual microcarriers have almost full coverage 
of BMSCs. As differentiation of mesenchymal stem cells are known to be triggered by 
increasing cell density (Osdoby and Caplan 1979; Osdoby and Caplan 1981; Caplan et 
al. 1983), it is possible that a proportion of spinner flask BMSCs from our study began 
to differentiate along the osteogenic lineage during cell expansion, prior to osteogenic 
medium culture. This may have accounted for the lower ALP activity of the 
experimental groups relative to the control, given that ALP activity peaks at days 10-14 
(Storrie and Stupp 2005). If this explanation is true, then the conclusion of partial loss 
of osteogenic potential would therefore not be valid. Future work should therefore 
examine the multipotency of harvested cells at earlier (< 9 days) and later (< 9 days) 
stages of the growth cycle. This would shed light on the variations of cell density and 
differentiation potential during the growth cycle. However, it must be considered that 
BMSC harvest after day 9 would increase the probability of multilayer cell formation 
and contact inhibition (Levine et al. 1965; Cherry and Papoutsakis 1989b); the former 
would inevitably decrease harvest efficiency. Additionally, age plays a role in 
expansion (Bruder et al. 1997; Kim et al. 2008) and differentiation (Bruder et al. 1997; 
Neuhuber et al. 2008). Human BMSC proliferation rates decrease as the cells achieve 
higher numbers of population doublings (Bruder et al. 1997). Loss of osteogenic 
potential has been shown to occur above 30 population doublings (Bruder et al. 1997). 
The mechanotransduction mechanism by which the shear stress transduces the 
biochemical signals of the cell from membrane to nuclei is not well understood (Kapur 
et al. 2003). However, cell growth and differentiation responses to shear-induced 
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stimuli have been an effective means of improving that understanding (Goldstein et al. 
2001; Sikavitsas et al. 2003). For example, significant differences in early and late 
marker expression of cell undergoing osteogenesis are known to occur when fluid flow 
shear stress are applied within a planar environment in the short-term (minutes to hours) 
(Bakker et al. 2001; You et al. 2001; Saunders et al. 2003) as opposed to the long-term 
(days to weeks) (Bancroft et al. 2002; van den Dolder et al. 2003). Our study has 
employed PIV to quantify shear-induced stimuli on medium-term spinner flask 
microcarrier culture (9 days). On inspection of the ALP activities of the experimental 
groups, post-culture, no significant differences were found between the three lower 
shear stress groups (Figure 61 and Figure 62). However, there were significant 
differences when comparing the highest shear stress group (impeller region mean shear 
stress of 1.1 x 10
-2
 N/m
2
.). This higher ALP activity at higher shear stress was expected 
as it was in line with trends revealed in previous studies (Zhao et al. 2007; Stiehler et al. 
2009). 
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6.6 Conclusion 
This study has focused on the effect of microcarrier concentration and impeller speed on 
BMSC expansion within spinner flask bioreactor culture systems. It tested the 
hypothesis that the impeller spatial mean shear stress of the range, 3.4 x 10
-3
 to 4.6 x 10
-
3
 N/m
2
, would result in higher BMSC population doublings on Cytodex 1 microcarriers, 
as compared to the range to the range of 5.45 x 10
-3
 to 1.27 x 10
-2
 N/m
2
. Growth rate 
was superior within the lower shear stress range as compared to the higher shear stress 
range. Lower microcarrier concentration was found to favour BMSC expansion. 
Interestingly, two experimental groups with similar shear stress resulted in significantly 
different proliferation rates, which were attributed to differences in microcarrier-
microcarrier collision frequencies. Harvested BMSCs were shown to retain their 
multipotency. 
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7 General Discussion 
This chapter reviews the studies undertaken to explore the effect of microcarrier 
composition, structure and shear stress on Bone Marrow Stromal Cell (BMSC) growth. 
Various studies within this thesis (chapters 3, 6) have shown that BMSC growth rates 
on microcarriers can match those on tissue culture plastic. BMSC growth on PHBV 
microcarriers was superior to PCL and PLGA microcarriers and comparable to Cytodex 
1. The surface roughness of PCL microcarriers were altered by two different impeller 
designs during the w/o/w method of microcarrier synthesis. A higher level of 
microcarrier surface roughness was found to significantly improve cell proliferation 
rates (chapter 4). Particle-image velocimetry (PIV) was used to quantify shear stress 
within a spinner flask bioreactor (chapter 5) at different microcarrier concentrations and 
impeller rotational rates. Shear stress was found to increase as microcarrier 
concentration and impeller rotation increased. Superior BMSC proliferation rates were 
shown within the experimental group with the lowest level of shear stress (20 cm
2
/ml, 
45 rpm). All BMSCs harvested from microcarriers these studies (chapters 2-3, 6) 
maintained their differentiation potential to atleast two lineages. 
7.1 The Characterisation of PHBV, PCL and PLGA microcarriers 
and their support of the attachment and proliferation of BMSCs 
Cell expansion on microcarriers has proven to be more space-saving and media 
utilisation efficient as compared to tissue culture plastic (Malda and Frondoza 2006). 
Various studies have demonstrated promising data involving BMSC expansion on 
Cytodex 1 microcarriers (Frauenschuh et al. 2007; Weber et al. 2007; Schop et al. 2008; 
Schop et al. 2009a; Schop et al. 2009b). Whilst significant advances have been made in 
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the optimisation of the bioprocessing of human BMSC spinner flask Cytodex 1 
microcarrier culture, there is still a need to improve the seeding and harvesting 
efficiencies, as well as the expansion rates (Weber et al. 2007; Schop et al. 2008). 
Alternatives to Cytodex 1 were investigated in chapters 2 and 3. 
Our study showed that BMSC proliferation rates on PHBV microcarriers were superior 
(p < 0.001) to PCL and PLGA microcarriers and comparable to Cytodex 1 
microcarriers. It has previously been shown that lower crystalline/amorphous ratios 
within polymers favour cell attachment and growth (Park and Cima 1996; 
Balasundaram et al. 2006; Czarnecki et al. 2008). Of the three polymers, PCL has the 
highest crystallinity (Jiang et al. 2001; Gomes et al. 2003). BMSC expansion rates on 
PCL microcarriers were significantly lower than the other two polymers on account of 
high crystallinity content. However, SEM images revealed rougher surfaces on PHBV 
and PLGA microcarriers as compared to PCL. Previous studies have reported superior 
expansion rates on 2D surfaces at the higher end of the surface roughness range: 0.3 μm 
≤ Ra ≤ 5.1 μm (Degasne et al. 1999; Deligianni et al. 2001a; Deligianni et al. 2001b). 
The magnitude of influence of surface roughness as a competing factor in determining 
expansion rates is unknown. The effect of surface roughness on cell growth was 
evaluated in chapter 4. 
These microcarriers are intended for use in spinner flask bioreactors. Observations from 
our work revealed that during static culture, Cytodex 1 and PHBV microcarriers sank to 
the bottom of proliferation medium within the well-plates. The only exception was that 
a proportion of the PHBV microcarriers did not sink to the bottom, but occupied 
different levels of the proliferation medium. It is conceivable that within a spinner flask 
bioreactor culture, the lower density PHBV microcarriers may require lower impeller 
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rotational rates as compared to the Cytodex 1 microcarriers. Various studies have 
detailed the impact of shear stress on cells in terms of expansion, viability and 
morphology (Stathopoulos and Hellums 1985; Zeng et al. 2006; Zhao et al. 2007). The 
lower density PHBV microcarriers therefore show promise as an alternative to Cytodex 
1 microcarriers, especially as our study revealed no significant difference in BMSC 
expansion rates on these two microcarriers. Future work should compare cell 
proliferation rates on lower and higher density PHBV microcarriers and Cytodex 1 
microcarriers within spinner flask culture and assess the impact of shear stress from 
different impeller rotational speeds. However, any such study must consider that the 
diameter ranges of Cytodex 1 (147 – 248 μm) and PHBV (212 - 300 μm) microcarriers 
would influence the magnitude of shear stress on the microcarriers, as Qiu et al. (1998) 
found that as the density difference between the microcarrier and the culture medium 
increased, so did the shear stress imparted on the microcarrier (Qiu et al. 1998). 
Our study demonstrated that BMSCs expanded on the microcarrier types successfully 
retained their differentiation potential along the osteogenic and adipogenic lineages, and 
no differences were detected between the groups in terms of intensity of staining 
marker. The former observation was in line with previous studies which showed that 
stem cells retain their stemness on various polymeric scaffolds (Li et al. 2002; 
Gauthaman et al. 2009). Curran et al. (2009) demonstrated that PLGA doping of PCL 
affected the differentiation potential of human BMSCs on films over a 28-day period 
(Curran et al. 2009). That study found that PCL containing 0 – 30 wt % PLGA 
enhanced chondrogenic potential both in basal and chondrogenic conditioned media, in 
particular 30 wt % PLGA showing the greatest enhanced chondrogenic potential. 
Furthermore, the osteogenic potential of these PCL/PLGA films were found to be 
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lacking osteogenic potential (Marletta et al. 2007; Curran et al. 2009), with only PCL 
containing 20 wt % PLGA facilitating osteogenic differentiation of BMSCs under 
osteogenic conditions. Any expansion strategy involving BMSC culture on polymeric 
microcarriers greater than 5 days may affect the differentiation potential of attached or 
harvested cells, considering that ALP activity peaks between days 10-14 (Storrie and 
Stupp 2005) during in vitro osteogenesis and that the oil droplets were stained at day 21 
during osteogenesis in our study. Therefore, future work should focus on the 
differentiation potential of attached and harvested BMSCs from polymeric microcarrier 
cultures over longer periods of culture. 
7.2 BMSC Expansion on Microcarriers: The Effect of Surface 
Microstructure 
The results from chapters 2 and 3 showed superior BMSC growth on the less crystalline 
microcarriers with higher levels of surface roughness. The magnitude of influence of 
microcarrier surface roughness as a competing factor in determining expansion rates is 
unknown. Chapter 4 evaluated the role of surface microstructure on cell growth. 
We have shown that two different impeller designs (Figure 30), used during the w/o/w 
method (section 2.3.2), result in the synthesis of PCL microcarriers with different 
surface roughness. The difference in surface roughness was validated by both SEM and 
laser profilometry. Based on laser profilometry, PCL-r microcarriers had Ra = 6.4 ± 1.5 
microns and PCL-s microcarriers had a Ra = 1.7 ± 0.4 microns (p = 0.006). Whilst 
thermal and chemical means have been used to alter surface roughness (Crotts and Park 
1998; Yang et al. 2000; Chun et al. 2004), to our knowledge, impeller designs have not 
been explored as an alternative. On closer inspection of the three-hour stirring stage 
(section 2.3.2), it was noted that the circulating microcarriers (both PCL-s and PCL-r) 
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did not reside within the impeller region. This suggested that different mixing regimes, 
rather than direct interaction of the PCL microcarriers with impeller blades, caused the 
difference in the microcarrier surface roughness. It has previously been shown that 
impeller design defines the flow pattern which determine mixing regime (Doran 2002). 
As impeller diameter was increased for a given rotational speed within a stirred vessel, 
the intensity of agitation was also increased (Hooker et al. 1990). Within a 
biocentrifugal pump, a 16 forward-swept-blade impeller resulted in a lower frequency 
of vortices and high-shear-stress spots as compared to a 16-straight blade impeller; the 
velocity vector distribution and lower shear stress levels differed when a 8-backward-
swept blade impeller was compared to the 16 forward-swept-blade impeller (Chua et al. 
2008). 
BMSCs from all three human donors showed superior proliferation rates on PCL-r as 
opposed to PCL-s. For the human donor presented in this study, 2.16 ± 0.11 population 
doublings were recorded for PCL-r as compared to the 1.33 ± 0.20 population doublings 
for the PCL-s (p = 0.025). This was consistent with previous findings (Degasne et al. 
1999; Deligianni et al. 2001a; Deligianni et al. 2001b) where a variety of cell types were 
expanded on 2D surfaces with a combined range of degrees of surface roughness, 0.29 
μm ≤ Ra ≤ 5.11 μm. 
The harvested BMSCs from the microcarriers retained their differentiation potential to 
the osteogenic and adipogenic lineages. This was expected as previous studies have 
demonstrated stem cells retaining their stemness on a variety of polymeric scaffolds (Li 
et al. 2002; Gauthaman et al. 2009). Osteoblast-like cells have been cultured on 
smoother and rougher titanium disks (0.22 μm ≤ Ra ≤ 4.37 μm) and it has been shown 
that the rougher surface resulted in higher concentrations of differentiation markers 
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(Lincks et al. 1998). Increased osteogenic differentiation potential has been supported 
by other studies (Martin et al. 1995; Lohmann et al. 1999). Future studies should 
evaluate the differentiation potential of harvested BMSCs which have been cultured 
over a longer period of time on polymeric surfaces of different levels of surface 
roughness. 
7.3 The Use of Particle Imaging Velocimetry to assess shear within a 
Spinner Flask Bioreactor 
Shear stress measurement has proven integral in order to understand the nature of stem 
cells. However, the complexities of different bioreactors have posed challenges to 
gaining reliable shear stress data. PIV is a flow visualisation technique (Raffel et al. 
2007), which is a relatively new tool in the evaluation of shear stress in spinner flask 
bioreactors. This technique was used in chapter 5 to quantify shear stress within a 
spinner flask so that it may be used to determine its effect on cell culture (chapter 6). 
To our knowledge, this is the only study where Cytodex 1 microcarriers have been used as tracers 
for PIV systems. These microcarriers were suitable as tracers as they were able to move with the 
fluid flow and to scatter light (Somerscales et al. 1981; Raffel et al. 2007). The relaxation time data 
showed that the fluid residence time exceeded the particle relaxation time by five orders of 
magnitude ( 
Table 8). Furthermore, the maximum velocity recorded by the system did not exceed the 
calculated tip speed. Images taken using the PIV system software showed light scatter 
from the microcarriers (Figure 47). No absolute zero shear stress values were found in 
any experimental group, which bear testimony to the accuracy and sensitivity of PIV. 
The Cytodex 1 microcarriers show promise as tracers for PIV systems for the 
assessment of velocity flow fields and shear stress distribution. 
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Our study found that mean shear stress within the impeller region was approximately 
four times that within the non-impeller region (p < 0.001 for all four experimental 
groups). With the impeller region occupying approximately 55% of the working 
volume, it can be concluded that the microcarriers spend more than half of the culture 
time in regions of much higher mean shear stress. In general, when comparing the 
experimental groups, an increase in microcarrier concentration and rotational speed 
resulted in an increase in mean shear stress for the impeller region. However, for the 
non-impeller region, the increase in mean shear stress was far less pronounced as 
demonstrated by the statistical analyses. In fact, no statistical difference was observed 
when comparing the three lowest mean shear stress groups. 
7.4 The Effect of Cytodex 1 Microcarrier Concentration and Impeller 
Speed on the expansion of BMSCs within a Spinner Flask 
Bioreactor 
Zhao et al. (2007) demonstrated higher BMSC proliferation rates within a perfusion 
bioreactor at the lower end of the shear stress range: 1.0 x 10
-4
 N/m
2
 to 1.0 x 10
-5
 N/m
2
 
(Zhao et al. 2007). In consideration of these data and the results of chapter 5, it was 
hypothesised that impeller spatial ensemble mean shear stress of a 100 ml spinner flask 
bioreactor, of the range, 3.4 x 10
-3 
to 4.6 x 10
-3
 N/m
2
, would result in higher BMSC 
culture on Cytodex 1 microcarrier proliferation rates, as compared to the range of 5.5 x 
10
-3
 to 1.3 x 10
-2
 N/m
2
. 
Our study has shown that spinner flask BMSC growth within the lowest shear stress 
group (3.4 x 10
-3 ≤ mean impeller shear stress ≤ 4.6 x 10-3 N/m2,; I = 3.9 x 10-3 N/m2, NI 
= 1.1 x 10
-3
 N/m
2
) was superior to the highest shear stress group (I = 10.7 x 10
-3
 N/m
2
, 
NI = 3.5 x 10
-3
 N/m
2
) (Figure 56). As expected, significantly higher BMSC population 
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doublings (2.6 ± 0.6 doublings) on microcarriers were noted in the lowest shear stress 
group (3.4 x 10
-3
 ≤ impeller region mean shear stress ≤ 4.6 x 10-3 N/m2) as compared to 
the higher shear stress and the control group during days 3-6. Higher impeller speeds 
(60 rpm versus 45 rpm) and microcarrier concentrations (60 cm
2
/ml versus 20 cm
2
/ml) 
resulted in lower proliferation rates. Generally as shear stress decreased, the 
proliferation rates increased. However, there was an exception in the case of two groups 
(60 cm
2
/ml, 45 rpm and 20 cm
2
/ml, 60 rpm) (Figure 56) with I (Impeller Region) = 7.7 
x 10
-3
 N/m
2
, NI (Non-Impeller Region)  = 2.2 x 10
-3
 N/m
2
 and I = 9.4 x 10
-3
 N/m
2
, NI = 
1.9 x 10
-3
 N/m
2
, respectively. The group with I = 9.4 x 10
-3
 N/m
2
 had a slightly higher 
shear stress and superior growth rate as compared to the group with I = 7.7 x 10
-3
 N/m
2
. 
This may be attributed to the fact that the latter had a three-fold microcarrier 
concentration and thus conceivably higher microcarrier-microcarrier collisions (Cherry 
and Papoutsakis 1988; Papoutsakis 1991). Microcarriers are small, almost neutrally 
buoyant and can follow fluid flow (Cherry and Papoutsakis 1988; Papoutsakis 1991) 
and previous studies have provided evidence of no substantial cell damage between 
microcarriers and well-designed impellers (Cherry and Papoutsakis 1989a; Cherry and 
Papoutsakis 1989b). Consequently, microcarrier-bioreactor collisions may not have 
significantly contributed to the lower BMSC growth of higher microcarrier 
concentration group. It is more likely that microcarrier-microcarrier collisions was the 
cause of that lower BMSC growth, as it has been demonstrated that at higher levels of 
agitation, the microcarrier-microcarrier interaction becomes the dominant cause of cell 
damage at higher Cytodex 1 microcarrier concentration (Croughan et al. 1988). As our 
study was conducted under a spinner flask laminar mixing regime, future work should 
focus on microcarrier-to-microcarrier collisions in order to assess BMSC damage. 
   Page | 189  
 
Harvested BMSCs from microcarriers which had undergone 9 days of culture were 
demonstrated to retain their multipotency in our study. In comparing the experimental 
groups, the ALP activity was found to be significantly higher for the group (60 cm
2
/ml, 
60 rpm) which underwent the highest level of shear stress (I = 10.7 x 10
-3
 N/m
2
, NI = 
3.5 x 10
-3
 N/m
2
) as compared to the others. There were no significant differences 
amongst the three other groups. Higher ALP activity at higher shear stress has been 
demonstrated in perfusion and spinner flask systems (Zhao et al. 2007; Stiehler et al. 
2009). The ALP activity of the control was significantly higher than the experimental 
groups. One possible reason for this observation may have been high cell density 
triggering the osteogenic differentiation during cell culture, prior to cell harvest. Cell 
bridges between microcarriers are known to occur within spinner flask culture which 
may aggregate (Cherry and Papoutsakis 1988; Papoutsakis 1991) and as seen in Figure 
60, some individual microcarriers have almost full coverage of BMSCs. As 
differentiation of mesenchymal stem cells are known to be triggered by increasing cell 
density (Osdoby and Caplan 1979; Osdoby and Caplan 1981; Caplan et al. 1983), it is 
possible that a proportion of spinner flask BMSCs from our study began to differentiate 
along the osteogenic and adipogenic lineages during cell culture, prior to osteogenic 
medium culture. This would account for the lower ALP activity of the experimental 
groups relative to the control, given that ALP activity peaks at days 10-14 (Storrie and 
Stupp 2005).  Future work should evaluate the multipotency of harvested cells at earlier 
and later stages of the growth cycle. This would provide information on the variations 
of cell density and differentiation potential on the growth cycle. 
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7.5 Future Work and General Considerations 
Microcarrier cell culture within spinner flask bioreactors has demonstrated great 
promise as an alternative scaffold to tissue culture plastic. As a means of expanding 
large numbers of cells, it is space-saving, more media utilisation efficient and 
potentially useful in reducing the risk of contamination as compared to multiple well-
plates and T-flasks in several incubators (Freshney 2000a; Malda and Frondoza 2006). 
Spinner flask microcarrier technology could be used in cell-based tissue engineering 
strategies for clinical application. 
Many interesting novel facts were discovered during this thesis with regard to 
polymeric microcarrier composition and surface structure and spinner flask shear stress 
on BMSC proliferation. However, more experiments are necessary in order to establish 
spinner flask microcarrier technology for clinical application. BMSC expansion on 
Cytodex 1 and PHBV microcarriers were found to be comparable. Yet, the lower 
density PHBV microcarriers show promise as an alternative to Cytodex 1 as they may 
require lower impeller rotational rates, thus lower shear stress, to achieve suspension 
within a spinner flask. Differentiation potential was retained along the osteogenic and 
adipogenic lineages of harvested BMSC which were cultured on microcarrier types of 
PHBV, PCL and PLGA over a 5-day period. Future work should examine the 
differentiation potential of attached and harvested BMSCs cultured over longer periods 
of time as recent research suggest varying potential depending on polymeric content. 
We developed a novel method of creating two different surface roughnesses on PCL 
microcarriers using different impeller designs during the w/o/w process. How these 
designs resulted in significantly different roughnesses should be investigated. Again, 
differentiation potential was retained along the osteogenic and adipogenic lineages of 
   Page | 191  
 
harvested BMSC which were cultured on PCL microcarriers of different microstructure. 
Future work should evaluate the potential of harvested BMSCs cultured over longer 
periods on surfaces of different roughness. 
The effect of shear stress on BMSC growth on microcarriers was evaluated within 
spinner flasks. The effect of impeller design on cell growth should be evaluated in order 
to optimise mixing and cell growth. Two experimental groups of similar shear stress 
were found to have different BMSC proliferation rates. The explanation may lie with 
microcarrier-microcarrier collision frequency and this should be examined as a 
competing factor with shear stress on cell growth. It is suggested that the multipotency 
of BMSC growth be evaluated at different stages of cell culture to provide information 
on the variation of cell density and differentiation potential on the growth cycle. 
7.6 Concluding Remarks 
The studies described in this thesis contributed to the further understanding of spinner 
flask microcarrier technology. PHBV microcarriers proved a superior scaffold to PCL 
and PLGA, and comparable to Cytodex 1 in terms of BMSC proliferation rates. The 
lower density PHBV microcarriers may yet prove superior to Cytodex 1. Two impeller 
designs employed during the w/o/w process of microcarrier synthesis resulted in PCL 
microcarriers of two different levels of microstructure. BMSC expansion was superior 
on rough PCL microcarriers. 
A novel use of Cytodex 1 microcarriers as tracers within PIV systems was 
demonstrated. PIV has once again been demonstrated as an invaluable tool in 
understanding cell expansion. Shear stress was evaluated within a 100 ml spinner flask 
bioreactor and it was found that 80% of the shear stress was localised within the 
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impeller region, which accounted for 55% of the working volume. Lower microcarrier 
concentration and impeller rotational rates favoured BMSC proliferation. Despite the 
many novel facts revealed by this thesis, further investigation is necessary to achieve the 
promises of spinner flask microcarrier technology. 
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8 Appendices 
8.1 Sample calculation of Microcarrier Surface Area 
Microcarriers were sieved into the 212-300 µm range. Hence, the average diameter of 
the microsphere = (212 + 300)/2 µm = 256 µm. 
 
In the case of PLGA microcarriers, one of the three consecutive measurements revealed 
that 0.0594g PLGA occupied 0.5 ml of an eppendorf vial (sketch above). The 
microcarriers were compacted prior to weight measurement. 
The volume of 1 microcarrier of diameter, 256 µm, or alternatively, radius 256/2 µm, = 
(4/3) (22/7) (256/2 µm)
3
 ≈ 8788066 µm3 ≈ 8.8 x 10-6 cm3 = 8.8 x 10-6 ml. The number 
of microcarriers in a 0.5 ml vial = 0.5 ml/8.8 x 10
-6
 ml = 56895 microcarriers. 
The surface area of 56895 microcarriers = 56895 x [(4) (22/7) (256/2 µm)
2] ≈ 117.0 x 
10
8
 µm
2
 = 117 cm
2
. Finally, if the 117 cm
2
 area of PLGA microcarriers weighed 
0.0594g, then the surface area of PLGA microcarriers is (117/0.0594) cm
2/g ≈ 1973 
cm
2
/g. The standard deviation was calculated based on the three consecutive 
measurements. The range of diameters is illustrated in Figure 64. 
0.5 ml 
Vial 
Compact Microcarriers 
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Polymer Type Light Micrograph 
PHBV 
 
PCL 
 
PLGA 
 
Figure 64: Light micrograph images of microcarriers sieved into the 212 -300 μm diameter ranges, 
illustrating the range of diameters measured by Leica Application Software (LAS). 
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8.2 Pilot Study quantitatively assessing the growth of Goat BMSCs on 
PHBV, PCL and PLGA microcarriers 
This pilot study was conducted to examine the growth of goat BMSCs on PHBV, PCL 
and PLGA microcarriers. Two passage 9 goat BMSC donors were used for this study 
and the materials and methods were exactly the same as for chapter 3, with the 
exclusion of the differentiation protocols. Key observations from this pilot study 
included: 
(1) General linear, rather than exponential, growth of goat BMSCs (Figure 66). 
(2) No significant differences in proliferation rates were observed among the different 
scaffold types (Figure 67 and Figure 68), with the exception of a significant difference 
between Cytodex 1 and PHBV; Cytodex 1 was superior. 
(3) Using the human BMSC harvest protocol on the expanding cells on the 
microcarriers yielded no live goat BMSCs. 
These pilot studies influenced the cell numbers used to construct the standard curve for 
the quantification of human cell numbers through the alamarBlue
TM
 assay (appendix 
8.3). Given the linear, rather than exponential growth of the goat BMSCs and coupled 
with the fact that they proliferate faster than human BMSCs, the static culture time of 
120 hours was deemed sufficient for human cell culture studies. 
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Figure 65: Goat BMSC expansion on different scaffold types over a 120-hour period. Seeding was 
performed at time 0 hours at a density of 2000 BMSCs/cm
2
. 
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Figure 66: Number of Population Doublings using Goat BMSC population numbers from time-
points 24 and 120 hours. 
 
Figure 67: BMSC doubling times on the scaffold types using Goat BMSC population numbers from 
time-points 24 and 120 hours. 
p = 0.043 
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8.3 The alamarBlueTM assay to construct a Standard Curve for the 
quantification of cell numbers 
According to the catalogue information (catalogue number DAL1025) of Biosource 
International Inc, USA and the technical datasheet (catalogue number BUF012B) of 
AbD Serotec, United Kingdom, the alamarBlue
TM
 assay is a metabolic assay which 
monitors the proliferation of cells. The alamarBlue
TM
 assay is non-toxic and may be 
used to monitor cell proliferation over a period of time, without having to detach or kill 
cells. The alamarBlue
TM
 acts as an electron acceptor, as it is reduced by FMNH2, 
FADH2, NADH, NADPH and cytochromes of cells. Essentially, alamarBlue
TM
 is a 
detector of reduction of all elements of the electron transport chain. As it accepts 
electrons, it changes colour from oxidised indigo blue to the reduced fluorescent pink 
state. The level of this reduction is measured by the fluorimeter, which is expressed in 
wavelength. Essentially, this assay measures the metabolic activity. The standard curve 
is based on the metabolic activity of proliferating cells on tissue culture plastic, which is 
subsequently converted into cell numbers. To improve the accuracy of cell 
quantification, the standard curve was constructed for given a passage number for a 
given human donor. 
At time-point 0 hours, for passage 1 human BMSCs from a given donor, 6 different 
numbers of BMSCs were plated into each well of a 6-well plate. These numbers were 
determined (pre-determined by pilot studies) so that the BMSC numbers derived from 
the wavelengths of the experimental and control groups were interpolated, and not 
extrapolated, from the standard curve. This 6-well plate was subjected to the exact 
medium replenishment regime as the experimental and control groups. At time 120 
hours, the alamarBlue
TM
 assay was applied as per experimental and control groups. The 
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fluorimeter measurement the alamarBlue
TM
 reduction and the output was expressed as 
wavelength. The BMSCs in the 6-well plate were then washed with pre-warmed PBS. 
They were harvested using 0.25% trypsin-EDTA. The harvested BMSCs were counted 
using the haemocytometer (Burker-Turk, Germany). A standard curve was constructed, 
plotting wavelength versus cell number. From this standard curve, the wavelengths from 
the experimental and control groups were interpolated. Hence, the cell numbers were 
determined for these groups. 
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8.4 Rough and Smooth Microcarriers 
 
Figure 68: SEM micrograph of unsieved PCL-s microcarriers. They all appear smooth for a variety 
of diameters. 
As seen in Figure 68, the PCL-s microcarriers show smooth surfaces across different 
diameters. In comparison to Figure 69, the majority of PCL-r microcarriers appear 
rough. It appears that the PCL-r microcarriers with larger diameters appear rougher than 
those with smaller diameters. Figure 70 illustrates the difference in roughness of PCL-s 
and PCL-r. 
  
Figure 69: SEM micrographs of unsieved PCL-r microcarriers. It appears that surface roughness 
increases as microcarrier diameter increases. 
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Figure 70: SEM images of PCL-s (left) and PCL-r (right) microcarriers within the 212-300 μm 
range. 
In order to measure surface roughness, a laser profilometer was used. The microcarriers 
were placed onto a stage and placed into a focus using a camera. The roughness of PCL-
s and PCL-r microcarriers (n = 6) were measured through scans as seen in Figure 71. 
For each microcarrier, as seen in Figure 71 in the top left-hand corner scan (aerial scan), 
a 100 μm x 100 μm square window area was drawn (ensuring that no part of this 
window did not cover outside of the microcarrier), area loaded and a surface filter of 
“1” was applied. From this square window, the software calculated the Ra, Rz and RzDIN 
values. As 6 microcarriers were used to obtain the values, the surface roughness was 
calculated based on the average and standard deviation. 
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Figure 71: Snapshot of the software when measuring the surface roughness of the microcarriers. 
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8.5 Data for two other donors supplementary to chapter 3 
 
Figure 72: Human BMSC growth (donor 2) on the different scaffold types over a 120-hour period. 
Note that the seeding density applied was 2000 BMSCs/cm
2
 at time 0 hours. 
Growth data for donor 2 (Figure 72, Figure 73 and Figure 74) and donor 3 (Figure 75, 
Figure 76 and Figure 77) are listed in this section. BMSC growth is superior on PHBV 
microcarriers as compared to PCL and PLGA microcarriers. No significant difference in 
growth rates were observed among PHBV, Cytodex 1 and tissue culture plastic (2D). 
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Figure 73: Human BMSC Population Doublings (donor 2) on the scaffold types. The data was 
calculated utilising BMSC population numbers at time-points 24 and 120 hours. 
 
Figure 74: Human BMSC doubling times (donor 2) on the scaffold types. The data was calculated 
utilising BMSC population numbers at time-points 24 and 120 hours. 
p < 0.001 
p = 0.021 
p < 0.001 
p = 0.004 
p = 0.019 
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Figure 75: Human BMSC growth (donor 3) on the different scaffold types over a 120-hour period. 
Note that the seeding density applied was 2000 BMSCs/cm
2
 at time 0 hours. 
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Figure 76: Human BMSC Population Doublings (donor 3) on the scaffold types. The data was 
calculated utilising BMSC population numbers at time-points 24 and 120 hours. 
 
Figure 77: Human BMSC doubling times (donor 3) on the scaffold types. The data was calculated 
utilising BMSC population numbers at time-points 24 and 120 hours. 
p = 0.037 
p = 0.011 
p < 0.001 
p = 0.005 
p = 0.024 
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8.6 Data for two other donors supplementary to chapter 4 
 
Figure 78: Human BMSC populations (donor 2) on the different scaffold types over a 120-hour 
period. Cytodex 1 is the 3D control and well-plates are the 2D control. The seeding density of 2000 
BMSCs/cm
2
 was applied at time 0 hours. 
Growth data for donor 2 (Figure 78, Figure 79 and Figure 80) and donor 3 (Figure 81, 
Figure 82 and Figure 83) are shown within this section. BMSC growth on PCL-r are 
superior to PCL-s for all three donors. 
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Figure 79: Human BMSC Population Doublings (donor 2) on the scaffold types. The data was 
calculated utilising BMSC population numbers at time-points 24 and 120 hours. 
 
Figure 80: Human BMSC doubling times (donor 2) on the scaffold types. The data was calculated 
utilising BMSC population numbers at time-points 24 and 120 hours. 
p < 0.001 
p < 0.001 
p = 0.006 
p = 0.042 
p < 0.001 
p < 0.001 
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Figure 81: Human BMSC populations (donor 3) on the different scaffold types over a 120-hour 
period. Cytodex 1 is the 3D control and well-plates are the 2D control. The seeding density of 2000 
BMSCs/cm
2
 was applied at time 0 hours. 
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Figure 82: Human BMSC Population Doublings (donor 3) on the scaffold types. The data was 
calculated utilising BMSC population numbers at time-points 24 and 120 hours. 
 
Figure 83: Human BMSC doubling times (donor 3) on the scaffold types. The data was calculated 
utilising BMSC population numbers at time-points 24 and 120 hours. 
p < 0.001 
p = 0.009 
p = 0.039 
p = 0.007 
p < 0.007 
   Page | 211  
 
8.7 Analysis of raw PIV data 
This section supplements the details of the analysis of raw PIV data as described in 
section 5.3.7. Using the Insight 3G software, for each image of a given impeller position 
for a given level of the PIV replica (n = 100), a “processing mask” (region of interest -
ROI) was defined. This was done to ensure that data gathering covered regions where 
laser scatter was possible (Figure 47). The PIV processor setup included a grid engine 
(RecursiveNyquistGrid), a correlation engine (FFTCorrelator), a peak engine 
(GaussianPeak), frame spot starting and final dimensions of 64 and 32 respectively and 
maximum displacement of dx = dy = 0.25. The post-processing was used to validate 
fluid flow vectors (Raw data → image →processing → post-processing → setup → 
local validation → method → median test → remove vector field conditioning → start). 
Using raw data images, a data list was created by clicking the following on the Insight 
3G software: macro editor, “image source”, “calibration”, “masks” (ROI), “kernel 
processor” to verify information held, “execute”. The large volume of data warranted 
overnight processing. 
Using Matlab, Matlab → Load data → Analysis → Spatial toolbox → Arrow size → 
Ensemble (for more than one image only) → Contour (Variable e.g. strain rate, + Type 
e.g. Flood) → Colour bar. In order to calculate the shear stress values (mean and 
standard deviation), the following Matlab programming was employed, where 
ProcessedDatalist is the processed overnight data, L = Level, A = Impeller Position and 
Pos = Positive values: 
 L6A=ProcessedDatalist (ProcessedDatalist ~=0); 
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[This is done to allow Matlab to recognise the numerical figures; this is in the 
form of an excel spreadsheet of 15,000 cells owing to the size of the ROI; the 
zero values all fall outside of the ROI; L6A represent the strain rates] 
 viscosity = 0.9325; 
[This defines the viscosity] 
 PosL6A = sqrt(L6A^2); 
[Matlab has recognised approximately 15,000 positive and negative values 
owing to different directions of fluid. In order to accurately calculate mean and 
standard deviation values, all negative value are converted into positive values] 
 shearstressL6A = PosL6A.* viscosity; 
[Newton’s law of viscosity to calculate shear stress] 
 mean(shearstressL6A); 
 std(shearstressL6A); 
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9 Promotion of Research 
9.1 List of Award Shortlists 
1. IChemE Awards for innovation and excellence 2010 in association with tce 
magazine, WSP/CEL Bioprocess Award, “Spinner Flask Bioreactor Shear 
Stress”, 4th November 2010, Palace Hotel, Manchester, UK, 
http://cms.icheme.org/MainWebSite/General-
Baraec56ff8bc017325.aspx?Map=1FA4EFEF3C2B379373F641BFF51673FB 
9.2 List of Publications 
1. Ramlogan A.S., Gardner C., De Bruijn J.D., The Effect of Spinner Flask 
Bioreactor Shear on BMSC Growth, Biotechnology & Bioengineering (In 
submission). 
2. Ramlogan A.S., More Spin, Less Shear, TCE: The Chemical Engineer, Flavell-
White C., Forsdyke D. editors, November 2010, Issue 833:58 
3. Wilkop T., Ramlogan A.S., Alberts I.L., De Bruijn J.D., Ray A.K., Surface 
Plasmon Resonance Imaging for Medical and Biosensing, IEEE Conference 
Proceedings, 2009, Vol 1-3:1493-1496. 
4. Ramlogan A.S., De Bruijn J.D., Polymeric Microspheres composed of PHBV, 
PCL and PLGA support the attachment and proliferation of Stem Cells, Tissue 
Engineering. 2007, 13(7):1741. 
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9.3 List of Presentations (*presenting author) 
1. Thomas Wilkop, Anil Shiva Ramlogan, Joost de Bruijn, Ian L. Alberts, Asim K. 
Ray*, Oral Presentation on “Surface Plasmon Resonance Imaging for Medical 
and Biosensing”, IEEE Sensors 2009, Christchurch Convention Centre, 
Christchurch, New Zealand, Oct 25
th 
- 28
th
 2009. 
2. Anil Shiva Ramlogan*, Raheleh Ahmadi*, Inés Jiménes Palomar*, Cheen Peen 
Khoo*, Kruba Shankar*, Oral Presentation on “Business Plan on BioSmart 
Technologies Ltd.”, Biotechnology Young Entrepreneurs Scheme (YES) 2009, 
Jury’s Inn Newcastle, United Kingdom, Oct 21st - 24th 2008. 
3. Anil Shiva Ramlogan*, Joost de Bruijn. Poster Presentation on “Bone marrow-
derived stromal cell Expansion on Microspheres: The Effect of Surface 
Microstructure”, World Biomaterials Congress 2008, Amsterdam, The 
Netherlands, May 28
th
 – June 1st 2008. 
4. Anil Shiva Ramlogan*, Joost de Bruijn. Poster Presentation on “Polymeric 
Microspheres composed of PHBV, PCL and PLGA support the attachment and 
proliferation of Bone marrow-derived stromal cells”, European Society for 
Biomaterials 2008, Brighton, United Kingdom, Sep 9
th
 – 13th 2007. 
5. Anil Shiva Ramlogan*, Joost de Bruijn. Oral Presentation on “Polymeric 
Microspheres composed of PHBV, PCL and PLGA support the attachment and 
proliferation of Bone marrow-derived stromal cells”, Termis-Eu 2008, Brighton, 
United Kingdom, Sep 4
th
 – 7th 2007. 
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6. Progentix BV, Queen Mary University of London, Raheleh Ahmadi*, Anil 
Shiva Ramlogan*, Riemke van Dijkhuizen*, Frank W. Janssen*, Joost D. de 
Bruijn. Poster Presentation on “Bone Tissue Engineering and Adult Stem Cell 
Technology” to the London Technology Network at Whitehall, London (United 
Kingdom), 28
th
 March 2007. 
7. Anil Shiva Ramlogan*, Joost de Bruijn. Poster Presentation on “Stem Cell 
Expansion and Bioreactor Development” to the School of Engineering and 
Materials Science at Queen Mary, University of London (United Kingdom), 28
th
 
November 2006. 
8. Anil Shiva Ramlogan*, Joost de Bruijn. Oral Presentation on “Stem Cell 
Expansion and Bioreactor Development” to the research group of Prof. Dietmar 
W. Hutmacher (Division of Bioengineering, National University of Singapore) 
at the Defence Science Organisation (Singapore), 10
th
 November 2006. 
9. Anil Shiva Ramlogan*, Joost de Bruijn. Oral Presentation on “Stem Cell 
Expansion and Bioreactor Development” to the School of Engineering and 
Materials Science Department of Queen Mary, University of London (United 
Kingdom), 16
th
 October 2006. 
9.4 List of Travel Grant Awards 
1. Queen Mary University of London £450 
2. Armourers and Brasiers Company £900 
3. IOM3 Andrew Carnegie Research Fund £250 
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4. Armourers and Brasiers Company and Corus £300 
5. Armourers and Brasiers Company £400 
6. IOM3 Andrew Carnegie Research Fund £250 
7. Royal Academy of Engineering International Travel Grant £500 
8. Society of Chemical Industry Bursary (Messel Fund) £100 
9.5 Student Research Management 
1. Supervisor to Ian L. Alberts, Medical Student Research Intern, on experimental 
research project “Investigation of Cellular Events in Osseointegration by Surface 
Plasmon Resonance” (July 2009 – August 2009). 
2. Supervisor to Daniel Rivilla, B.Eng student, on experimental research project 
“Mesenchymal stem cell Expansion on Microspheres: The Effect of Surface 
Microstructure” (August 2007 – April 2008). 
3. Supervisor to Noor Latif, B.Eng student, on experimental research project 
“Mesenchymal stem cell Expansion on Microspheres: The Effect of Surface 
Microstructure” (August 2007 – April 2008). 
4. Supervisor to Amir Taheri, B.Eng student, on experimental research project 
“Mesenchymal stem cell Expansion on polymeric microspheres” (August 2006 – 
April 2007). 
   Page | 217  
 
5. Supervisor to Sharadha Wisidagama, B.Eng student, on experimental research 
project “Scaffold Development and Cell Expansion in Regenerative Medicine” 
(August 2006 – April 2007). 
6. Supervisor to 11 undergraduates, on problem-based learning group “Designing 
bio-artificial Cartilage using Embryonic Stem cells and Poly-L-Lactic acid 
Scaffolds”. (November 2007 – December 2007). 
7. Supervisor to 10 undergraduates, Ajayi Bisola, Baloch Faisal Ali, Bhairav Patel, 
Bukhari Farhat Syeda, Elmadani Esam, Muzaffar Danish, Pirvani Madiha, 
Siddiqui Adel Zia and Theocharopoulos Antonios, on problem-based learning 
group “Mesenchymal stem cells for Therapeutic Applications”. (September 
2006 – December 2006). 
8. Supervisor to 10 undergraduates, Anick Akbar, Saleh Hassan, Alex El-Kheir, 
Samantha Low, Usman Mahmood, Manoochehr Rasekh, Orly Selouk and Anas 
Sherif, on problem-based learning group “Expansion of Mesenchymal stem cells 
for Cell Therapy”. (September 2006 – December 2006). 
9. Supervisor to 8 undergraduates, Bisola Ajayi, Bilal Ahmad, Dominique Strasdin, 
Kalaivani Sekar, Mahammad Akbar, Marayam Tanko, Taranjot Paneser and 
Thomas White, on problem-based learning group “Strategy for Cartilage 
Replacement”. (October 2005 – December 2005). 
   Page | 218  
 
10 References 
Ahmadi R, Burns AJ, de Bruijn JD. 2009. Chitosan-based hydrogels do not induce 
angiogenesis. Journal of Tissue Engineering and Regenerative Medicine 
4(4):309-315. 
Ahmadi R, de Bruijn JD. 2008. Biocompatibility and gelation of chitosan-glycerol 
phosphate hydrogels. J Biomed Mater Res A 86(3):824-32. 
Alison MR, Poulsom R, Forbes S, Wright NA. 2002. An introduction to stem cells. J 
Pathol 197(4):419-23. 
Altman DG, Bland JM. 2005. Standard deviations and standard errors. BMJ 
331(7521):903. 
Ashton BA, Allen TD, Howlett CR, Eaglesom CC, Hattori A, Owen M. 1980. 
Formation of bone and cartilage by marrow stromal cells in diffusion chambers 
in vivo. Clin Orthop Relat Res(151):294-307. 
Aubin J, Le Sauze N, Bertrand J, Fletcher DF, Xuereb C. 2004. PIV measurements of 
flow in an aerated tank stirred by a down- and an up-pumping axial flow 
impeller. Experimental Thermal and Fluid Science 28(5):447-456. 
Bakker AD, Soejima K, Klein-Nulend J, Burger EH. 2001. The production of nitric 
oxide and prostaglandin E-2 by primary bone cells is shear stress dependent. 
Journal of Biomechanics 34(5):671-677. 
Balasundaram G, Sato M, Webster TJ. 2006. Using hydroxyapatite nanoparticles and 
decreased crystallinity to promote osteoblast adhesion similar to functionalizing 
with RGD. Biomaterials 27(14):2798-805. 
Bancroft GN, Sikavitsas VI, Mikos AG. 2003. Design of a flow perfusion bioreactor 
system for bone tissue-engineering applications. Tissue Eng 9(3):549-54. 
Bancroft GN, Sikavitsas VI, van den Dolder J, Sheffield TL, Ambrose CG, Jansen JA, 
Mikos AG. 2002. Fluid flow increases mineralized matrix deposition in 3D 
perfusion culture of marrow stromal osteoblasts in a dose-dependent manner. 
Proc Natl Acad Sci U S A 99(20):12600-5. 
Bartl R, Frisch B. 2003. Normal bone marrow: histology, histochemistry and 
immunohistochemistry. In: Wickramasinghe SN, McCullough J, editors. Blood 
and Bone Marrow Pathology. 1st ed. London: Elsevier Ltd. p 53-69. 
Bilgen B, Barabino GA. 2007. Location of scaffolds in bioreactors modulates the 
hydrodynamic environment experienced by engineered tissues. Biotechnol 
Bioeng 98(1):282-94. 
Bilgen B, Sucosky P, Neitzel GP, Barabino GA. 2006. Flow characterization of a wavy-
walled bioreactor for cartilage tissue engineering. Biotechnol Bioeng 
95(6):1009-22. 
Bird A. 2007. Perceptions of epigenetics. Nature 447(7143):396-8. 
Bluman A. 2008. The Normal Distribution. In: Bluman A, editor. Elementary Statistics: 
A Step by Step Approach A Brief Version. New York: McGraw-Hill. p 320. 
Both SK, van der Muijsenberg AJ, van Blitterswijk CA, de Boer J, de Bruijn JD. 2007. 
A rapid and efficient method for expansion of human mesenchymal stem cells. 
Tissue Eng 13(1):3-9. 
Braccini A, Wendt D, Jaquiery C, Jakob M, Heberer M, Kenins L, Wodnar-Filipowicz 
A, Quarto R, Martin I. 2005. Three-dimensional perfusion culture of human 
   Page | 219  
 
bone marrow cells and generation of osteoinductive grafts. Stem Cells 
23(8):1066-72. 
Bruder SP, Jaiswal N, Haynesworth SE. 1997. Growth kinetics, self-renewal, and the 
osteogenic potential of purified human mesenchymal stem cells during extensive 
subcultivation and following cryopreservation. J Cell Biochem 64(2):278-94. 
Bussolati B, Bruno S, Grange C, Ferrando U, Camussi G. 2008. Identification of a 
tumor-initiating stem cell population in human renal carcinomas. Faseb J 
22(10):3696-705. 
Cameron CM, Hu WS, Kaufman DS. 2006. Improved development of human 
embryonic stem cell-derived embryoid bodies by stirred vessel cultivation. 
Biotechnol Bioeng 94(5):938-48. 
Campbell JJ, Lee DA, Bader DL. 2006. Dynamic compressive strain influences 
chondrogenic gene expression in human mesenchymal stem cells. Biorheology 
43(3-4):455-70. 
Cao Y, Vacanti JP, Paige KT, Upton J, Vacanti CA. 1997. Transplantation of 
chondrocytes utilizing a polymer-cell construct to produce tissue-engineered 
cartilage in the shape of a human ear. Plast Reconstr Surg 100(2):297-302; 
discussion 303-4. 
Caplan AI. 1991. Mesenchymal stem cells. J Orthop Res 9(5):641-50. 
Caplan AI. 1994. The mesengenic process. Clin Plast Surg 21(3):429-35. 
Caplan AI. 2005. Review: mesenchymal stem cells: cell-based reconstructive therapy in 
orthopedics. Tissue Eng 11(7-8):1198-211. 
Caplan AI, Bruder SP. 2001. Mesenchymal stem cells: building blocks for molecular 
medicine in the 21st century. Trends Mol Med 7(6):259-64. 
Caplan AI, Syftestad G, Osdoby P. 1983. The development of embryonic bone and 
cartilage in tissue culture. Clin Orthop Relat Res(174):243-63. 
Çatiker E, Gümüscedderelioglu M, Güner A. 2000. Degradation of PLA, PLGA homo- 
and copolymers in the presence of serum albumin: a spectroscopic investigation. 
Polymer International 49(7):728-734. 
Cherry RS. 1993. Animal-Cells in Turbulent Fluids - Details of the Physical Stimulus 
and the Biological Response. Biotechnology Advances 11(2):279-299. 
Cherry RS, Kwon KY. 1990. Transient shear stresses on a suspension cell in turbulence. 
Biotechnol Bioeng 36(6):563-71. 
Cherry RS, Papoutsakis ET. 1986. Hydrodynamic Effects on Cells in Agitated Tissue-
Culture Reactors. Bioprocess Engineering 1(1):29-41. 
Cherry RS, Papoutsakis ET. 1988. Physical mechanisms of cell damage in microcarrier 
cell culture bioreactors. Biotechnol Bioeng 32(8):1001-14. 
Cherry RS, Papoutsakis ET. 1989a. Growth and Death Rates of Bovine Embryonic 
Kidney-Cells in Turbulent Microcarrier Bioreactors. Bioprocess Engineering 
4(2):81-89. 
Cherry RS, Papoutsakis ET. 1989b. Modeling of contact-inhibited animal cell growth 
on flat surfaces and spheres. Biotechnol Bioeng 33(3):300-5. 
Chia SM, Lin PC, Quek CH, Yin C, Mao HQ, Leong KW, Xu X, Goh CH, Ng ML, Yu 
H. 2005. Engineering microenvironment for expansion of sensitive anchorage-
dependent mammalian cells. J Biotechnol 118(4):434-47. 
Chua LP, Ong KS, Song G. 2008. Study of velocity and shear stress distributions in the 
impeller passages and the volute of a bio-centrifugal ventricular assist device. 
Artif Organs 32(5):376-87. 
   Page | 220  
 
Chun KW, Yoo HS, Yoon JJ, Park TG. 2004. Biodegradable PLGA microcarriers for 
injectable delivery of chondrocytes: effect of surface modification on cell 
attachment and function. Biotechnol Prog 20(6):1797-801. 
Clarotti G, Schue F, Sledz J, Ait Ben Aoumar A, Geckeler KE, Orsetti A, Paleirac G. 
1992. Modification of the biocompatible and haemocompatible properties of 
polymer substrates by plasma-deposited fluorocarbon coatings. Biomaterials 
13(12):832-40. 
Colter DC, Class R, DiGirolamo CM, Prockop DJ. 2000. Rapid expansion of recycling 
stem cells in cultures of plastic-adherent cells from human bone marrow. Proc 
Natl Acad Sci U S A 97(7):3213-8. 
Conget PA, Minguell JJ. 1999. Phenotypical and functional properties of human bone 
marrow mesenchymal progenitor cells. J Cell Physiol 181(1):67-73. 
Coulson J, Richardson J. 1999. Flow of Liquids in Pipes and Open Channels. Chemical 
Engineering. 6th ed. Oxford: Butterworth-Heinemann. p 59-62. 
Coulson JM, Richardson JF, Backhurst JR, Harker JH. 1999. Liquid Mixing. In: 
Coulson JM, Richardson JF, Backhurst JR, Harker JH, editors. Coulson & 
Richardson's Chemical Engineering. 6th ed. Oxford: Butterworth-Heinemann. p 
283-285. 
Crotts G, Park TG. 1998. Protein delivery from poly(lactic-co-glycolic acid) 
biodegradable microspheres: release kinetics and stability issues. J 
Microencapsul 15(6):699-713. 
Croughan MS, Hamel JF, Wang DI. 1988. Effects of microcarrier concentration in 
animal cell culture. Biotechnol Bioeng 32(8):975-82. 
Curran JM, Tang Z, Hunt JA. 2009. PLGA doping of PCL affects the plastic potential 
of human mesenchymal stem cells, both in the presence and absence of 
biological stimuli. J Biomed Mater Res A 89(1):1-12. 
Czarnecki JS, Lafdi K, Tsonis PA. 2008. A novel approach to control growth, 
orientation, and shape of human osteoblasts. Tissue Eng Part A 14(2):255-65. 
Dai NT, Williamson MR, Khammo N, Adams EF, Coombes AG. 2004. Composite cell 
support membranes based on collagen and polycaprolactone for tissue 
engineering of skin. Biomaterials 25(18):4263-71. 
Dang SM, Gerecht-Nir S, Chen J, Itskovitz-Eldor J, Zandstra PW. 2004. Controlled, 
scalable embryonic stem cell differentiation culture. Stem Cells 22(3):275-82. 
De Bari C, Dell'Accio F, Tylzanowski P, Luyten FP. 2001. Multipotent mesenchymal 
stem cells from adult human synovial membrane. Arthritis Rheum 44(8):1928-
42. 
Degasne I, Baslé MF, Demais V, Huré G, Lesourd M, Grolleau B, Mercier L, Chappard 
D. 1999. Effects of Roughness, Fibronectin and Vitronectin on Attachment, 
Spreading, and Proliferation of Human Osteoblast-Like Cells (Saos-2) on 
Titanium Surfaces. Calcified Tissue International 64(6):499-507. 
Deligianni DD, Katsala N, Ladas S, Sotiropoulou D, Amedee J, Missirlis YF. 2001a. 
Effect of surface roughness of the titanium alloy Ti-6Al-4V on human bone 
marrow cell response and on protein adsorption. Biomaterials 22(11):1241-
1251. 
Deligianni DD, Katsala ND, Koutsoukos PG, Missirlis YF. 2001b. Effect of surface 
roughness of hydroxyapatite on human bone marrow cell adhesion, proliferation, 
differentiation and detachment strength. Biomaterials 22(1):87-96. 
Delorme B, Ringe J, Pontikoglou C, Gaillard J, Langonne A, Sensebe L, Noel D, 
Jorgensen C, Haupl T, Charbord P. 2009. Specific lineage-priming of bone 
   Page | 221  
 
marrow mesenchymal stem cells provides the molecular framework for their 
plasticity. Stem Cells 27(5):1142-51. 
Deng Y, Zhao K, Zhang XF, Hu P, Chen GQ. 2002. Study on the three-dimensional 
proliferation of rabbit articular cartilage-derived chondrocytes on 
polyhydroxyalkanoate scaffolds. Biomaterials 23(20):4049-56. 
Dominici M, Le Blanc K, Mueller I, Slaper-Cortenbach I, Marini F, Krause D, Deans R, 
Keating A, Prockop D, Horwitz E. 2006. Minimal criteria for defining 
multipotent mesenchymal stromal cells. The International Society for Cellular 
Therapy position statement. Cytotherapy 8(4):315-7. 
Doran P. 2002. Bioprocess Engineering Principles. London: Academic Press Limited. p 
132-383. 
Doyle C, Tanner ET, Bonfield W. 1991. In vitro and in vivo evaluation of 
polyhydroxybutyrate and of polyhydroxybutyrate reinforced with 
hydroxyapatite. Biomaterials 12(9):841-7. 
Drife JM, BA. 2004. Human Embryogenesis. In: Drife JM, BA., editor. Clinical 
Obstetrics and Gynaecology. 1st ed. London: Elsevier Limited. p 57. 
Dusting J, Sheridan J, Hourigan K. 2006. A fluid dynamics approach to bioreactor 
design for cell and tissue culture. Biotechnol Bioeng 94(6):1196-208. 
Eibl R, Eibl D, Eibl R, Werner S, Eibl D. 2010. Bag Bioreactor Based on Wave-Induced 
Motion: Characteristics and Applications. Disposable Bioreactors: Springer 
Berlin / Heidelberg. p 55-87. 
Ellis M, Jarman-Smith. M, Chaudhuri J. 2005. Bioreactor Systems for Tissue 
Engineering: A Four-Dimensional Challenge. In: Chaudhuri JM, AR., editor. 
Bioreactors for Tissue Engineering. Dordrecht: Springer. p 3. 
Ferrari G, Cusella-De Angelis G, Coletta M, Paolucci E, Stornaiuolo A, Cossu G, 
Mavilio F. 1998. Muscle regeneration by bone marrow-derived myogenic 
progenitors. Science 279(5356):1528-30. 
Fischer EM, Layrolle P, Van Blitterswijk CA, De Bruijn JD. 2003. Bone formation by 
mesenchymal progenitor cells cultured on dense and microporous 
hydroxyapatite particles. Tissue Eng 9(6):1179-88. 
Fischman J. 1999. How to build a body part. Time 153(8):54-5. 
Fok EY, Zandstra PW. 2005. Shear-controlled single-step mouse embryonic stem cell 
expansion and embryoid body-based differentiation. Stem Cells 23(9):1333-42. 
Fong WJ, Tan HL, Choo A, Oh SK. 2005. Perfusion cultures of human embryonic stem 
cells. Bioprocess Biosyst Eng 27(6):381-7. 
Frauenschuh S, Reichmann E, Ibold Y, Goetz PM, Sittinger M, Ringe J. 2007. A 
microcarrier-based cultivation system for expansion of primary mesenchymal 
stem cells. Biotechnol Prog 23(1):187-93. 
Freedman D, Pisani R, Purves R. 1998. The Average and the Standard Deviation. In: 
Freedman D, Pisani R, Purves R, editors. Statistics. 3rd ed. New York: W. W. 
Norton & Company, Inc. p 57-77. 
Freshney R. 2000a. Contamination. In: Freshney R, editor. Culture of Animal Cells: A 
Manual of Basic Techniques. 4th ed. New York: Wiley-Liss, Inc. p 285-288. 
Freshney R. 2000b. Culture Vessels. In: Freshney R, editor. Culture of Animal Cells: A 
Manual of Basic Techniques. 4th ed. New York: Wiley-Liss, Inc. p 77-87. 
Freshney R. 2005. Culture of Specific Cell Types. In: Freshney R, editor. Culture of 
Animal Cells: A manual of basic techniques. 5th ed. Hoboken, New Jersey: John 
Wiley & Sons Inc. p 400. 
   Page | 222  
 
Friedenstein AJ, Chailakhjan RK, Lalykina KS. 1970. The development of fibroblast 
colonies in monolayer cultures of guinea-pig bone marrow and spleen cells. Cell 
Tissue Kinet 3(4):393-403. 
Friedenstein AJ, Piatetzky S, II, Petrakova KV. 1966. Osteogenesis in transplants of 
bone marrow cells. J Embryol Exp Morphol 16(3):381-90. 
Gauthaman K, Venugopal JR, Yee FC, Peh GSL, Ramakrishna S, Bongso A. 2009. 
Nanofibrous substrates support colony formation and maintain stemness of 
human embryonic stem cells. Journal of Cellular and Molecular Medicine 
13(9b):3475-3484. 
George W. 1987. Spectroscopic Analysis of Organic Compounds. In: George W, editor. 
Infrared Spectroscopy: Wiley. p 299. 
Gilding D. 1981. Biodegradable polymers. 209 – 232 p. 
Goldstein AS, Juarez TM, Helmke CD, Gustin MC, Mikos AG. 2001. Effect of 
convection on osteoblastic cell growth and function in biodegradable polymer 
foam scaffolds. Biomaterials 22(11):1279-88. 
Gomes ME, Bossano CM, Johnston CM, Reis RL, Mikos AG. 2006. In vitro 
localization of bone growth factors in constructs of biodegradable scaffolds 
seeded with marrow stromal cells and cultured in a flow perfusion bioreactor. 
Tissue Eng 12(1):177-88. 
Gomes ME, Sikavitsas VI, Behravesh E, Reis RL, Mikos AG. 2003. Effect of flow 
perfusion on the osteogenic differentiation of bone marrow stromal cells 
cultured on starch-based three-dimensional scaffolds. J Biomed Mater Res A 
67(1):87-95. 
Goodwin TJ, Prewett TL, Wolf DA, Spaulding GF. 1993a. Reduced shear stress: a 
major component in the ability of mammalian tissues to form three-dimensional 
assemblies in simulated microgravity. J Cell Biochem 51(3):301-11. 
Goodwin TJ, Schroeder WF, Wolf DA, Moyer MP. 1993b. Rotating-wall vessel 
coculture of small intestine as a prelude to tissue modeling: aspects of simulated 
microgravity. Proc Soc Exp Biol Med 202(2):181-92. 
Gotherstrom C, Ringden O, Westgren M, Tammik C, Le Blanc K. 2003. 
Immunomodulatory effects of human foetal liver-derived mesenchymal stem 
cells. Bone Marrow Transplant 32(3):265-72. 
Grellier M, Bareille R, Bourget C, Amedee J. 2009. Responsiveness of human bone 
marrow stromal cells to shear stress. J Tissue Eng Regen Med 3(4):302-9. 
Grove JE, Bruscia E, Krause DS. 2004. Plasticity of bone marrow-derived stem cells. 
Stem Cells 22(4):487-500. 
Hammond TG, Hammond JM. 2001. Optimized suspension culture: the rotating-wall 
vessel. Am J Physiol Renal Physiol 281(1):F12-25. 
Hayflick L. 1979. The cell biology of aging. J Invest Dermatol 73(1):8-14. 
Higuera G, Schop D, Janssen F, van Dijkhuizen-Radersma R, van Boxtel T, van 
Blitterswijk CA. 2009. Quantifying in vitro growth and metabolism kinetics of 
human mesenchymal stem cells using a mathematical model. Tissue Eng Part A 
15(9):2653-63. 
Hillsley MV, Frangos JA. 1994. Bone tissue engineering: the role of interstitial fluid 
flow. Biotechnol Bioeng 43(7):573-81. 
Hines WW, Montgomery DC, Goldsman DM, Borror CM. 2003. Statistics and 
Sampling Distributions. In: Anderson W, Welter J, editors. Probability and 
Statistics in Engineering. 4th ed. New Jersey: John Wiley & Sons, Inc. p 203. 
   Page | 223  
 
Hirtenstein M, Clark J, Lindgren G, Vretblad P. 1980. Microcarriers for animal cell 
culture: a brief review of theory and practice. Dev Biol Stand 46:109-16. 
Hooke R. 1667. Micrographia: or some physiological descriptions of minute bodies 
made by magnifying glasses : with observations and inquiries thereupon. 
London: John Martin. 246 p. 
Hooker BS, Lee JM, An G. 1990. Cultivation of plant cells in a stirred vessel: Effect of 
impeller design. Biotechnol Bioeng 35(3):296-304. 
Horwitz EM, Gordon PL, Koo WK, Marx JC, Neel MD, McNall RY, Muul L, Hofmann 
T. 2002. Isolated allogeneic bone marrow-derived mesenchymal cells engraft 
and stimulate growth in children with osteogenesis imperfecta: Implications for 
cell therapy of bone. Proc Natl Acad Sci U S A 99(13):8932-7. 
Hutmacher DW, Schantz T, Zein I, Ng KW, Teoh SH, Tan KC. 2001. Mechanical 
properties and cell cultural response of polycaprolactone scaffolds designed and 
fabricated via fused deposition modeling. J Biomed Mater Res 55(2):203-16. 
In 't Anker PS, Scherjon SA, Kleijburg-van der Keur C, Noort WA, Claas FH, Willemze 
R, Fibbe WE, Kanhai HH. 2003. Amniotic fluid as a novel source of 
mesenchymal stem cells for therapeutic transplantation. Blood 102(4):1548-9. 
Jabbarzadeh E, Jiang T, Deng M, Nair LS, Khan YM, Laurencin CT. 2007. Human 
endothelial cell growth and phenotypic expression on three dimensional 
poly(lactide-co-glycolide) sintered microsphere scaffolds for bone tissue 
engineering. Biotechnol Bioeng 98(5):1094-102. 
Jackson KA, Mi T, Goodell MA. 1999. Hematopoietic potential of stem cells isolated 
from murine skeletal muscle. Proc Natl Acad Sci U S A 96(25):14482-6. 
Jacobs T. 2001. Full stem ahead. Newsweek 137(7):63-5. 
Jaiswal N, Haynesworth SE, Caplan AI, Bruder SP. 1997. Osteogenic differentiation of 
purified, culture-expanded human mesenchymal stem cells in vitro. J Cell 
Biochem 64(2):295-312. 
Jiang S, Ji X, An L, Jiang B. 2001. Crystallization behavior of PCL in hybrid confined 
environment. Polymer 42(8):3901-3907. 
Jiang Y, Jahagirdar BN, Reinhardt RL, Schwartz RE, Keene CD, Ortiz-Gonzalez XR, 
Reyes M, Lenvik T, Lund T, Blackstad M and others. 2002. Pluripotency of 
mesenchymal stem cells derived from adult marrow. Nature 418(6893):41-9. 
Jukes J, Both S, Post J, Van Blitterswijk CA, Karperien M, De Boer J. 2008. Stem 
Cells. In: Van Blitterswijk CA, editor. Tissue Engineering. 1st ed. London: 
Elsevier Inc. p 3. 
Kang B, Kang K, Lee Y. 2005. Biocompatibility and Long-Term Toxicity of InnoPol® 
Implant, a Biodegradable Polymer Scaffold. Experimental Animals/ Japanese 
Association for Laboratory Animal Science 54(1):37-52. 
Kapur S, Baylink DJ, Lau KH. 2003. Fluid flow shear stress stimulates human 
osteoblast proliferation and differentiation through multiple interacting and 
competing signal transduction pathways. Bone 32(3):241-51. 
Kaye GWC, Laby TH. 1995. Mechanical Properties of Materials. In: Kaye GWC, Laby 
TH, editors. Tables of Physical and Chemical Constants. 16th ed. Essex: 
Longman Group. p 52. 
Kim BS, Lee CC, Christensen JE, Huser TR, Chan JW, Tarantal AF. 2008. Growth, 
differentiation, and biochemical signatures of rhesus monkey mesenchymal stem 
cells. Stem Cells Dev 17(1):185-98. 
   Page | 224  
 
Kim HJ, Kim UJ, Leisk GG, Bayan C, Georgakoudi I, Kaplan DL. 2007. Bone 
regeneration on macroporous aqueous-derived silk 3-D scaffolds. Macromol 
Biosci 7(5):643-55. 
Klee D, Höcker H, Eastmond G. 1999. Advances in Polymer Science. Berlin 
Heidelberg: Springer-Verlag Berlin Heidelberg. 67-69 p. 
Kogame M, Matsuo S, Nakatani M, Kurisaki A, Nishitani H, Tsuchida K, Sugino H. 
2006. ALK7 is a novel marker for adipocyte differentiation. J Med Invest 53(3-
4):238-45. 
Koopman R, Schaart G, Hesselink MK. 2001. Optimisation of oil red O staining permits 
combination with immunofluorescence and automated quantification of lipids. 
Histochem Cell Biol 116(1):63-8. 
Kose GT, Korkusuz F, Korkusuz P, Purali N, Ozkul A, Hasirci V. 2003. Bone 
generation on PHBV matrices: an in vitro study. Biomaterials 24(27):4999-
5007. 
Kose GT, Korkusuz F, Ozkul A, Soysal Y, Ozdemir T, Yildiz C, Hasirci V. 2005. 
Tissue engineered cartilage on collagen and PHBV matrices. Biomaterials 
26(25):5187-97. 
Kumarasuriyar A, Jackson RA, Grondahl L, Trau M, Nurcombe V, Cool SM. 2005. 
Poly(beta-hydroxybutyrate-co-beta-hydroxyvalerate) supports in vitro 
osteogenesis. Tissue Eng 11(7-8):1281-95. 
Lagasse E, Connors H, Al-Dhalimy M, Reitsma M, Dohse M, Osborne L, Wang X, 
Finegold M, Weissman IL, Grompe M. 2000. Purified hematopoietic stem cells 
can differentiate into hepatocytes in vivo. Nat Med 6(11):1229-34. 
Langer R, Vacanti JP. 1993. Tissue engineering. Science 260(5110):920-6. 
Langer RS, Vacanti JP. 1999. Tissue engineering: the challenges ahead. Sci Am 
280(4):86-9. 
Lanza R, Langer R, Vacanti J. 2000. Principles of Tissue Engineering. San Diego: 
Academic Press USA. 
Larson BL, Ylostalo J, Prockop DJ. 2008. Human multipotent stromal cells undergo 
sharp transition from division to development in culture. Stem Cells 26(1):193-
201. 
Lee OK, Kuo TK, Chen WM, Lee KD, Hsieh SL, Chen TH. 2004. Isolation of 
multipotent mesenchymal stem cells from umbilical cord blood. Blood 
103(5):1669-75. 
Lemare F, Steimberg N, Le Griel C, Demignot S, Adolphe M. 1998. Dedifferentiated 
chondrocytes cultured in alginate beads: restoration of the differentiated 
phenotype and of the metabolic responses to interleukin-1beta. J Cell Physiol 
176(2):303-13. 
Levine EM, Becker Y, Boone CW, Eagle H. 1965. Contact Inhibition, Macromolecular 
Synthesis, and Polyribosomes in Cultured Human Diploid Fibroblasts. Proc Natl 
Acad Sci U S A 53:350-6. 
Li WJ, Laurencin CT, Caterson EJ, Tuan RS, Ko FK. 2002. Electrospun nanofibrous 
structure: a novel scaffold for tissue engineering. J Biomed Mater Res 
60(4):613-21. 
Lincks J, Boyan BD, Blanchard CR, Lohmann CH, Liu Y, Cochran DL, Dean DD, 
Schwartz Z. 1998. Response of MG63 osteoblast-like cells to titanium and 
titanium alloy is dependent on surface roughness and composition. Biomaterials 
19(23):2219-32. 
   Page | 225  
 
Lohmann CH, Sagun R, Jr., Sylvia VL, Cochran DL, Dean DD, Boyan BD, Schwartz Z. 
1999. Surface roughness modulates the response of MG63 osteoblast-like cells 
to 1,25-(OH)(2)D(3) through regulation of phospholipase A(2) activity and 
activation of protein kinase A. J Biomed Mater Res 47(2):139-51. 
Lu L, Mikos A. 1996. The importance of new processing techniques in tissue 
engineering. Mater Res Soc Bull 21:28-32. 
Macdonald JM, Xu A, Kubota H, LeCluye E, Hamilton G, Liu H, Rong Y, Moss N, 
Lodestro C, Luntz T and others. 2002. Liver Cell Culture. In: Atala A, Lanza 
RP, editors. Methods of Tissue Engineering. California: Elsevier. p 153. 
Majumdar MK, Keane-Moore M, Buyaner D, Hardy WB, Moorman MA, McIntosh 
KR, Mosca JD. 2003. Characterization and functionality of cell surface 
molecules on human mesenchymal stem cells. J Biomed Sci 10(2):228-41. 
Malda J, Frondoza CG. 2006. Microcarriers in the engineering of cartilage and bone. 
Trends Biotechnol 24(7):299-304. 
Malm T, Bowald S, Bylock A, Busch C. 1992. Prevention of postoperative pericardial 
adhesions by closure of the pericardium with absorbable polymer patches. An 
experimental study. J Thorac Cardiovasc Surg 104(3):600-7. 
Malm T, Bowald S, Bylock A, Busch C, Saldeen T. 1994. Enlargement of the right 
ventricular outflow tract and the pulmonary artery with a new biodegradable 
patch in transannular position. Eur Surg Res 26(5):298-308. 
Marletta G, Ciapetti G, Satriano C, Perut F, Salerno M, Baldini N. 2007. Improved 
osteogenic differentiation of human marrow stromal cells cultured on ion-
induced chemically structured poly-epsilon-caprolactone. Biomaterials 
28(6):1132-40. 
Martin JY, Schwartz Z, Hummert TW, Schraub DM, Simpson J, Lankford J, Jr., Dean 
DD, Cochran DL, Boyan BD. 1995. Effect of titanium surface roughness on 
proliferation, differentiation, and protein synthesis of human osteoblast-like cells 
(MG63). J Biomed Mater Res 29(3):389-401. 
Meijer GJ, de Bruijn JD, Koole R, van Blitterswijk CA. 2007. Cell-based bone tissue 
engineering. PLoS Med 4(2):e9. 
Meisenberg G, Simmons WH. 2006a. Carbohydrate Metabolism. In: Stibbe A, Gruliow 
R, editors. Principles of Medical Biochemistry. 2nd ed. Philadelphia: Mosby 
Elsevier. p 407-409. 
Meisenberg G, Simmons WH. 2006b. Glycolysis, Tricarboxylic Acid Cycle, and 
Oxidative Phosphorylation. In: Stibbe A, Gruliow R, editors. Principles of 
Medical Biochemistry. 2nd ed. Philadelphia: Mosby Elsevier. p 383. 
Melton DA, Cowan C. 2004. "Stemness": Definitions, Criteria and Standards. In: Lanza 
R, Gearhart J, Hogan B, Melton D, Pedersen R, Thomson J, West M, editors. 
Handbook of Stem Cells. Burlington, USA: Elsevier Inc. p xxv-xxxi. 
Mendes SC, Van Den Brink I, De Bruijn JD, Van Blitterswijk CA. 1998. In vivo bone 
formation by human bone marrow cells: effect of osteogenic culture 
supplements and cell densities. J Mater Sci Mater Med 9(12):855-8. 
Micheletti M, Yianneskis M. 2004. Study of fluid velocity characteristics in stirred 
solid-liquid suspensions with a refractive index matching technique. Proceedings 
of the Institution of Mechanical Engineers Part E-Journal of Process Mechanical 
Engineering 218(E4):191-204. 
Moioli EK, Hong L, Mao JJ. 2007. Inhibition of osteogenic differentiation of human 
mesenchymal stem cells. Wound Repair Regen 15(3):413-21. 
   Page | 226  
 
Moore GF, Saunders SM. 1998. The search for Biodegradable Polymers. Shropshire: 
iSmithers Rapra Publishing. Report nr 1859571182. 14-16 p. 
Moore KA, Lemischka IR. 2006. Stem cells and their niches. Science 311(5769):1880-
5. 
Mueller S, Llewellin EW, Mader HM. 2010. The rheology of suspensions of solid 
particles. Proceedings of the Royal Society a-Mathematical Physical and 
Engineering Sciences 466(2116):1201-1228. 
Muschler GF, Nakamoto C, Griffith LG. 2004. Engineering principles of clinical cell-
based tissue engineering. J Bone Joint Surg Am 86-A(7):1541-58. 
Nakanishi K. 1962a. Band Positions and Intensity. In: Nakanishi K, editor. Infrared 
Absorption Spectroscopy. Tokyo: Nankodo Company Limited. p 44. 
Nakanishi K. 1962b. Tables of Characteristic Frequencies. In: Nakanishi K, editor. 
Infrared Absorption Spectroscopy. Tokyo: Nankodo Company Limited. p 20. 
Nakanishi K, and Solomon, P.H. 1977a. Tables of Characteristic Frequencies. Infrared 
Absorption Spectroscopy. San Francisco: Holden-Day, Inc. p 31. 
Nakanishi K, and Solomon, P.H. 1977b. Tables of Characteristic Frequencies. Infrared 
Absorption Spectroscopy. San Francisco: Holden-Day, Inc. p 14. 
Neuhuber B, Swanger SA, Howard L, Mackay A, Fischer I. 2008. Effects of plating 
density and culture time on bone marrow stromal cell characteristics. Exp 
Hematol 36(9):1176-85. 
Noth U, Osyczka AM, Tuli R, Hickok NJ, Danielson KG, Tuan RS. 2002. Multilineage 
mesenchymal differentiation potential of human trabecular bone-derived cells. J 
Orthop Res 20(5):1060-9. 
Odabas S, Sayar F, Güven G, YanIkkaya-Demirel G, Piskin E. 2008. Separation of 
mesenchymal stem cells with magnetic nanosorbents carrying CD105 and CD73 
antibodies in flow-through and batch systems. Journal of Chromatography B 
861(1):74-80. 
Ohlstein B, Kai T, Decotto E, Spradling A. 2004. The stem cell niche: theme and 
variations. Curr Opin Cell Biol 16(6):693-9. 
Osdoby P, Caplan AI. 1979. Osteogenesis in cultures of limb mesenchymal cells. Dev 
Biol 73(1):84-102. 
Osdoby P, Caplan AI. 1981. Characterization of a bone-specific alkaline phosphatase in 
chick limb mesenchymal cell cultures. Dev Biol 86(1):136-46. 
Papoutsakis ET. 1991. Fluid-mechanical damage of animal cells in bioreactors. Trends 
Biotechnol 9(12):427-37. 
Park A, Cima LG. 1996. In vitro cell response to differences in poly-L-lactide 
crystallinity. J Biomed Mater Res 31(1):117-30. 
Park A, Wu B, Griffith LG. 1998. Integration of surface modification and 3D 
fabrication techniques to prepare patterned poly(L-lactide) substrates allowing 
regionally selective cell adhesion. J Biomater Sci Polym Ed 9(2):89-110. 
Pitt C, Andrady A, Bao Y, Sarnuei N. 1987. Estimation of the rate of drug diffusion in 
polymers. American Chemical Society 348:49-77. 
Pittenger MF, Mackay AM, Beck SC, Jaiswal RK, Douglas R, Mosca JD, Moorman 
MA, Simonetti DW, Craig S, Marshak DR. 1999. Multilineage potential of adult 
human mesenchymal stem cells. Science 284(5411):143-7. 
Poole AR, Kojima T, Yasuda T, Mwale F, Kobayashi M, Laverty S. 2001. Composition 
and structure of articular cartilage: a template for tissue repair. Clin Orthop Relat 
Res(391 Suppl):S26-33. 
   Page | 227  
 
Provin C, Takano K, Sakai Y, Fujii T, Shirakashi R. 2008. A method for the design of 
3D scaffolds for high-density cell attachment and determination of optimum 
perfusion culture conditions. J Biomech 41(7):1436-49. 
Qiu Q, Ducheyne P, Gao H, Ayyaswamy P. 1998. Formation and differentiation of 
three-dimensional rat marrow stromal cell culture on microcarriers in a rotating-
wall vessel. Tissue Eng 4(1):19-34. 
Raffel M, Willert C, Wereley S, Kompenhans J. 2007. Particle Image Velocimetry. 
Raffel M, Willert C, Wereley S, Kompenhans J, editors. Berlin: Springer. 448 p. 
Rai B, Teoh SH, Ho KH, Hutmacher DW, Cao T, Chen F, Yacob K. 2004. The effect of 
rhBMP-2 on canine osteoblasts seeded onto 3D bioactive polycaprolactone 
scaffolds. Biomaterials 25(24):5499-506. 
Reh TA, Nagy T, Gretton H. 1987. Retinal pigmented epithelial cells induced to 
transdifferentiate to neurons by laminin. Nature 330(6143):68-71. 
Ren T, Ren J, Jia X, Pan K. 2005. The bone formation in vitro and mandibular defect 
repair using PLGA porous scaffolds. J Biomed Mater Res A 74(4):562-9. 
Riddle RC, Taylor AF, Genetos DC, Donahue HJ. 2006. MAP kinase and calcium 
signaling mediate fluid flow-induced human mesenchymal stem cell 
proliferation. Am J Physiol Cell Physiol 290(3):C776-84. 
Russo VEA, Martienssen RA, Riggs AD. 1996. Epigenetic Mechanisms of Gene 
Regulation. Russo VEA, Martienssen RA, Riggs AD, editors. New York: Cold 
Spring Harbor Laboratory Press. 692 p. 
Saito T, Tomita K, Juni K, Ooba K. 1991. In vivo and in vitro degradation of poly(3-
hydroxybutyrate) in rat. Biomaterials 12(3):309-12. 
Salgado AJ, Coutinho OP, Reis RL. 2004. Bone tissue engineering: state of the art and 
future trends. Macromol Biosci 4(8):743-65. 
Salingcarnboriboon R, Yoshitake H, Tsuji K, Obinata M, Amagasa T, Nifuji A, Noda 
M. 2003. Establishment of tendon-derived cell lines exhibiting pluripotent 
mesenchymal stem cell-like property. Exp Cell Res 287(2):289-300. 
Saunders MM, You J, Zhou Z, Li Z, Yellowley CE, Kunze EL, Jacobs CR, Donahue 
HJ. 2003. Fluid flow-induced prostaglandin E2 response of osteoblastic ROS 
17/2.8 cells is gap junction-mediated and independent of cytosolic calcium. 
Bone 32(4):350-356. 
Sawae Y, Shelton JC, Bader DL, Knight MM. 2004. Confocal analysis of local and 
cellular strains in chondrocyte-agarose constructs subjected to mechanical shear. 
Ann Biomed Eng 32(6):860-70. 
Schlaeppi JM, Henke M, Mahnke M, Hartmann S, Schmitz R, Pouliquen Y, Kerins B, 
Weber E, Kolbinger F, Kocher HP. 2006. A semi-automated large-scale process 
for the production of recombinant tagged proteins in the Baculovirus expression 
system. Protein Expr Purif 50(2):185-95. 
Schofield R. 1978. The relationship between the spleen colony-forming cell and the 
haemopoietic stem cell. Blood Cells 4(1-2):7-25. 
Schop D, Janssen FW, Borgart E, de Bruijn JD, van Dijkhuizen-Radersma R. 2008. 
Expansion of mesenchymal stem cells using a microcarrier-based cultivation 
system: growth and metabolism. J Tissue Eng Regen Med 2(2-3):126-35. 
Schop D, Janssen FW, van Rijn LD, Fernandes H, Bloem RM, de Bruijn JD, van 
Dijkhuizen-Radersma R. 2009a. Growth, metabolism, and growth inhibitors of 
mesenchymal stem cells. Tissue Eng Part A 15(8):1877-86. 
Schop D, van Dijkhuizen-Radersma R, Borgart E, Janssen FW, Rozemuller H, Prins HJ, 
de Bruijn JD. 2009b. Expansion of human mesenchymal stromal cells on 
   Page | 228  
 
microcarriers: growth and metabolism. Journal of Tissue Engineering and 
Regenerative Medicine 4(2):131-140. 
Schroeder M, Niebruegge S, Werner A, Willbold E, Burg M, Ruediger M, Field LJ, 
Lehmann J, Zweigerdt R. 2005. Differentiation and lineage selection of mouse 
embryonic stem cells in a stirred bench scale bioreactor with automated process 
control. Biotechnol Bioeng 92(7):920-33. 
Sekiya I, Larson BL, Smith JR, Pochampally R, Cui JG, Prockop DJ. 2002. Expansion 
of human adult stem cells from bone marrow stroma: conditions that maximize 
the yields of early progenitors and evaluate their quality. Stem Cells 20(6):530-
41. 
Sen A, Kallos MS, Behie LA. 2002. Expansion of mammalian neural stem cells in 
bioreactors: effect of power input and medium viscosity. Brain Res Dev Brain 
Res 134(1-2):103-13. 
Senuma Y, Franceschin S, Hilborn JG, Tissieres P, Bisson I, Frey P. 2000. 
Bioresorbable microspheres by spinning disk atomization as injectable cell 
carrier: from preparation to in vitro evaluation. Biomaterials 21(11):1135-44. 
Shao X, Goh JC, Hutmacher DW, Lee EH, Zigang G. 2006. Repair of large articular 
osteochondral defects using hybrid scaffolds and bone marrow-derived 
mesenchymal stem cells in a rabbit model. Tissue Eng 12(6):1539-51. 
Shen FH, Zeng Q, Lv Q, Choi L, Balian G, Li X, Laurencin CT. 2006. Osteogenic 
differentiation of adipose-derived stromal cells treated with GDF-5 cultured on a 
novel three-dimensional sintered microsphere matrix. Spine J 6(6):615-23. 
Shepard N, Mitchell N. 1976. The localization of proteoglycan by light and electron 
microscopy using safranin O. A study of epiphyseal cartilage. J Ultrastruct Res 
54(3):451-60. 
Sikavitsas VI, Bancroft GN, Holtorf HL, Jansen JA, Mikos AG. 2003. Mineralized 
matrix deposition by marrow stromal osteoblasts in 3D perfusion culture 
increases with increasing fluid shear forces. Proc Natl Acad Sci U S A 
100(25):14683-8. 
Sikavitsas VI, Bancroft GN, Mikos AG. 2002. Formation of three-dimensional 
cell/polymer constructs for bone tissue engineering in a spinner flask and a 
rotating wall vessel bioreactor. J Biomed Mater Res 62(1):136-48. 
Sittinger M, Reitzel D, Dauner M, Hierlemann H, Hammer C, Kastenbauer E, Planck H, 
Burmester GR, Bujia J. 1996. Resorbable polyesters in cartilage engineering: 
affinity and biocompatibility of polymer fiber structures to chondrocytes. J 
Biomed Mater Res 33(2):57-63. 
Skalak R, Fox C. Tissue Engineering. In: Skalak R, Fox C, editors; 1988; Lake Tahoe, 
California, USA. Alan R Liss Inc. p 343. 
Slack JM, Tosh D. 2001. Transdifferentiation and metaplasia--switching cell types. Curr 
Opin Genet Dev 11(5):581-6. 
Slayton W, Spangrude G. 2004. Adult Stem Cell Plasticity. In: Turksen K, editor. Adult 
Stem Cells. Totowa, New Jersey: Humana Press Inc. p 5. 
Smiler D, Soltan M, Albitar M. 2008. Toward the identification of mesenchymal stem 
cells in bone marrow and peripheral blood for bone regeneration. Implant Dent 
17(3):236-47. 
Somerscales EFC, Papyrin AN, Soloukin RI. 1981. Tracer Methods. In: Emrich RJ, 
editor. Fluid Dynamics. London: Academic Press, Inc. (London) LTD. p 1-64. 
Stathopoulos NA, Hellums JD. 1985. Shear stress effects on human embryonic kidney 
cells in Vitro. Biotechnol Bioeng 27(7):1021-6. 
   Page | 229  
 
Stiehler M, Bunger C, Baatrup A, Lind M, Kassem M, Mygind T. 2009. Effect of 
dynamic 3-D culture on proliferation, distribution, and osteogenic differentiation 
of human mesenchymal stem cells. J Biomed Mater Res A 89(1):96-107. 
Storrie H, Stupp SI. 2005. Cellular response to zinc-containing organoapatite: an in 
vitro study of proliferation, alkaline phosphatase activity and biomineralization. 
Biomaterials 26(27):5492-9. 
Sucosky P, Osorio DF, Brown JB, Neitzel GP. 2004. Fluid mechanics of a spinner-flask 
bioreactor. Biotechnol Bioeng 85(1):34-46. 
Takahashi M, Kamei Y, Ezaki O. 2005. Mest/Peg1 imprinted gene enlarges adipocytes 
and is a marker of adipocyte size. Am J Physiol Endocrinol Metab 288(1):E117-
24. 
Tang XJ, Wu QY. 2006. Mesenchymal stem cellular adhesion and cytotoxicity study of 
random biopolyester scaffolds for tissue engineering. J Mater Sci Mater Med 
17(7):627-32. 
Tepliashin AS, Chupikova NI, Korzhikova SV, Sharifullina SZ, Rostovskaia MS, 
Topchiashvili ZA, Savchenkova IP. 2005. [Comparative analysis of cell 
populations with a phenotype similar to that of mesenchymal stem cells derived 
from subcutaneous fat]. Tsitologiia 47(7):637-43. 
Terada N, Hamazaki T, Oka M, Hoki M, Mastalerz DM, Nakano Y, Meyer EM, Morel 
L, Petersen BE, Scott EW. 2002. Bone marrow cells adopt the phenotype of 
other cells by spontaneous cell fusion. Nature 416(6880):542-5. 
Tewes F, Boury F, Benoit J. 2006. Biodegradable Microspheres: Advances in 
Production Technology. In: Benita S, editor. Microencapsulation: . 2nd ed. Boca 
Raton, Florida: Taylor & Francis Group, LLC. p 31. 
Thissen H, Chang KY, Tebb TA, Tsai WB, Glattauer V, Ramshaw JA, Werkmeister JA. 
2006. Synthetic biodegradable microparticles for articular cartilage tissue 
engineering. J Biomed Mater Res A 77(3):590-8. 
Till JE, McCulloch EA, Siminovitch L. 1964. A Stochastic Model of Stem Cell 
Proliferation, Based on the Growth of Spleen Colony-Forming Cells. Proc Natl 
Acad Sci U S A 51:29-36. 
Tonomura A, Sumita Y, Ando Y, Iejima D, Kagami H, Honda MJ, Ueda M. 2007. 
Differential inducibility of human and porcine dental pulp-derived cells into 
odontoblasts. Connect Tissue Res 48(5):229-38. 
Uematsu K, Hattori K, Ishimoto Y, Yamauchi J, Habata T, Takakura Y, Ohgushi H, 
Fukuchi T, Sato M. 2005. Cartilage regeneration using mesenchymal stem cells 
and a three-dimensional poly-lactic-glycolic acid (PLGA) scaffold. Biomaterials 
26(20):4273-9. 
Vacanti CA. 2006. History of tissue engineering and a glimpse into its future. Tissue 
Eng 12(5):1137-42. 
van den Dolder J, Bancroft GN, Sikavitsas VI, Spauwen PH, Jansen JA, Mikos AG. 
2003. Flow perfusion culture of marrow stromal osteoblasts in titanium fiber 
mesh. J Biomed Mater Res A 64(2):235-41. 
van Dijkhuizen-Radersma R, Moroni L, van Apeldoorn A, Zhang Z, Grijpma D. 2008. 
Degradable Polymers for Tissue Engineering. In: Van Blitterswijk CA, editor. 
Tissue Engineering. 1st ed. London: Elsevier Inc. p 201-204. 
Van Exan RJ, Hardy MH. 1980. A spatial relationship between innervation and the 
early differentiation of vibrissa follicles in the embryonic mouse. J Anat 131(Pt 
4):643-56. 
   Page | 230  
 
Venkat RV, Stock LR, Chalmers JJ. 1996. Study of hydrodynamics in microcarrier 
culture spinner vessels: A particle tracking velocimetry approach. Biotechnol 
Bioeng 49(4):456-66. 
Visser S, Hergenrother R, Cooper S. 1996. Polymers. In: Ratner BD HA, Schoen FJ, 
Lemons JE, editor. Biomaterials Science. San Diego: Academic Press, USA. p 
484. 
von der Mark K, Gauss V, von der Mark H, Muller P. 1977. Relationship between cell 
shape and type of collagen synthesised as chondrocytes lose their cartilage 
phenotype in culture. Nature 267(5611):531-2. 
Waddington CH. 1962. Principles of Embryology. Waddington CH, editor. Norwich: 
Jarrold and Sons Ltd. 510 p. 
Waddington CH. 1966. Principles of Development and Differentiation. Giles NH, 
Kenworthy W, Torrey JG, editors. Ontario, Canada: The Macmillan Company. 
115 p. 
Wan C, He Q, Li G. 2006. Allogenic peripheral blood derived mesenchymal stem cells 
(MSCs) enhance bone regeneration in rabbit ulna critical-sized bone defect 
model. J Orthop Res 24(4):610-8. 
Wan Y, Qu X, Lu J, Zhu C, Wan L, Yang J, Bei J, Wang S. 2004. Characterization of 
surface property of poly(lactide-co-glycolide) after oxygen plasma treatment. 
Biomaterials 25(19):4777-83. 
Wang L, Chaw CS, Yang YY, Moochhala SM, Zhao B, Ng S, Heller J. 2004. 
Preparation, characterization, and in vitro evaluation of physostigmine-loaded 
poly(ortho ester) and poly(ortho ester)/poly(D,L-lactide-co-glycolide) blend 
microspheres fabricated by spray drying. Biomaterials 25(16):3275-82. 
Weber C, Pohl S, Portner R, Wallrapp C, Kassem M, Geigle P, Czermak P. 2007. 
Expansion and Harvesting of hMSC-TERT. Open Biomed Eng J 1:38-46. 
Westerweel J. 1994. Efficient Detection of Spurious Vectors in Particle Image 
Velocimetry Data. Experiments in Fluids 16(3-4):236-247. 
Wieland M, Sittig, C., Brunette, M., Textor, M., Spencer, N.D. 1999. Measurement and 
Evaluation of the Chemical Composition and Topography of Titanium Implant 
Surfaces. In: Davies JE, editor. Bone Engineering. 1st ed. Toronto: em squared 
incorporated. p 172. 
Xin X, Hussain M, Mao JJ. 2007. Continuing differentiation of human mesenchymal 
stem cells and induced chondrogenic and osteogenic lineages in electrospun 
PLGA nanofiber scaffold. Biomaterials 28(2):316-25. 
Yagmurlu MF, Korkusuz F, Gursel I, Korkusuz P, Ors U, Hasirci V. 1999. Sulbactam-
cefoperazone polyhydroxybutyrate-co-hydroxyvalerate (PHBV) local antibiotic 
delivery system: in vivo effectiveness and biocompatibility in the treatment of 
implant-related experimental osteomyelitis. J Biomed Mater Res 46(4):494-503. 
Yan Chen GYaQC. 2002. Solid-state NMR study on the structure and mobility of the 
noncrystalline region of poly(3-hydroxybutyrate) and poly(3-hydroxybutyrate-
co-3-hydroxyvalerate). Polymer 43(7):2095. 
Yang Y-Y, Chung T-S, Bai X-L, Chan W-K. 2000. Effect of preparation conditions on 
morphology and release profiles of biodegradable polymeric microspheres 
containing protein fabricated by double-emulsion method. Chemical 
Engineering Science 55(12):2223-2236. 
Yang YY, Chung TS, Ng NP. 2001. Morphology, drug distribution, and in vitro release 
profiles of biodegradable polymeric microspheres containing protein fabricated 
   Page | 231  
 
by double-emulsion solvent extraction/evaporation method. Biomaterials 
22(3):231-41. 
Yin T, Li L. 2006. The stem cell niches in bone. J Clin Invest 116(5):1195-201. 
Ying QL, Nichols J, Evans EP, Smith AG. 2002. Changing potency by spontaneous 
fusion. Nature 416(6880):545-8. 
You J, Reilly GC, Zhen X, Yellowley CE, Chen Q, Donahue HJ, Jacobs CR. 2001. 
Osteopontin gene regulation by oscillatory fluid flow via intracellular calcium 
mobilization and activation of mitogen-activated protein kinase in MC3T3-E1 
osteoblasts. J Biol Chem 276(16):13365-71. 
Zeng L, Xiao Q, Margariti A, Zhang Z, Zampetaki A, Patel S, Capogrossi MC, Hu Y, 
Xu Q. 2006. HDAC3 is crucial in shear- and VEGF-induced stem cell 
differentiation toward endothelial cells. J Cell Biol 174(7):1059-69. 
Zeng L, Zhang Y, Chien S, Liu X, Shyy JY. 2003. The role of p53 deacetylation in 
p21Waf1 regulation by laminar flow. J Biol Chem 278(27):24594-9. 
Zhao F, Chella R, Ma T. 2007. Effects of shear stress on 3-D human mesenchymal stem 
cell construct development in a perfusion bioreactor system: Experiments and 
hydrodynamic modeling. Biotechnol Bioeng 96(3):584-95. 
Zhao F, Ma T. 2005. Perfusion bioreactor system for human mesenchymal stem cell 
tissue engineering: dynamic cell seeding and construct development. Biotechnol 
Bioeng 91(4):482-93. 
Zheng Z, Bei FF, Tian HL, Chen GQ. 2005. Effects of crystallization of 
polyhydroxyalkanoate blend on surface physicochemical properties and 
interactions with rabbit articular cartilage chondrocytes. Biomaterials 
26(17):3537-48. 
Zhu XH, Gan SK, Wang CH, Tong YW. 2007a. Proteins combination on PHBV 
microsphere scaffold to regulate Hep3B cells activity and functionality: a model 
of liver tissue engineering system. J Biomed Mater Res A 83(3):606-16. 
Zhu XH, Wang C-H, Tong YW. 2007b. Growing tissue-like constructs with 
Hep3B/HepG2 liver cells on PHBV microspheres of different sizes. Journal of 
Biomedical Materials Research Part B: Applied Biomaterials 82B(1):7-16. 
Zhu XH, Wang CH, Tong YW. 2009. In vitro characterization of hepatocyte growth 
factor release from PHBV/PLGA microsphere scaffold. J Biomed Mater Res A 
89(2):411-23. 
Zimmermann S, Voss M, Kaiser S, Kapp U, Waller CF, Martens UM. 2003. Lack of 
telomerase activity in human mesenchymal stem cells. Leukemia 17(6):1146-9. 
Zitoun KB, Sastry SK, Guezennec Y. 2001. Investigation of three dimensional 
interstitial velocity, solid motion, and orientation in solid-liquid flow using 
particle tracking velocimetry. Int J Multiphase Flow 27(8):1397-1414. 
Zuk PA, Zhu M, Ashjian P, De Ugarte DA, Huang JI, Mizuno H, Alfonso ZC, Fraser 
JK, Benhaim P, Hedrick MH. 2002. Human adipose tissue is a source of 
multipotent stem cells. Mol Biol Cell 13(12):4279-95. 
 
 
 
